<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Protease activity as a prognostic factor for wound healing in venous leg ulcers - Westby, MJ - 2018 | Cochrane Library</title> <meta content="Protease activity as a prognostic factor for wound healing in venous leg ulcers - Westby, MJ - 2018 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012841.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Protease activity as a prognostic factor for wound healing in venous leg ulcers - Westby, MJ - 2018 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012841.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD012841.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Protease activity as a prognostic factor for wound healing in venous leg ulcers" name="citation_title"/> <meta content="Maggie J Westby" name="citation_author"/> <meta content="University of Manchester, Manchester Academic Health Science Centre" name="citation_author_institution"/> <meta content="maggie.westby@manchester.ac.uk" name="citation_author_email"/> <meta content="Jo C Dumville" name="citation_author"/> <meta content="University of Manchester, Manchester Academic Health Science Centre" name="citation_author_institution"/> <meta content="Nikki Stubbs" name="citation_author"/> <meta content="St Mary's Hospital" name="citation_author_institution"/> <meta content="Gill Norman" name="citation_author"/> <meta content="University of Manchester, Manchester Academic Health Science Centre" name="citation_author_institution"/> <meta content="Jason KF Wong" name="citation_author"/> <meta content="Manchester University NHS Foundation Trust" name="citation_author_institution"/> <meta content="Nicky Cullum" name="citation_author"/> <meta content="University of Manchester, Manchester Academic Health Science Centre" name="citation_author_institution"/> <meta content="Richard D Riley" name="citation_author"/> <meta content="Keele University" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="9" name="citation_issue"/> <meta content="10.1002/14651858.CD012841.pub2" name="citation_doi"/> <meta content="2018" name="citation_date"/> <meta content="2018/09/01" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012841.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012841.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012841.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Wound Healing; Case‐Control Studies; Peptide Hydrolases [*metabolism]; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Regression Analysis; Retrospective Studies; Survival Analysis; Varicose Ulcer [*enzymology]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012841.pub2&amp;doi=10.1002/14651858.CD012841.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012841.pub2&amp;doi=10.1002/14651858.CD012841.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012841.pub2&amp;doi=10.1002/14651858.CD012841.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012841.pub2&amp;doi=10.1002/14651858.CD012841.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012841.pub2&amp;doi=10.1002/14651858.CD012841.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012841.pub2&amp;doi=10.1002/14651858.CD012841.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012841.pub2&amp;doi=10.1002/14651858.CD012841.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012841.pub2&amp;doi=10.1002/14651858.CD012841.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012841.pub2&amp;doi=10.1002/14651858.CD012841.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012841.pub2&amp;doi=10.1002/14651858.CD012841.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012841.pub2&amp;doi=10.1002/14651858.CD012841.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012841.pub2&amp;doi=10.1002/14651858.CD012841.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012841.pub2&amp;doi=10.1002/14651858.CD012841.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012841.pub2&amp;doi=10.1002/14651858.CD012841.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012841.pub2&amp;doi=10.1002/14651858.CD012841.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012841.pub2&amp;doi=10.1002/14651858.CD012841.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012841.pub2&amp;doi=10.1002/14651858.CD012841.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012841.pub2&amp;doi=10.1002/14651858.CD012841.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012841.pub2&amp;doi=10.1002/14651858.CD012841.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012841.pub2&amp;doi=10.1002/14651858.CD012841.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012841.pub2&amp;doi=10.1002/14651858.CD012841.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012841.pub2&amp;doi=10.1002/14651858.CD012841.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012841.pub2&amp;doi=10.1002/14651858.CD012841.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="FKeXZrqu";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD012841\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD012841\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012841\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012841\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ru","fr","ms","fa","zh_HANS"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD012841.pub2",title:"Protease activity as a prognostic factor for wound healing in venous leg ulcers",firstPublishedDate:"Sep 1, 2018 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Wounds Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=FKeXZrqu&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012841.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012841.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD012841.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD012841.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012841.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD012841.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD012841.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD012841.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD012841.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD012841.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>5668 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD012841.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012841.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012841.pub2/full#CD012841-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012841.pub2/full#CD012841-sec-0087"> Authors' conclusions </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012841.pub2/full#CD012841-sec-0029"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012841.pub2/full#CD012841-sec-0035"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012841.pub2/full#CD012841-sec-0036"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012841.pub2/full#CD012841-sec-0060"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012841.pub2/full#CD012841-sec-0079"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012841.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012841.pub2/appendices#CD012841-sec-0090"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012841.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012841.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/table_n/CD012841StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/table_n/CD012841StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012841.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012841.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012841.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012841.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012841.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD012841.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2018 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Prognosis</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Protease activity as a prognostic factor for wound healing in venous leg ulcers</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012841.pub2/information#CD012841-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Maggie J Westby</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012841.pub2/information#CD012841-cr-0003">Jo C Dumville</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012841.pub2/information#CD012841-cr-0004">Nikki Stubbs</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012841.pub2/information#CD012841-cr-0005">Gill Norman</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012841.pub2/information#CD012841-cr-0006">Jason KF Wong</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012841.pub2/information#CD012841-cr-0007">Nicky Cullum</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012841.pub2/information#CD012841-cr-0008">Richard D Riley</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/information/en#CD012841-sec-0137">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 01 September 2018 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD012841.pub2">https://doi.org/10.1002/14651858.CD012841.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD012841-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012841-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012841-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012841-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD012841-abs-0002">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD012841-abs-0011">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD012841-abs-0001" lang="en"> <section id="CD012841-sec-0001"> <h3 class="title" id="CD012841-sec-0001">Background</h3> <p>Venous leg ulcers (VLUs) are a common type of complex wound that have a negative impact on people's lives and incur high costs for health services and society. It has been suggested that prolonged high levels of protease activity in the later stages of the healing of chronic wounds may be associated with delayed healing. Protease modulating treatments have been developed which seek to modulate protease activity and thereby promote healing in chronic wounds. </p> </section> <section id="CD012841-sec-0002"> <h3 class="title" id="CD012841-sec-0002">Objectives</h3> <p>To determine whether protease activity is an independent prognostic factor for the healing of venous leg ulcers. </p> </section> <section id="CD012841-sec-0003"> <h3 class="title" id="CD012841-sec-0003">Search methods</h3> <p>In February 2018, we searched the following databases: Cochrane Central Register of Controlled Trials (CENTRAL), Ovid MEDLINE, Ovid Embase and CINAHL. </p> </section> <section id="CD012841-sec-0004"> <h3 class="title" id="CD012841-sec-0004">Selection criteria</h3> <p>We included prospective and retrospective longitudinal studies with any follow‐up period that recruited people with VLUs and investigated whether protease activity in wound fluid was associated with future healing of VLUs. We included randomised controlled trials (RCTs) analysed as cohort studies, provided interventions were taken into account in the analysis, and case‐control studies if there were no available cohort studies. We also included prediction model studies provided they reported separately associations of individual prognostic factors (protease activity) with healing. Studies of any type of protease or combination of proteases were eligible, including proteases from bacteria, and the prognostic factor could be examined as a continuous or categorical variable; any cut‐off point was permitted. The primary outcomes were time to healing (survival analysis) and the proportion of people with ulcers completely healed; the secondary outcome was change in ulcer size/rate of wound closure. We extracted unadjusted (simple) and adjusted (multivariable) associations between the prognostic factor and healing. </p> </section> <section id="CD012841-sec-0005"> <h3 class="title" id="CD012841-sec-0005">Data collection and analysis</h3> <p>Two review authors independently assessed studies for inclusion at each stage, and undertook data extraction, assessment of risk of bias and GRADE assessment. We collected association statistics where available. No study reported adjusted analyses: instead we collected unadjusted results or calculated association measures from raw data. We calculated risk ratios when both outcome and prognostic factor were dichotomous variables. When the prognostic factor was reported as continuous data and healing outcomes were dichotomous, we either performed regression analysis or analysed the impact of healing on protease levels, analysing as the standardised mean difference. When both prognostic factor and outcome were continuous data, we reported correlation coefficients or calculated them from individual participant data. </p> <p>We displayed all results on forest plots to give an overall visual representation. We planned to conduct meta‐analyses where this was appropriate, otherwise we summarised narratively. </p> </section> <section id="CD012841-sec-0006"> <h3 class="title" id="CD012841-sec-0006">Main results</h3> <p>We included 19 studies comprising 21 cohorts involving 646 participants. Only 11 studies (13 cohorts, 522 participants) had data available for analysis. Of these, five were prospective cohort studies, four were RCTs and two had a type of case‐control design. Follow‐up time ranged from four to 36 weeks. Studies covered 10 different matrix metalloproteases (MMPs) and two serine proteases (human neutrophil elastase and urokinase‐type plasminogen activators). Two studies recorded complete healing as an outcome; other studies recorded partial healing measures. There was clinical and methodological heterogeneity across studies; for example, in the definition of healing, the type of protease and its measurement, the distribution of active and bound protease species, the types of treatment and the reporting of results. Therefore, meta‐analysis was not performed. No study had conducted multivariable analyses and all included evidence was of very low certainty because of the lack of adjustment for confounders, the high risk of bias for all studies except one, imprecision around the measures of association and inconsistency in the direction of association. Collectively the research indicated complete uncertainty as to the association between protease activity and VLU healing. </p> </section> <section id="CD012841-sec-0007"> <h3 class="title" id="CD012841-sec-0007">Authors' conclusions</h3> <p>This review identified very low validity evidence regarding any association between protease activity and VLU healing and there is complete uncertainty regarding the relationship. The review offers information for both future research and systematic review methodology. </p> </section> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD012841-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012841-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012841-abs-0007">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012841-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD012841-abs-0006">Français</a> </li> <li class="section-language"> <a class="" href="full/ms#CD012841-abs-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/ru#CD012841-abs-0005">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD012841-abs-0012">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD012841-abs-0004" lang="en"> <h3>Protease activity and its association with future healing of venous leg ulcers</h3> <p><b>What is the aim of this review?</b> </p> <p>The aim of this Cochrane Review was to find out if there is a link between different levels of protease in venous leg ulcers (open skin wounds on the lower leg caused by problems with the way blood flows through the veins) now and the healing of wounds at some time in the future. Protease is an enzyme, a chemical naturally produced by the body that breaks down proteins and which may affect wound healing. We wanted to know whether having higher protease levels meant that wounds were less likely to heal or to heal more slowly. If so, this could help find the most useful treatments for each person with a leg ulcer. Review authors from Cochrane collected and analysed all relevant studies to answer this question and found 19 studies. </p> <p><b>Key messages</b> </p> <p>At the moment, there is complete uncertainty about any association between protease activity and venous leg ulcer healing, but this review did give pointers on what may be important for future research on natural chemicals present in wounds and their effect on healing. </p> <p><b>What was studied in the review?</b> </p> <p>Venous leg ulcers can last weeks, months or years. Leg ulcers can be painful, may become infected, and may affect mobility and quality of life. The usual treatment for venous leg ulcers is compression therapy (e.g. compression (elastic) bandages), but even this does not work for everyone (about a third of people still have wounds that have not healed after six months). We wanted to find out why these wounds often do not heal, and whether there are factors in the wound (called biomarkers) that can indicate which wounds are unlikely to heal. It has been suggested that wounds are slow to heal when there are high levels of protease. In this review, we investigated whether there was any evidence that higher protease levels at the start of a study were associated with slower healing leg ulcers or less healing at a future time point (such as six months). </p> <p>In February 2018, we searched for relevant studies that had a reliable design and that investigated links between protease levels and future healing of venous leg ulcers. We found 19 studies involving 646 people. Not all studies reported the age and sex of participants. In those that did, the average age of the participants varied from 51 to 75 years. Eleven studies gave results we could use, involving 13 groups of people. Most people had wounds that had been there for at least three months. </p> <p><b>What were the main results of the review?</b> </p> <p>There were many differences among the included studies: for example, how they defined healing, the type of proteases and how they measured them, the types of treatment and how they reported results. This lack of consistency meant we could not combine and compare the results, so we summarised the findings in a general way. </p> <p>A bigger problem was that none of the studies had analysed the data appropriately as they did not take into account the impact of age or infection or treatments, and so we could not be sure that it was the protease levels that were important for healing, rather than age or other factors. Most studies were small and could have been better conducted, so it was difficult to be sure how meaningful the results were. Overall, the certainty of the evidence was very low. Further studies are needed to explore the importance of biomarkers for wound healing. </p> <p><b>How up to date is this review?</b> </p> <p>We searched for studies that had been published up to February 2018.</p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD012841-sec-0087" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD012841-sec-0087"></div> This review of protease activity as a prognostic factor for wound healing in VLUs has demonstrated the very low validity of the evidence, which means that no reliance can be placed on the findings beyond the conclusion of total uncertainty. The review can inform future research and give pointers on the methodology of systematic reviews of biomarkers as prognostic factors for wound healing. With modern protein assessment tools and validation using an 'Omics' approach, future complex wound studies should be able to highlight the significance of many of the proteases in chronic venous leg ulcers. </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD012841-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD012841-sec-0029"></div> <section id="CD012841-sec-0030"> <h3 class="title" id="CD012841-sec-0030">Description of the condition</h3> <p>Venous leg ulcers (VLUs) are open skin ulcers (wounds) on the lower leg (from below the ankle up to mid‐calf), that can last weeks, months or years, and are a consequence of problems in either the superficial or deep veins (or both) of the legs. Damage to the valves or vein blockages results in malfunctioning of the venous system, reducing the efficient return of blood to the heart and increasing the pressure in the leg veins (<a href="./references#CD012841-bbs2-0160" title="GhauriAS , NyamekyeIK . Leg ulceration: the importance of treating the underlying pathophysiology. Phlebology2010;25(1 Suppl):42‐51. ">Ghauri 2010</a>; <a href="./references#CD012841-bbs2-0240" title="VlajinacH , MarinkovicJ , MaksimovicM , RadakD . Factors related to venous ulceration: a cross‐sectional study. Angiology2014;65(9):824‐30. ">Vlajinac 2014</a>), which, if prolonged, may result in VLUs. The precise chain of events that links the high venous pressures with skin breakdown and a chronic wound is not fully understood (<a href="./references#CD012841-bbs2-0148" title="Coleridge SmithPD , ThomasP , ScurrJH , DormandyJA . Causes of venous ulceration: a new hypothesis. BMJ1988;296(6638):1726‐7. ">Coleridge Smith 1988</a>; <a href="./references#CD012841-bbs2-0237" title="ValenciaIC , FalabellaA , KirsnerRS , EaglesteinWH . Chronic venous insufficiency and venous leg ulceration. Journal of the American Academy of Dermatology2001;44:401‐21. ">Valencia 2001</a>). Leg ulcers are frequently associated with venous disease in combination with vascular disease, which impairs arterial blood supply, and such ulcers are said to have a 'mixed aetiology' (<a href="./references#CD012841-bbs2-0196" title="MarstonW . Mixed arterial and venous ulcers. Wounds2011;23(12):351‐6. ">Marston 2011</a>). </p> <p>Accurate current estimates of leg ulcer prevalence are difficult to identify because most surveys do not differentiate between causes of leg ulceration, or do so per limb but not per participant (<a href="./references#CD012841-bbs2-0198" title="MoffattCJ , FranksPJ , DohertyDC , MartinR , BlewettR , RossF . Prevalence of leg ulceration in a London population. QJM: Monthly Journal of the Association of Physicians2004;97(7):431‐7. ">Moffatt 2004</a>; <a href="./references#CD012841-bbs2-0230" title="SrinivasaiahN , DugdallH , BarrettS , DrewPJ . A point prevalence survey of wounds in north‐east England. Journal of Wound Care2007;16(10):413‐9. ">Srinivasaiah 2007</a>; <a href="./references#CD012841-bbs2-0241" title="VowdenKR , VowdenP . The prevalence, management and outcome for acute wounds identified in a wound care survey within one English health care district. Journal of Tissue Viability2009;18(1):7‐12. ">Vowden 2009</a>). One 2011 estimate suggested that venous ulceration has a point prevalence of 0.29 cases per 1000 in the UK, whilst mixed arterial/venous leg ulceration has a point prevalence of 0.11 per 1000 (<a href="./references#CD012841-bbs2-0169" title="HallJ , BuckleyHL , LambKA , StubbsN , SaramagoP , DumvilleJC , et al. Point prevalence of complex wounds in a defined United Kingdom population. Wound Repair and Regeneration2014;22(6):694‐700. ">Hall 2014</a>). One systematic review also reported the point prevalence of leg ulcers in non‐UK studies as: 0.39 per 1000 in New Zealand in 2004, 1.4 per 1000 in Portugal in 2005 and 2.4 per 1000 in Sweden in 2008 (<a href="./references#CD012841-bbs2-0152" title="CullumN , BuckleyH , DumvilleJ , HallJ , LambK , MaddenM , et al. Wounds research for patient benefit: a 5‐year programme of research. Programme Grants for Applied Research2016;4(13):10.3310/pgfar04130. ">Cullum 2016</a>). </p> <p>Venous disease is a chronic condition characterised by periods of ulceration (i.e. an open wound) followed by healing and then recurrence, though published contemporary data are lacking: one cross‐sectional study from the 1980s reported that half of current or recent ulcers had been open for up to nine months and that 35% of people with leg ulcers had experienced four or more episodes (<a href="./references#CD012841-bbs2-0144" title="CallamMJ , HarperDR , DaleJJ , RuckleyCV . Chronic ulcer of the leg: clinical history. British Medical Journal1987;294(6584):1389‐91. ">Callam 1987</a>). This picture was supported by a subsequent (1988) cross‐sectional study (<a href="./references#CD012841-bbs2-0202" title="NelzénO , BerqvistD , LindhagenA . Venous and non‐venous leg ulcers: clinical history and appearance in a population study. British Journal of Surgery1994;81(2):182‐7. ">Nelzén 1994</a>). </p> <p>Several prognostic factors have been independently associated with slower or reduced healing of VLUs, for example, wound area, duration of ulcer, age, number of wounds, lack of mobility (especially ankle) and weight (<a href="./references#CD012841-bbs2-0134" title="AshbyRL , GabeR , AliS , AdderlyU , BlandJM , CullumNA , et al. Clinical and cost‐effectiveness of compression hosiery versus compression bandages in treatment of venous leg ulcers (Venous leg Ulcer Study IV, VenUS IV): a randomised controlled trial. Lancet2014;383(9920):871‐9. ">Ashby 2014</a>; <a href="./references#CD012841-bbs2-0139" title="BarwellJR , GhauriAS , TaylorM , DeaconJ , WakelyC , PoskittKR , et al. Risk factors for healing and recurrence of chronic venous leg ulcers. Phlebology2000;15(2):49‐52. ">Barwell 2000</a>; <a href="./references#CD012841-bbs2-0140" title="BarwellJR , TaylorM , DeaconJ , DaviesC , WhymanMR , PoskittKR . Ankle motility is a risk factor for healing of chronic venous leg ulcers. Phlebology2001;16(1):38‐40. ">Barwell 2001</a>; <a href="./references#CD012841-bbs2-0145" title="ChabyG , SenetP , GanryO , CaudronA , ThuillierD , DebureC , et al. Prognostic factors associated with healing of venous leg ulcers: a multicentre, prospective, cohort study. British Journal of Dermatology2013;169(5):1106‐13. ">Chaby 2013</a>; <a href="./references#CD012841-bbs2-0163" title="GohelMS , TaylorM , EarnshawJJ , HeatherBP , PoskittKR , WhymanMR . Risk factors for delayed healing and recurrence of chronic venous leg ulcers ‐ an analysis of 1324 legs. European Journal of Vascular and Endovascular Surgery2005;29(1):74‐7. ">Gohel 2005</a>; <a href="./references#CD012841-bbs2-0171" title="HarrisonMB , Van denKerkhofEG , HopmanWM , GrahamID , CarleyME , NelsonEA . The Canadian bandaging trial: evidence‐informed leg ulcer care and the effectiveness of two compression technologies. BMC Nursing2011;10:20. ">Harrison 2011</a>; <a href="./references#CD012841-bbs2-0181" title="IglesiasC , NelsonEA , CullumNA , TorgersonDJ , VenUS Team. VenUS I: a randomised controlled trial of two types of bandage for treating venous leg ulcers. Health Technology Assessment2004;8(29):iii, 1‐105. ">Iglesias 2004</a>; <a href="./references#CD012841-bbs2-0187" title="LantisJC2nd , MarstonWA , FarberA , KirsnerRS , ZhangY , LeeTD , et al. The influence of patient and wound variables on healing of venous leg ulcers in a randomized controlled trial of growth‐arrested allogeneic keratinocytes and fibroblasts. Journal of Vascular Surgery2013;58(2):433‐9. ">Lantis 2013</a>; <a href="./references#CD012841-bbs2-0194" title="MargolisDJ , BerlinJA , StromBL . Risk factors associated with the failure of a venous leg ulcer to heal. Archives of Dermatology1999;135(8):920‐6. ">Margolis 1999</a>; <a href="./references#CD012841-bbs2-0195" title="MargolisDJ , Allen‐TaylorL , HoffstadO , BerlinJA . The accuracy of venous leg ulcer prognostic models in a wound care system. Wound Repair and Regeneration2004;12(2):163‐8. ">Margolis 2004</a>; <a href="./references#CD012841-bbs2-0197" title="MilicDJ , ZivicSS , BogdanovicDC , KaranovicND , GolubovicZV . Risk factors related to the failure of venous leg ulcers to heal with compression treatment. Journal of Vascular Surgery2009;49(5):1242‐7. ">Milic 2009</a>; <a href="./references#CD012841-bbs2-0199" title="MoffattCJ , DohertyDC , SmithdaleR , FranksPJ . Clinical predictors of leg ulcer healing. British Journal of Dermatology2010;162(1):51‐8. ">Moffatt 2010</a>; <a href="./references#CD012841-bbs2-0223" title="ScottonMF , MiotHA , AbbadeLP . Factors that influence healing of chronic venous leg ulcers: a retrospective cohort. Anais Brasileiros de Dermatologia2014;89(3):414‐22. ">Scotton 2014</a>). </p> <p>The first‐line treatment for VLUs is compression therapy in the form of bandages, stockings or mechanical devices (<a href="./references#CD012841-bbs2-0207" title="O'MearaS , CullumN , NelsonEA , DumvilleJC . Compression for venous leg ulcers. Cochrane Database of Systematic Reviews2012, Issue 11. [DOI: 10.1002/14651858.CD000265.pub3] ">O'Meara 2012</a>). This application of external pressure around the lower leg assists venous return and reduces the pooling of blood in the legs (venous reflux) (<a href="./references#CD012841-bbs2-0158" title="FletcherJ , MoffattC , PartschH , VowdenK , VowdenP . Principles of compression in venous disease: a practitioner’s guide to treatment and prevention of venous leg ulcers. Wounds International 2013. www.woundsinternational.com/media/issues/672/files/content_10802.pdf (accessed 31 January 2018). ">Fletcher 2013</a>; <a href="./references#CD012841-bbs2-0207" title="O'MearaS , CullumN , NelsonEA , DumvilleJC . Compression for venous leg ulcers. Cochrane Database of Systematic Reviews2012, Issue 11. [DOI: 10.1002/14651858.CD000265.pub3] ">O'Meara 2012</a>). Alongside compression, dressings are almost always applied to open ulcers (<a href="./references#CD012841-bbs2-0208" title="O'MearaS , Al‐KurdiD , OlogunY , OvingtonLG , Martyn‐St JamesM , RichardsonR . Antibiotics and antiseptics for venous leg ulcers. Cochrane Database of Systematic Reviews2014, Issue 1. [DOI: 10.1002/14651858.CD003557.pub5] ">O'Meara 2014</a>). Other treatments for VLUs include venous surgery (removal of incompetent superficial veins) (<a href="./references#CD012841-bbs2-0226" title="Scottish Intercollegiate Guidelines Network (SIGN). Management of chronic venous leg ulcers. Clinical guideline 120. August 2010. www.sign.ac.uk/guidelines/fulltext/120/ (accessed 31 January 2018). ">SIGN 2010</a>), and drugs such as pentoxifylline (<a href="./references#CD012841-bbs2-0183" title="JullAB , ArrollB , ParagV , WatersJ . Pentoxifylline for treating venous leg ulcers. Cochrane Database of Systematic Reviews2012, Issue 12. [DOI: 10.1002/14651858.CD001733.pub3] ">Jull 2012</a>). </p> <p>Leg ulcers are associated with considerable cost to patients and to healthcare providers.</p> <p>Two systematic reviews summarised the literature on health‐related quality of life in people with leg ulcers (<a href="./references#CD012841-bbs2-0177" title="HerberOR , SchneppW , RiegerMA . A systematic review on the impact of leg ulceration on patients' quality of life. Health and Quality of Life Outcomes2007;5:44. ">Herber 2007</a>; <a href="./references#CD012841-bbs2-0211" title="PersoonA , HeinenMM , Van derVleutenCJ , DeRoojiMJ , Van deKerkhofPC , VanAchterbergT . Leg ulcers: a review of their impact on daily life. Journal of Clinical Nursing2004;13(3):341‐54. ">Persoon 2004</a>). Both included qualitative and quantitative evaluations, and reported that presence of leg ulceration was associated with pain, restriction of work and leisure activities, impaired mobility, sleep disturbance, reduced psychological well‐being and social isolation. Ulcers can be painful, malodorous, prone to infection, and may severely affect people's mobility and quality of life (<a href="./references#CD012841-bbs2-0156" title="DumvilleJC , WorthyG , SoaresMO , BlandJM , CullumN , DowsonC , et al. VenUS II: a randomised controlled trial of larval therapy in the management of leg ulcers. Health Technology Assessment2009;13(55):1‐182; iii‐iv. ">Dumville 2009</a>; <a href="./references#CD012841-bbs2-0177" title="HerberOR , SchneppW , RiegerMA . A systematic review on the impact of leg ulceration on patients' quality of life. Health and Quality of Life Outcomes2007;5:44. ">Herber 2007</a>). In severe cases, ulceration can lead to limb amputation, though this is more likely in people who also have arterial insufficiency (<a href="./references#CD012841-bbs2-0156" title="DumvilleJC , WorthyG , SoaresMO , BlandJM , CullumN , DowsonC , et al. VenUS II: a randomised controlled trial of larval therapy in the management of leg ulcers. Health Technology Assessment2009;13(55):1‐182; iii‐iv. ">Dumville 2009</a>; <a href="./references#CD012841-bbs2-0203" title="NelzénO . Prevalence of venous leg ulcer: the importance of the data collection method. Phlebolymphology2008;15(4):143‐50. ">Nelzén 2008</a>; <a href="./references#CD012841-bbs2-0237" title="ValenciaIC , FalabellaA , KirsnerRS , EaglesteinWH . Chronic venous insufficiency and venous leg ulceration. Journal of the American Academy of Dermatology2001;44:401‐21. ">Valencia 2001</a>), or even to a type of cancer known as Marjolin's ulcer (<a href="./references#CD012841-bbs2-0146" title="ChoaR , RayattS , MahtaniK . Marjolin's ulcer. BMJ2015;350:h3997. ">Choa 2015</a>). Research suggested that people with complex wounds, including people with VLUs, commonly see complete ulcer healing as the most important outcome to them (<a href="./references#CD012841-bbs2-0193" title="MaddenM . Is research in chronic wound care focusing on the outcomes that matter most to patients?. British Sociological Association Annual Conference: Changing Society; 2014 Apr 23‐25; Leeds, UK. 2014:232. ">Madden 2014</a>). </p> <p>The financial cost of treating a person with an open VLU in the UK was estimated at around GBP 1700 per year at 2012 prices: the largest component of ulcer treatment cost is nursing time (<a href="./references#CD012841-bbs2-0134" title="AshbyRL , GabeR , AliS , AdderlyU , BlandJM , CullumNA , et al. Clinical and cost‐effectiveness of compression hosiery versus compression bandages in treatment of venous leg ulcers (Venous leg Ulcer Study IV, VenUS IV): a randomised controlled trial. Lancet2014;383(9920):871‐9. ">Ashby 2014</a>). Another evaluation estimated the mean cost of treating a person with a VLU in Sweden as between EUR 1332 and EUR 2585 (based on costs for material for dressing changes) and in the UK as between EUR 814 and EUR 1994 (price year 2002), with higher costs associated with larger and more chronic wounds (<a href="./references#CD012841-bbs2-0215" title="Ragnarson TennvallG , HjelmgrenJ . Annual costs of treatment for venous leg ulcers in Sweden and the United Kingdom. Wound Repair and Regeneration2005;13(1):13‐8. ">Ragnarson Tennvall 2005</a>). Data from one German study, which estimated total costs including those classified as indirect or intangible costs, estimated mean annual costs of treating leg ulcers as EUR 9060 per person (2006 evaluation). This figure was higher than other estimates because it included non‐health service costs to the person and to society (<a href="./references#CD012841-bbs2-0136" title="AugustinM , BrocattiLK , RustenbachSJ , SchaferI , HerbergerK . Cost‐of‐illness of leg ulcers in the community. International Wound Journal2012;11(3):283‐92. ">Augustin 2012</a>). One Australian cost‐effectiveness study of 905 people estimated the mean cost per person per week for treatment of a chronic leg or foot ulcer below the knee for 24 weeks was AUD 53.31 (which corresponds to AUD 2772 per year); costs included consultations with healthcare professionals, compression bandaging, other dressings and treatments, and community care services, such as Meals‐on‐Wheels and home help (<a href="./references#CD012841-bbs2-0164" title="GravesN , FinlaysonK , GibbM , O'ReillyM , EdwardsH . Modelling the economic benefits of gold standard care for chronic wounds in a community setting. Wound Practice and Research2014;22(3):163‐8. ">Graves 2014</a>). </p> <p>Research has shown that not all VLUs heal, even under trial conditions: one large study of 453 participants showed that about 30% of VLUs did not heal following first‐line treatment with compression therapy over 12 months (<a href="./references#CD012841-bbs2-0134" title="AshbyRL , GabeR , AliS , AdderlyU , BlandJM , CullumNA , et al. Clinical and cost‐effectiveness of compression hosiery versus compression bandages in treatment of venous leg ulcers (Venous leg Ulcer Study IV, VenUS IV): a randomised controlled trial. Lancet2014;383(9920):871‐9. ">Ashby 2014</a>). There is interest in additional treatments that may improve wound healing, and one dressing option is the use of protease‐modulating dressings, which are suggested to reduce the activity of a group of enzymes known as proteases. As discussed below, it is thought that prolonged and elevated activity of proteases may be a feature of non‐healing wounds, such that appropriate use of protease‐modulating dressings could promote healing. However, evidence for the effectiveness of these dressings in VLUs is largely unclear (<a href="./references#CD012841-bbs2-0242" title="WestbyMJ , NormanG , DumvilleJC , StubbsN , CullumN . Protease‐modulating matrix treatments for healing venous leg ulcers. Cochrane Database of Systematic Reviews2016, Issue 12. [DOI: 10.1002/14651858.CD011918.pub2] ">Westby 2016</a>). Such dressings are a new development in wound care in that they are intended to be a 'targeted' treatment aimed at wounds with high protease activity. In this context, protease activity dictates subsequent treatment, but there is limited evidence supporting the use of a test‐and‐treat approach (<a href="./references#CD012841-bbs2-0205" title="NormanG , WestbyMJ , StubbsN , DumvilleJC , CullumN . A 'test and treat' strategy for elevated wound protease activity for healing in venous leg ulcers. Cochrane Database of Systematic Reviews2016, Issue 1. [DOI: 10.1002/14651858.CD011753] ">Norman 2016</a>). In fact, the prognostic nature of protease levels in relation to wound healing is unclear and this will be the focus of this Cochrane Review. </p> </section> <section id="CD012841-sec-0031"> <h3 class="title" id="CD012841-sec-0031">Description of the prognostic factor</h3> <p>A prognostic factor is any measure that, among people with a given health condition, is associated with a future clinical outcome; for example, in people with a VLU, lower body mass index (BMI) may be associated with less time to healing. The prognostic factor for this review was a biomarker, protease activity, which is sometimes elevated in open wounds. A biomarker is defined by the National Institutes of Health Biomarkers Definitions Working Group (1999) as "a characteristic that is objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention" (<a href="./references#CD012841-bbs2-0143" title="Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clinical Pharmacology and Therapeutics2001;69(3):89‐95. ">Biomarkers Definitions Working Group 2001</a>). Biomarkers are medical signs, as opposed to medical symptoms (which are indications of health or illness perceived by patients themselves) (<a href="./references#CD012841-bbs2-0234" title="StrimbuK , TavelJA . What are biomarkers?. Current Opinion in HIV and AIDS2010;5(6):463‐6. ">Strimbu 2010</a>). Biomarkers may predict health outcomes, but do not necessarily do so. However, there are still no accepted definitive biomarkers for making assessments of chronic wounds (<a href="./references#CD012841-bbs2-0209" title="PatelS , MaheshwariA , ChandraA . Biomarkers for wound healing and their evaluation. Journal of Wound Care2016;25(1):46‐55. ">Patel 2016</a>; <a href="./references#CD012841-bbs2-0244" title="YagerDR , KulinaRA , GilmanLA . Wound fluids: a window Into the wound environment?. International Journal of Lower Extremity Wounds2007;6(4):262‐72. ">Yager 2007</a>). </p> <p>One possible biomarker type that has received some attention for wounds is proteases, which are enzymes that break down proteins into peptides and amino acids (<a href="./references#CD012841-bbs2-0227" title="SittampalamGS , CoussensNP , BrimacombeK , GrossmanA , ArkinM , AuldD , et al. editor(s) . Protease assays. Assay guidance manual. Updated 20 November 2017. www.ncbi.nlm.nih.gov/books/NBK53196/pdf/Bookshelf_NBK53196.pdf (accessed 31 January 2018). ">Sittampalam 2017</a>); in general, the various wound‐related proteases break down different proteins. The principal proteases involved in the wound healing process are the matrix metalloproteinases (MMPs) and the serine proteases, which break down extracellular matrix (ECM) and connective tissue proteins such as collagen and elastin (<a href="./references#CD012841-bbs2-0168" title="HahmG , GlaserJJ , ElsterEA . Biomarkers to predict wound healing: the future of complex war wound management. Plastic and Reconstructive Surgery2011;127(1 Suppl):21‐6S. ">Hahm 2011</a>; <a href="./references#CD012841-bbs2-0186" title="LadwigGP , RobsonMC , LiuR , KuhnMA , MuirDF , SchultzGS . Ratios of activated matrix metalloproteinase‐9 to tissue inhibitor of matrix metalloproteinase‐1 in wound fluids are inversely correlated with healing of pressure ulcers. Wound Repair and Regeneration2002;10(1):26‐37. ">Ladwig 2002</a>; <a href="./references#CD012841-bbs2-0076" title="McCartySM , PercivalSL . Proteases and delayed wound healing. Advances in Wound Care2013;2(8):438‐47. ">McCarty 2013</a>; <a href="./references#CD012841-bbs2-0084" title="NwomehBC , LiangHX , CohenIK , YagerDR . MMP‐8 is the predominant collagenase in healing wounds and nonhealing ulcers. Journal of Surgical Research1999;81(2):189‐95. ">Nwomeh 1999</a>; <a href="./references#CD012841-bbs2-0238" title="VelnarT , BaileyT , SmrkoljV . The wound healing process: an overview of the cellular and molecular mechanisms. Journal of International Medical Research2009;37(5):1528‐42. ">Velnar 2009</a>). This protein breakdown is thought to be important in the early stages of the healing process because it facilitates movement of inflammatory cells into the injury site, which aids removal of unwanted material and bacteria. However, in the later stages of wound healing, protein breakdown is believed to be undesirable because the proteases damage newly formed tissue, preventing completion of healing (<a href="./references#CD012841-bbs2-0076" title="McCartySM , PercivalSL . Proteases and delayed wound healing. Advances in Wound Care2013;2(8):438‐47. ">McCarty 2013</a>; <a href="./references#CD012841-bbs2-0238" title="VelnarT , BaileyT , SmrkoljV . The wound healing process: an overview of the cellular and molecular mechanisms. Journal of International Medical Research2009;37(5):1528‐42. ">Velnar 2009</a>). </p> <p>Proteases are produced by an inflammatory process, which also inhibits the synthesis of chemicals that inhibit the action of metalloproteinases (tissue inhibitors of metalloproteinases; TIMPs). Some studies have measured the ratio of MMPs and TIMPs as a biomarker (<a href="./references#CD012841-bbs2-0076" title="McCartySM , PercivalSL . Proteases and delayed wound healing. Advances in Wound Care2013;2(8):438‐47. ">McCarty 2013</a>; <a href="./references#CD012841-bbs2-0201" title="MullerM , TrocmeC , LardyB , MorelF , HalimiS , BenhamouPY . Matrix metalloproteinases and diabetic foot ulcers: the ratio of MMP‐1 to TIMP‐1 is a predictor of wound healing. Diabetic Medicine2008;25(4):419‐26. ">Muller 2008</a>), and it may be more valuable to consider the balance of proteases and their inhibitors as a biomarker (<a href="./references#CD012841-bbs2-0191" title="LöffekS , SchillingO , FranzkeCW . Series 'matrix metalloproteinases in lung health and disease': biological role of matrix metalloproteinases: a critical balance. European Respiratory Journal2011;38(1):191‐208. ">Löffek 2011</a>; <a href="./references#CD012841-bbs2-0244" title="YagerDR , KulinaRA , GilmanLA . Wound fluids: a window Into the wound environment?. International Journal of Lower Extremity Wounds2007;6(4):262‐72. ">Yager 2007</a>). </p> <p>MMPs are divided into seven subtypes on the basis of their substrates and their domain structure (chemical components) (<a href="./references#CD012841-bbs2-0188" title="LazaroJL , IzzoV , MeaumeS , DaviesAH , LobmannR , UccioliL . Elevated levels of matrix metalloproteinases and chronic wound healing: an updated review of clinical evidence. Journal of Wound Care2016;25(5):277‐87. ">Lazaro 2016</a>; <a href="./references#CD012841-bbs2-0191" title="LöffekS , SchillingO , FranzkeCW . Series 'matrix metalloproteinases in lung health and disease': biological role of matrix metalloproteinases: a critical balance. European Respiratory Journal2011;38(1):191‐208. ">Löffek 2011</a>; <a href="./references#CD012841-bbs2-0239" title="VihinenP , KähäriVM . Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets. International Journal of Cancer2002;99(2):157‐66. ">Vihinen 2002</a>): gelatinases (MMP‐2 and MMP‐9); collagenases (MMP‐1, MMP‐8, MMP‐13); stromelysins (MMP‐3, MMP‐10, MMP‐11); metalloelastase (MMP‐12); matrilysins (MMP‐7, MMP‐26); membrane‐type MMPs (MMP‐14, MMP‐15, MMP‐16, MMP‐17, MMP‐24, MMP‐25); and other MMPs (MMP‐19, MMP‐20, MMP‐23, MMP‐28). The main serine proteases are mast cell tryptase and chymase, plasmin, human neutrophil elastase (HNE), cathepsin G, urokinase‐type plasminogen activators (uPA) and tissue‐type plasminogen activators (t‐PA) (<a href="./references#CD012841-bbs2-0165" title="Grøndahl‐HansenJ , LundLR , RalfkiaerE , OttevangerV , DanøK . Urokinase‐ and tissue‐type plasminogen activators in keratinocytes during wound reepithelialization in vivo. Journal of Investigative Dermatology1988;90(6):790‐5. ">Grøndahl‐Hansen 1988</a>). Other protease biomarkers include modular proteins that combine proteases with other biological species: for example, the families of A disintegrin and metalloproteinase (ADAMs) (<a href="./references#CD012841-bbs2-0155" title="DuffyMJ , McKiernanE , O'DonovanN , McGowanPM . The role of ADAMs in disease pathophysiology. Clinica Chimica Acta2009;403(1‐2):31‐6. ">Duffy 2009</a>; <a href="./references#CD012841-bbs2-0157" title="EdwardsDR , HandsleyMM , PenningtonCJ . The ADAM metalloproteinases. Molecular Aspects of Medicine2008;29(5):258‐89. ">Edwards 2008</a>), and A disintegrin and metalloproteinase with thrombospondin motifs (ADAMTSs) (<a href="./references#CD012841-bbs2-0184" title="KelwickR , DesanlisI , WheelerGN , EdwardsDR . The ADAMTS (A Disintegrin and Metalloproteinase with Thrombospondin motifs) family. Genome Biology2015;16:113. ">Kelwick 2015</a>). Chronic wounds also contain proteases associated with several types of bacteria (<a href="./references#CD012841-bbs2-0075" title="McCartySM , CochraneCA , CleggPD , PercivalSL . The role of endogenous and exogenous enzymes in chronic wounds: a focus on the implications of aberrant levels of both host and bacterial proteases in wound healing. Wound Repair and Regeneration2012;20(2):125‐36. ">McCarty 2012</a>; <a href="./references#CD012841-bbs2-0076" title="McCartySM , PercivalSL . Proteases and delayed wound healing. Advances in Wound Care2013;2(8):438‐47. ">McCarty 2013</a>; <a href="./references#CD012841-bbs2-0210" title="PercivalSL , HillKE , WilliamsDW , HooperSJ , ThomasDW , CostertonJW . A review of the scientific evidence for biofilms in wounds. Wound Repair and Regeneration2012;20(5):647‐57. ">Percival 2012</a>; <a href="./references#CD012841-bbs2-0225" title="SibbaldRG , Contreras‐RuizJ , CouttsP , FierhellerM , RothmanA , WooK . Bacteriology, inflammation, and healing: a study of nanocrystalline silver dressings in chronic venous leg ulcers. Advances in Skin &amp; Wound Care2007;20(10):549‐58. ">Sibbald 2007</a>; <a href="./references#CD012841-bbs2-0235" title="SulemanL . Extracellular bacterial proteases in chronic wounds: a potential therapeutic target?. Advances in Wound Care2016;5(10):455‐63. ">Suleman 2016</a>). The activity level for each protease may be elevated at different stages of healing and there may also be different levels of activity in infected wounds (<a href="./references#CD012841-bbs2-0104" title="SerraR , GrandeR , BuffoneG , MolinariV , PerriP , PerriA , et al. Extracellular matrix assessment of infected chronic venous leg ulcers: role of metalloproteinases and inflammatory cytokines. International Wound Journal2016;13(1):53‐8. ">Serra 2016a</a>), but there is currently insufficient evidence to differentiate proteases according to their function in the unhealed wound (<a href="./references#CD012841-bbs2-0024" title="AmatoB , CorettiG , CompagnaR , AmatoM , BuffoneG , GigliottiD , et al. Role of matrix metalloproteinases in non‐healing venous ulcers. International Wound Journal2015;12(6):641‐5. ">Amato 2015</a>; <a href="./references#CD012841-bbs2-0188" title="LazaroJL , IzzoV , MeaumeS , DaviesAH , LobmannR , UccioliL . Elevated levels of matrix metalloproteinases and chronic wound healing: an updated review of clinical evidence. Journal of Wound Care2016;25(5):277‐87. ">Lazaro 2016</a>; <a href="./references#CD012841-bbs2-0214" title="RaffettoJD . Pathophysiology of wound healing and alterations in venous leg ulcers ‐ review. Phlebology2016;31(1S):56‐62. ">Raffetto 2016</a>; <a href="./references#CD012841-bbs2-0106" title="SerraR , GallelliL , ButricoL , BuffoneG , CalioFG , DeCaridiG , et al. From varices to venous ulceration: the story of chronic venous disease described by metalloproteinases. International Wound Journal2017;14(1):233‐40. ">Serra 2017</a>). </p> <p>Protease activity can be measured in wound fluid using various biochemical tests. Laboratory‐based scientific studies have used several different techniques, including approaches that primarily detect MMP‐2 and MMP‐9 (gelatin zymography), and methods that detect enzyme activity using either chemical (e.g. quenched fluorescence substrate hydrolysis) or biological antibody‐based methods (enzyme‐linked immunosorbent assays (ELISAs)) (<a href="./references#CD012841-bbs2-0170" title="HardingK , ArmstrongDG , BarrettS , KaufmanH , Lázaro‐MartínezJL , MayerD , et al. International consensus. The role of proteases in wound diagnostics: an expert working group review. Wounds International 2011. woundchek.com/uploads/downloads/consensus_documents/Role‐of‐proteases‐in‐wound‐diagnostics‐International.pdf (accessed 31 January 2018). ">Harding 2011</a>; <a href="./references#CD012841-bbs2-0076" title="McCartySM , PercivalSL . Proteases and delayed wound healing. Advances in Wound Care2013;2(8):438‐47. ">McCarty 2013</a>; <a href="./references#CD012841-bbs2-0227" title="SittampalamGS , CoussensNP , BrimacombeK , GrossmanA , ArkinM , AuldD , et al. editor(s) . Protease assays. Assay guidance manual. Updated 20 November 2017. www.ncbi.nlm.nih.gov/books/NBK53196/pdf/Bookshelf_NBK53196.pdf (accessed 31 January 2018). ">Sittampalam 2017</a>). A range of methods of obtaining wound fluid has been used and these vary with the type of protease measured (<a href="./references#CD012841-bbs2-0151" title="CullenBM , inventor , Ethicon , Inc , assignee . Monitoring of wounds by measurement of protease and protease inhibitor levels in wound fluids. United States patent US 20080132468.March 2006. ">Cullen 2006</a>; <a href="./references#CD012841-bbs2-0213" title="QuirkS , TyrellDJ , inventors , Kimberley ClarkWorldwide , Inc , assignee . Sensors and methods of detection for proteinase enzymes. United States patent US 20030119073.June 2003. ">Quirk 2003</a>; <a href="./references#CD012841-bbs2-0019" title="TrengoveNJ , StaceyMC , MacauleyS , BennettN , GibsonJ , BurslemF , et al. Analysis of the acute and chronic would environments: the role of proteases and their inhibitors. Wound Repair and Regeneration1999;7(6):442‐52. ">Trengove 1999</a>; <a href="./references#CD012841-bbs2-0244" title="YagerDR , KulinaRA , GilmanLA . Wound fluids: a window Into the wound environment?. International Journal of Lower Extremity Wounds2007;6(4):262‐72. ">Yager 2007</a>). There is also a commercial colorimetric indicator available, which is said to determine protease activity, giving a colour change if activity is elevated above a threshold; the test uses a weighted average of the activity of elastase and one or more MMPs (<a href="./references#CD012841-bbs2-0162" title="GibsonM , BayliffSW , CullenBM , inventors , Systagenix Wound Management IPCo , assignee . Wound prognosis. United States patent US 20140045761.February 2014. ">Gibson 2014</a>; <a href="./references#CD012841-bbs2-0204" title="National Institute for Health and Care Excellence (NICE). Woundchek Protease Status for assessing elevated protease status in chronic wounds. Medtech innovation briefing [MIB83]. October 2016. www.nice.org.uk/advice/mib83 (accessed 31 January 2018). ">NICE 2016</a>). </p> </section> <section id="CD012841-sec-0032"> <h3 class="title" id="CD012841-sec-0032">How the prognostic factor may be related to health outcomes</h3> <p>It has been suggested that, in chronic ulcers generally, non‐healing may be associated with prolonged high activity of proteases in the wound in the later stages of the wound healing process (<a href="./references#CD012841-bbs2-0170" title="HardingK , ArmstrongDG , BarrettS , KaufmanH , Lázaro‐MartínezJL , MayerD , et al. International consensus. The role of proteases in wound diagnostics: an expert working group review. Wounds International 2011. woundchek.com/uploads/downloads/consensus_documents/Role‐of‐proteases‐in‐wound‐diagnostics‐International.pdf (accessed 31 January 2018). ">Harding 2011</a>; <a href="./references#CD012841-bbs2-0172" title="HartJ , SilcockD , GunnigleS , CullenB , LightND , WattPW . The role of oxidised regenerated cellulose/collagen in wound repair: effects in vitro on fibroblast biology and in vivo in a model of compromised healing. International Journal of Biochemistry and Cell Biology2002;34(12):1557‐70. ">Hart 2002</a>; <a href="./references#CD012841-bbs2-0076" title="McCartySM , PercivalSL . Proteases and delayed wound healing. Advances in Wound Care2013;2(8):438‐47. ">McCarty 2013</a>; <a href="./references#CD012841-bbs2-0086" title="PalolahtiM , LauharantaJ , StephensRW , KuuselaP , VaheriA . Proteolytic activity in leg ulcer exudate. Experimental Dermatology1993;2(1):29‐37. ">Palolahti 1993</a>). </p> <p>Proteases are active in all phases of wound healing (haemostasis, inflammation, proliferation and remodelling) and are therefore thought to have a number of roles in the normal wound healing process (<a href="./references#CD012841-bbs2-0209" title="PatelS , MaheshwariA , ChandraA . Biomarkers for wound healing and their evaluation. Journal of Wound Care2016;25(1):46‐55. ">Patel 2016</a>; <a href="./references#CD012841-bbs2-0019" title="TrengoveNJ , StaceyMC , MacauleyS , BennettN , GibsonJ , BurslemF , et al. Analysis of the acute and chronic would environments: the role of proteases and their inhibitors. Wound Repair and Regeneration1999;7(6):442‐52. ">Trengove 1999</a>; <a href="./references#CD012841-bbs2-0238" title="VelnarT , BaileyT , SmrkoljV . The wound healing process: an overview of the cellular and molecular mechanisms. Journal of International Medical Research2009;37(5):1528‐42. ">Velnar 2009</a>). It is thought that there is a burst of protease activity at the start of acute wound healing, and that in normally healing wounds, the activity peaks in the first few days and then declines to very low levels by one week, as healing progresses (<a href="./references#CD012841-bbs2-0170" title="HardingK , ArmstrongDG , BarrettS , KaufmanH , Lázaro‐MartínezJL , MayerD , et al. International consensus. The role of proteases in wound diagnostics: an expert working group review. Wounds International 2011. woundchek.com/uploads/downloads/consensus_documents/Role‐of‐proteases‐in‐wound‐diagnostics‐International.pdf (accessed 31 January 2018). ">Harding 2011</a>; <a href="./references#CD012841-bbs2-0206" title="NwomehBC , LiangHX , DiegelmannRF , CohenIK , YagerDR . Dynamics of the matrix metalloproteinases MMP‐1 and MMP‐8 in acute open human dermal wounds. Wound Repair and Regeneration1998;6(2):127‐34. ">Nwomeh 1998</a>). </p> <p>However, in non‐healing wounds, it is thought that high protease activity may arise through two main routes (involving different types of proteases): relating to both the host cells (human) and to bacteria in the wound. It is thought that the two types of protease activity may reinforce each other (have a synergistic mechanism) (<a href="./references#CD012841-bbs2-0075" title="McCartySM , CochraneCA , CleggPD , PercivalSL . The role of endogenous and exogenous enzymes in chronic wounds: a focus on the implications of aberrant levels of both host and bacterial proteases in wound healing. Wound Repair and Regeneration2012;20(2):125‐36. ">McCarty 2012</a>; <a href="./references#CD012841-bbs2-0076" title="McCartySM , PercivalSL . Proteases and delayed wound healing. Advances in Wound Care2013;2(8):438‐47. ">McCarty 2013</a>; <a href="./references#CD012841-bbs2-0210" title="PercivalSL , HillKE , WilliamsDW , HooperSJ , ThomasDW , CostertonJW . A review of the scientific evidence for biofilms in wounds. Wound Repair and Regeneration2012;20(5):647‐57. ">Percival 2012</a>; <a href="./references#CD012841-bbs2-0225" title="SibbaldRG , Contreras‐RuizJ , CouttsP , FierhellerM , RothmanA , WooK . Bacteriology, inflammation, and healing: a study of nanocrystalline silver dressings in chronic venous leg ulcers. Advances in Skin &amp; Wound Care2007;20(10):549‐58. ">Sibbald 2007</a>; <a href="./references#CD012841-bbs2-0235" title="SulemanL . Extracellular bacterial proteases in chronic wounds: a potential therapeutic target?. Advances in Wound Care2016;5(10):455‐63. ">Suleman 2016</a>). In the host, complex inflammatory mechanisms may result in proteases reaching higher levels and persisting for longer than in normally healing wounds (<a href="./references#CD012841-bbs2-0076" title="McCartySM , PercivalSL . Proteases and delayed wound healing. Advances in Wound Care2013;2(8):438‐47. ">McCarty 2013</a>; <a href="./references#CD012841-bbs2-0019" title="TrengoveNJ , StaceyMC , MacauleyS , BennettN , GibsonJ , BurslemF , et al. Analysis of the acute and chronic would environments: the role of proteases and their inhibitors. Wound Repair and Regeneration1999;7(6):442‐52. ">Trengove 1999</a>). As previously noted, this persistent breakdown of proteins (proteolytic activity) is thought to damage newly formed tissue and to degrade growth factors, leading to non‐healing wounds (<a href="./references#CD012841-bbs2-0150" title="CullenB , SmithR , McCullochE , SilcockD , MorrissonL . Mechanism of action of PROMOGRAN, a protease modulating matrix, for the treatment of diabetic foot ulcers. Wound Repair and Regeneration2002;10(1):16‐25. ">Cullen 2002a</a>; <a href="./references#CD012841-bbs2-0170" title="HardingK , ArmstrongDG , BarrettS , KaufmanH , Lázaro‐MartínezJL , MayerD , et al. International consensus. The role of proteases in wound diagnostics: an expert working group review. Wounds International 2011. woundchek.com/uploads/downloads/consensus_documents/Role‐of‐proteases‐in‐wound‐diagnostics‐International.pdf (accessed 31 January 2018). ">Harding 2011</a>; <a href="./references#CD012841-bbs2-0126" title="WlaschekM , PeusD , AchterbergV , Meyer‐IngoldW , Scharffetter‐KochanekK . Protease inhibitors protect growth factor activity in chronic wounds. British Journal of Dermatology1997;137(4):646. ">Wlaschek 1997</a>; <a href="./references#CD012841-bbs2-0243" title="YagerDR , ChenSM , WardSI , OlutoyeOO , DiegelmannRF , CohenIK . Ability of chronic wound fluids to degrade peptide growth factors is associated with increased levels of elastase activity and diminished levels of proteinase inhibitors. Wound Repair and Regeneration1997;5(1):23‐32. ">Yager 1997</a>). Most chronic wounds are colonised with bacteria, though they are not necessarily infected. Bacterial proliferation and their formation into film‐like material (biofilms) in non‐healing wounds has been linked to chronic inflammation and then elevated protease levels. Infection refers to invasion of tissue by bacteria, leading to a clinically evident pathogenic inflammatory response and tissue damage (<a href="./references#CD012841-bbs2-0210" title="PercivalSL , HillKE , WilliamsDW , HooperSJ , ThomasDW , CostertonJW . A review of the scientific evidence for biofilms in wounds. Wound Repair and Regeneration2012;20(5):647‐57. ">Percival 2012</a>; <a href="./references#CD012841-bbs2-0212" title="PuglieseDJ . Infection in venous leg ulcers: considerations for optimal management in the elderly. Drugs &amp; Aging2016;33(2):87‐96. ">Pugliese 2016</a>; <a href="./references#CD012841-bbs2-0225" title="SibbaldRG , Contreras‐RuizJ , CouttsP , FierhellerM , RothmanA , WooK . Bacteriology, inflammation, and healing: a study of nanocrystalline silver dressings in chronic venous leg ulcers. Advances in Skin &amp; Wound Care2007;20(10):549‐58. ">Sibbald 2007</a>; <a href="./references#CD012841-bbs2-0235" title="SulemanL . Extracellular bacterial proteases in chronic wounds: a potential therapeutic target?. Advances in Wound Care2016;5(10):455‐63. ">Suleman 2016</a>). </p> <p>Limited evidence suggests correlations between elevated levels of MMPs and delayed healing in people with pressure ulcers (<a href="./references#CD012841-bbs2-0186" title="LadwigGP , RobsonMC , LiuR , KuhnMA , MuirDF , SchultzGS . Ratios of activated matrix metalloproteinase‐9 to tissue inhibitor of matrix metalloproteinase‐1 in wound fluids are inversely correlated with healing of pressure ulcers. Wound Repair and Regeneration2002;10(1):26‐37. ">Ladwig 2002</a>), or in foot ulcers of people with diabetes (<a href="./references#CD012841-bbs2-0189" title="LiuY , MinD , BoltonT , NubéV , TwiggSM , YueDK , et al. Increased matrix metalloproteinase‐9 predicts poor wound healing in diabetic foot ulcers. Diabetes Care2009;32(1):117‐9. ">Liu 2009</a>), as well as in people with VLUs (<a href="./references#CD012841-bbs2-0013" title="MwauraB , MahendranB , HynesN , DefreitasD , AvalosG , AdegbolaT , et al. The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase‐2, tissue inhibitor of matrix metalloproteinase‐2 and PDGF‐AA on the chronicity of venous leg ulcers. European Journal of Vascular and Endovascular Surgery2006;31(3):306‐10. ">Mwaura 2006</a>; <a href="./references#CD012841-bbs2-0015" title="SerraR , BuffoneG , FalconeD , MolinariV , ScaramuzzinoM , GallelliL , et al. Chronic venous leg ulcers are associated with high levels of metalloproteinases‐9 and neutrophil gelatinase‐associated lipocalin. Wound Repair and Regeneration2013;21(3):395‐401. ">Serra 2013</a>). It is possible that association of MMP level with delayed wound healing may be a general wound phenomenon, however differences between wound types have also been observed (<a href="./references#CD012841-bbs2-0188" title="LazaroJL , IzzoV , MeaumeS , DaviesAH , LobmannR , UccioliL . Elevated levels of matrix metalloproteinases and chronic wound healing: an updated review of clinical evidence. Journal of Wound Care2016;25(5):277‐87. ">Lazaro 2016</a>; <a href="./references#CD012841-bbs2-0076" title="McCartySM , PercivalSL . Proteases and delayed wound healing. Advances in Wound Care2013;2(8):438‐47. ">McCarty 2013</a>). </p> <p>For VLUs in particular, studies of protease activity in wound fluid have suggested that there are significantly higher levels of proteases in ulcer tissue compared with healthy tissue, and that these levels decrease following compression treatment in wounds that heal (<a href="./references#CD012841-bbs2-0141" title="BeidlerSK , DouilletCD , BerndtDF , KeagyBA , RichPB , MarstonWA . Multiplexed analysis of matrix metalloproteinases in leg ulcer tissue of patients with chronic venous insufficiency before and after compression therapy. Wound Repair and Regeneration2008;16(5):642‐8. ">Beidler 2008</a>); other studies have reported higher levels in chronic wounds compared with acute wounds (<a href="./references#CD012841-bbs2-0188" title="LazaroJL , IzzoV , MeaumeS , DaviesAH , LobmannR , UccioliL . Elevated levels of matrix metalloproteinases and chronic wound healing: an updated review of clinical evidence. Journal of Wound Care2016;25(5):277‐87. ">Lazaro 2016</a>; <a href="./references#CD012841-bbs2-0019" title="TrengoveNJ , StaceyMC , MacauleyS , BennettN , GibsonJ , BurslemF , et al. Analysis of the acute and chronic would environments: the role of proteases and their inhibitors. Wound Repair and Regeneration1999;7(6):442‐52. ">Trengove 1999</a>; <a href="./references#CD012841-bbs2-0127" title="WysockiAB , Staiano‐CoicoL , GrinnellF . Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP‐2 and MMP‐9. Journal of Investigative Dermatology1993;101(1):64‐8. ">Wysocki 1993</a>). </p> <p>However, association between protease activity and non‐healing is not clear cut. Limited data from two industry‐sponsored studies found that only 28% of 162 (<a href="./references#CD012841-bbs2-0224" title="SerenaT , CullenB , BayliffS , GibsonM , DeMarcoD , GalbraithJ , et al. Protease activity levels associated with healing status of chronic wounds. 2011. www.woundchek.com/uploads/downloads/posters_articles/Protease‐Activity‐Levels‐Associated‐with‐Healing‐Status‐of‐Chronic‐Wounds.pdf (accessed 31 January 2018). ">Serena 2011</a>) and 23% of 139 (<a href="./references#CD012841-bbs2-0161" title="GibsonM , SerenaTE , BartleC , BayliffS , ClarkJ , CullenB , et al. Testing chronic wounds for EPA. The benefits of testing all wounds, whether assessed as healing or non‐healing. www.wounds‐uk.com/pdf/cases_11013_199.pdf (accessed 31 January 2018). ">Gibson 2013</a>) non‐healing wounds of mixed aetiology had high protease activity; one of these studies reported that 22% of 101 leg ulcers had elevated protease activity (<a href="./references#CD012841-bbs2-0161" title="GibsonM , SerenaTE , BartleC , BayliffS , ClarkJ , CullenB , et al. Testing chronic wounds for EPA. The benefits of testing all wounds, whether assessed as healing or non‐healing. www.wounds‐uk.com/pdf/cases_11013_199.pdf (accessed 31 January 2018). ">Gibson 2013</a>). </p> <p>Wound fluid is a useful source of biomarkers, and its composition is broadly assumed to reflect the current clinical condition of a wound (<a href="./references#CD012841-bbs2-0192" title="LöfflerMW , SchusterH , BühlerS , BeckertS . Wound fluid in diabetic foot ulceration: more than just an undefined soup?. International Journal of Lower Extremity Wounds2013;12(2):113‐29. ">Löffler 2013</a>). Wound fluid can be obtained in a largely non‐invasive way, but to give reproducible and accurate measurement of biomarkers, the wound fluid has to be collected and processed reliably. There are several techniques for wound fluid sampling, including the use of occlusive dressings, entrapment of fluid in dressings, swabs, other techniques and devices. The duration of fluid collection can also be important (<a href="./references#CD012841-bbs2-0192" title="LöfflerMW , SchusterH , BühlerS , BeckertS . Wound fluid in diabetic foot ulceration: more than just an undefined soup?. International Journal of Lower Extremity Wounds2013;12(2):113‐29. ">Löffler 2013</a>). </p> </section> <section id="CD012841-sec-0033"> <h3 class="title" id="CD012841-sec-0033">Importance of evidence about prognostic factors</h3> <p>Biomarkers of this type may potentially be implicated in, or mediate, particular pathways to non‐healing. Studying the prognosis associated with protease biomarkers has a three‐fold purpose: first, it can help us understand mechanisms related to healing, including investigating the true causes of non‐healing. Second, it can allow identification of wounds at increased risk of non‐healing, which could allow selective treatment of these wounds according to the specific biomarker type and level. Third, biomarkers can be used to monitor a response to therapy (<a href="./references#CD012841-bbs2-0219" title="RileyRD , HaydenJA , SteyerbergEW , MoonsKG , AbramsK , KyzasPA , et al. Prognosis research strategy (PROGRESS) 2: prognostic factor research. PLoS Medicine2013;10(2):e1001380. ">Riley 2013</a>). </p> <p>Targeted treatment of this type (the 'test‐and‐treat' or 'stratified medicine' approach) is important, especially if treatments are costly or have adverse effects, so that they are not used where they will not be effective (<a href="./references#CD012841-bbs2-0179" title="HingoraniAD , Van derWindtDA , RileyRD , AbramsK , MoonsKG , SteyerbergEW , et al. Prognosis research strategy (PROGRESS) 4: stratified medicine research. BMJ2013;346:e5793. ">Hingorani 2013</a>). It is likely that there is more than one pathway to non‐healing and other pathways will probably be represented by other biomarkers. The best approach may be to determine a set of biomarkers and treat selectively according to their activity levels. </p> <p>A commercial test for protease activity is now available (<a href="./references#CD012841-bbs2-0162" title="GibsonM , BayliffSW , CullenBM , inventors , Systagenix Wound Management IPCo , assignee . Wound prognosis. United States patent US 20140045761.February 2014. ">Gibson 2014</a>), and is intended for use at the point of care, in conjunction with protease‐modulating treatments (<a href="./references#CD012841-bbs2-0138" title="BarrettS , DavisL , EdwardsJ , FletcherJ , HardingK , JackL , et al. Protease diagnostic in wound care: round‐table meeting. Wounds UK2011;7(4 Suppl):3‐10. ">Barrett 2011</a>; <a href="./references#CD012841-bbs2-0170" title="HardingK , ArmstrongDG , BarrettS , KaufmanH , Lázaro‐MartínezJL , MayerD , et al. International consensus. The role of proteases in wound diagnostics: an expert working group review. Wounds International 2011. woundchek.com/uploads/downloads/consensus_documents/Role‐of‐proteases‐in‐wound‐diagnostics‐International.pdf (accessed 31 January 2018). ">Harding 2011</a>; <a href="./references#CD012841-bbs2-0228" title="SnyderRJ , DriverV , FifeCE , LantisJ , PeirceB , SerenaT , et al. Using a diagnostic tool to identify elevated protease activity levels in chronic and stalled wounds: a consensus panel discussion. Ostomy/Wound Management2011;57(12):36‐46. ">Snyder 2011</a>; <a href="./references#CD012841-bbs2-0229" title="SnyderRJ , CullenB , NisbetLT . An audit to assess the perspectives of US wound care specialists regarding the importance of proteases in wound healing and wound assessment. International Wound Journal2013;10(6):653‐60. ">Snyder 2013</a>). This approach has mainly found application in diabetic foot ulcers (<a href="./references#CD012841-bbs2-0204" title="National Institute for Health and Care Excellence (NICE). Woundchek Protease Status for assessing elevated protease status in chronic wounds. Medtech innovation briefing [MIB83]. October 2016. www.nice.org.uk/advice/mib83 (accessed 31 January 2018). ">NICE 2016</a>). A Cochrane Review on test‐and‐treat for healing in VLUs did not identify any studies (<a href="./references#CD012841-bbs2-0205" title="NormanG , WestbyMJ , StubbsN , DumvilleJC , CullumN . A 'test and treat' strategy for elevated wound protease activity for healing in venous leg ulcers. Cochrane Database of Systematic Reviews2016, Issue 1. [DOI: 10.1002/14651858.CD011753] ">Norman 2016</a>). </p> </section> <section id="CD012841-sec-0034"> <h3 class="title" id="CD012841-sec-0034">Why it is important to do this review?</h3> <p>VLUs are a common type of complex wound that have a negative impact on people's lives and incur high costs for health services and society. Leg ulcers are painful, sometimes malodorous, prone to infection and may severely affect the person's mobility and quality of life; in severe cases, there is a risk of limb amputation. There are a number of treatments for VLUs, but many ulcers prove hard to heal. </p> <p>Two Cochrane Reviews investigated protease‐modulating matrix (PMM) dressings, but there was insufficient evidence on the modulation of protease activity. <a href="./references#CD012841-bbs2-0242" title="WestbyMJ , NormanG , DumvilleJC , StubbsN , CullumN . Protease‐modulating matrix treatments for healing venous leg ulcers. Cochrane Database of Systematic Reviews2016, Issue 12. [DOI: 10.1002/14651858.CD011918.pub2] ">Westby 2016</a> examined the effects of PMM dressings for healing VLUs, and found it was unclear whether PMM dressings increased the probability of healing at 12 weeks, in comparison with non‐PMM dressings (risk ratio (RR) 1.28, 95% confidence interval (CI) 0.95 to 1.71; 4 trials; 192 participants). The study populations typically comprised people with difficult‐to‐heal wounds, but only one study reported the level of protease. A second review searched for evidence on 'test‐and‐treat' approaches for healing VLUs; for example, PMM treatment given selectively to wounds with elevated protease activity (<a href="./references#CD012841-bbs2-0205" title="NormanG , WestbyMJ , StubbsN , DumvilleJC , CullumN . A 'test and treat' strategy for elevated wound protease activity for healing in venous leg ulcers. Cochrane Database of Systematic Reviews2016, Issue 1. [DOI: 10.1002/14651858.CD011753] ">Norman 2016</a>). It found no eligible studies. This current review is the third part of this set of Cochrane Reviews on protease activity‐related treatment. </p> <p>It is important to investigate whether elevated protease activity is a prognostic factor for healing. For practical use, the biomarker should be robust to adjustment for other factors such as age. This Cochrane Review was mainly exploratory in nature and its focus was on protease activity in general; it did not address associations of specific proteases, although we reported the actual proteases measured. </p> <p>One literature review summarised clinical evidence on MMPs in chronic wound healing (<a href="./references#CD012841-bbs2-0188" title="LazaroJL , IzzoV , MeaumeS , DaviesAH , LobmannR , UccioliL . Elevated levels of matrix metalloproteinases and chronic wound healing: an updated review of clinical evidence. Journal of Wound Care2016;25(5):277‐87. ">Lazaro 2016</a>). The authors reported studies that found correlations between MMP levels and various measures of healing, but did not give full quantitative data. They identified some studies investigating MMP thresholds for healing but these were in people with diabetic foot ulcers. The review did not examine the literature on proteases other than MMPs. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD012841-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD012841-sec-0035"></div> <p>To determine whether protease activity is an independent prognostic factor for wound healing in people with venous leg ulcers. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD012841-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD012841-sec-0036"></div> <p>The methods used in this review have two underlying assumptions: first, that biomarkers are representative of wound processes and can be used to monitor wound healing. Second, that the removal of wound fluid does not interfere with the healing processes (<a href="./references#CD012841-bbs2-0244" title="YagerDR , KulinaRA , GilmanLA . Wound fluids: a window Into the wound environment?. International Journal of Lower Extremity Wounds2007;6(4):262‐72. ">Yager 2007</a>). It is unclear how robust these assumptions are. </p> <section id="CD012841-sec-0037"> <h3 class="title" id="CD012841-sec-0037">PICOTS system for this review (population, index, comparator, outcome(s), timing, setting) </h3> <p>The PICOTS summary for this review was:</p> <p> <div class="table" id="CD012841-tblf-0001"> <table> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Index (prognostic factor under study)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Timing</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Setting</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>People with venous leg ulcers</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Protease activity</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Healing:</p> <p> <ul id="CD012841-list-0001"> <li> <p>time to healing (survival analysis)</p> </li> <li> <p>proportion of people with ulcers completely healed</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prognosis:</p> <p> <ul id="CD012841-list-0002"> <li> <p>any follow‐up period for outcome measurement (predicted 8‐24 weeks)</p> </li> <li> <p>prognostic factor measured at baseline, representing time of wound assessment</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Any</p> </td> </tr> </tbody> </table> </div> </p> <p>We used the PICOTS system to formulate the review question, the objective and the inclusion criteria for the review (<a href="./references#CD012841-bbs2-0153" title="DebrayTP , DamenJA , SnellKI , EnsorJ , HooftL , ReitsmaJB , et al. A guide to systematic review and meta‐analysis of prediction model performance. BMJ2017;356:i6460. ">Debray 2017</a>; <a href="./references#CD012841-bbs2-0200" title="MoonsKG , DeGrootJA , BouwmeesterW , VergouweY , MallettS , AltmanDG , et al. Critical appraisal and data extraction for systematic reviews of prediction modelling studies: the CHARMS checklist. PLoS Medicine2014;11(10):e1001744. ">Moons 2014</a>), the comparator was not relevant in our review. Further details are given below. </p> </section> <section id="CD012841-sec-0038"> <h3 class="title" id="CD012841-sec-0038">Criteria for considering studies for this review</h3> <section id="CD012841-sec-0039"> <h4 class="title">Types of studies</h4> <p>We included reports of prospective and retrospective longitudinal studies that investigated whether the prognostic factor, protease activity, was associated with healing of VLUs, as such studies can produce valid odds or hazard ratios of prognostic factors. We did not include studies that solely examined the validation of prediction models, but we did include prediction model development studies when they also reported associations of individual prognostic factors (protease activity) with the outcome under study (healing). We included randomised controlled trials (RCTs) analysed as cohort studies, provided interventions were taken into account in the analysis. We included case‐control studies only if there were no relevant eligible cohort studies for specific proteases. We included case‐control studies because the design can provide valid estimates of associations between a prognostic factor and outcomes provided that the follow‐up time is not too long. However, we acknowledge that case‐control studies often suffer from other deficiencies (<a href="./references#CD012841-bbs2-0133" title="AltmanDG . Systematic reviews of evaluations of prognostic variables. BMJ2001;323:224‐8. ">Altman 2001</a>): these were assessed in our risk of bias assessment. We did not include cross‐sectional studies or case reports because the association under study is inherently longitudinal. We included studies with any follow‐up period, given the prognostic nature of our objective. </p> <p>We planned to consider evidence separately within the different phases of prognostic factor investigation: phase 1 (exploratory), and phase 2 (confirmatory) studies, which provide different levels of evidence (<a href="./references#CD012841-bbs2-0173" title="HaydenJA , CôtéP , SteenstraIA , BombardierC , for the QUIPS‐LBP Working Group. Identifying phases of investigation helps planning, appraising, and applying the results of explanatory prognosis studies. Journal of Clinical Epidemiology2008;61(6):552‐60. ">Hayden 2008</a>; <a href="./references#CD012841-bbs2-0219" title="RileyRD , HaydenJA , SteyerbergEW , MoonsKG , AbramsK , KyzasPA , et al. Prognosis research strategy (PROGRESS) 2: prognostic factor research. PLoS Medicine2013;10(2):e1001380. ">Riley 2013</a>). Exploratory studies identify associations of many potential prognostic factors and outcomes. These studies measure associations between single factors and the outcome ('univariable' or 'univariate' associations), and provide the least conclusive information regarding the independence of a variable as a valid prognostic factor. Confirmatory studies aim to measure the independent effect of a prognostic factor on the relevant outcome while controlling for other factors. We planned to include all eligible studies in the review and, if possible, planned to restrict the results summary and any meta‐analyses to results from multivariable analyses. Where this was not possible, we included the results of univariable analyses, taking into account the phase of investigation in both the risk of bias assessment and GRADE rating on certainty of the summary estimates. </p> </section> <section id="CD012841-sec-0040"> <h4 class="title">Targeted population</h4> <p>We included studies of people with a VLU, who were managed in any care setting and receiving any type of treatment. We expected the method of diagnosis of venous ulceration to vary, so accepted definitions as used in the included studies. </p> <p>We included studies in people with VLUs alongside people with other types of wounds (e.g. arterial ulcers, pressure ulcers, diabetic foot ulcers) provided the results for people with venous ulcers were presented separately, or if most participants (at least 75%) had leg ulcers of venous aetiology. Where wounds were described only as leg ulcers without information as to aetiology, we assumed they were venous in origin because this is the most common type of leg ulcer. </p> <p>We included studies that involved participants at any stage in their treatment pathway, and we recorded, where available, baseline data on the time since diagnosis and treatments previously given, together with ongoing treatments. We included studies that involved participants with any infection status at baseline and recorded any available data on this. </p> <p>We excluded studies conducted solely in vitro and animal studies.</p> </section> <section id="CD012841-sec-0041"> <h4 class="title">Types of prognostic factor</h4> <p>The prognostic factor was protease activity. Any type of protease or combination of proteases was eligible, either from the host or from bacteria, including: </p> <p> <ul id="CD012841-list-0003"> <li> <p>MMPs: gelatinases (MMP‐2 and MMP‐9); collagenases (MMP‐1, MMP‐8 and MMP‐13); stromelysins (MMP‐3, MMP‐10 and MMP‐11); metalloelastase (MMP‐12); matrilysins (MMP‐7 and MMP‐26); membrane‐type MMPs (MMP‐14, MMP‐15, MMP‐16, MMP‐17, MMP‐24 and MMP‐25); and other MMPs (MMP‐19, MMP‐20, MMP‐23 and MMP‐28); </p> </li> <li> <p>serine proteases: mast cell tryptases and chymases; human nucleophil elastase; cathepsin G; plasmin; uPA; t‐PA; </p> </li> <li> <p>proteases combined with other biological species: ADAM; ADAMTS.</p> </li> </ul> </p> <p>Where possible, we combined these three major categories in the analyses, taking into consideration cut‐off points used (see 'Data synthesis' section below). </p> <p>We planned to include and report separately studies that investigated as biomarkers the ratio of proteases and their respective inhibitors (e.g. MMP‐2 (protease) and TIMP‐2 (inhibitor)). </p> <p>The prognostic factor could be examined as a continuous or categorical variable and any cut‐off point was permitted. </p> <p>We permitted any approach to obtaining samples from wounds, and any method of measurement of protease activity. We did not include measures of proteases in the blood or in tissue samples (biopsies). </p> <p>We reported all unadjusted (simple) associations between the prognostic factor and healing and planned to report adjusted (multivariable) associations between the prognostic factor and healing, with details on any adjustment factors used, especially taking into consideration key adjustment factors of age and infection. No studies conducted multivariable analyses, and for some studies, we calculated unadjusted associations from raw data (e.g. mean and standard deviations of protease levels for healed and non‐healed wounds). </p> </section> <section id="CD012841-sec-0042"> <h4 class="title">Types of outcomes</h4> <section id="CD012841-sec-0043"> <h5 class="title">Primary outcomes</h5> <p>We planned to include the following primary outcomes:</p> <p> <ul id="CD012841-list-0004"> <li> <p>time to healing (analysed by survival analysis);</p> </li> <li> <p>proportion of people with ulcers completely healed, at any follow‐up duration.</p> </li> </ul> </p> <p>We planned to consider subgroup analyses to explore the impact of follow‐up time. We accepted study authors' definitions of what constituted a healed wound. </p> <p>We recorded study‐reported associations and extracted raw data to calculate univariate associations. Binary outcomes would preferably have been reported as time‐to‐event measures (survival), but failing that, we considered dichotomous summary data at the longest time point or the key time point specified in the study's methods section. </p> </section> <section id="CD012841-sec-0044"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD012841-list-0005"> <li> <p>Change in size of ulcer/rate of wound closure (e.g. centimetres squared per day).</p> </li> </ul> </p> <p>If there were no ulcer healing data for a particular association, we planned to use data on the change (and percentage change) in ulcer size, with adjustment for baseline size. We did not contact study authors to request adjusted means when not presented. Where studies reported change in ulcer size without adjustment for baseline size, we analysed the results and assigned high risk of bias to the outcome measurement domain. </p> <p>For continuous outcomes, we reported either continuous summary data or dichotomous data with any cut‐off point. </p> </section> </section> </section> <section id="CD012841-sec-0045"> <h3 class="title" id="CD012841-sec-0045">Search methods for identification of studies</h3> <p>We developed a search strategy based only on population terms and protease terms. We considered adding prognosis filters, but this review concerned only one type of biomarker and the number of records identified was manageable without the use of filters. Therefore, we followed the procedure recommended by <a href="./references#CD012841-bbs2-0159" title="GeersingG‐J , BouwmeesterW , ZuithoffP , SpijkerR , LeeflangM , MoonsK . Search filters for finding prognostic and diagnostic prediction studies in Medline to enhance systematic reviews. PLoS ONE2012;7(2):e32844. ">Geersing 2012</a>. </p> <p>We searched the following databases:</p> <p> <ul id="CD012841-list-0006"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL) (2018, Issue 2);</p> </li> <li> <p>Ovid MEDLINE (1946 to February 2018);</p> </li> <li> <p>Ovid Embase (1974 to February 2018);</p> </li> <li> <p>CINAHL (1982 to February 2018).</p> </li> </ul> </p> <p>The search strategies are in <a href="./appendices#CD012841-sec-0091">Appendix 1</a>. </p> <p>In addition, we handsearched the bibliographies of all included studies and of identified relevant systematic reviews. </p> </section> <section id="CD012841-sec-0046"> <h3 class="title" id="CD012841-sec-0046">Data collection</h3> <p>We collected and analysed data according to methods stated in the published protocol (<a href="./references#CD012841-bbs2-0245" title="WestbyMJ , DumvilleJC , StubbsN , NormanG , WongJK , CullumN , et al. Protease activity as a prognostic factor for wound healing in venous leg ulcers. Cochrane Database of Systematic Reviews2017, Issue 10. [DOI: 10.1002/14651858.CD012841] ">Westby 2017</a>), which were based on the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012841-bbs2-0178" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>) and guidance from the Cochrane Prognosis Methods Group (<a href="./references#CD012841-bbs2-0147" title="Cochrane Prognosis Methods Group. Review tools. https://methods.cochrane.org/prognosis/sites/methods.cochrane.org.prognosis/files/public/uploads/protocol_template_prognosis_reviews.doc (accessed 13 July 2018). ">Cochrane Prognosis Methods Group 2018</a>; <a href="./references#CD012841-bbs2-0216" title="RileyRD , RidleyG , WilliamsK , AltmanDG , HaydenJ , DeVetHC . Prognosis research: toward evidence‐based results and a Cochrane methods group. Journal of Clinical Epidemiology2007;60:863e866. ">Riley 2007</a>). </p> <section id="CD012841-sec-0047"> <h4 class="title">Selection of studies</h4> <p>Two review authors independently assessed the titles and abstracts of retrieved records against the inclusion criteria. We obtained all potentially relevant studies in full and two review authors independently assessed these for eligibility. We resolved any disagreements at each stage through discussion and, where appropriate, we consulted a third review author. We did not contact the study authors to resolve the uncertainty. Where studies were reported in multiple publications/reports, we obtained all publications. Whilst we included a study only once in the review, we extracted data from all reports to ensure we obtained all available relevant data. We collated multiple reports of the same study, so that each study rather than each report was the unit of interest in the review. The study selection process is illustrated in a PRISMA diagram, see <a href="#CD012841-fig-0001">Figure 1</a>. All studies excluded after full‐text assessment are listed in a <a href="./references#CD012841-sec-0144" title="">Characteristics of excluded studies</a> table with their reasons for exclusion. </p> <div class="figure" id="CD012841-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD012841-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/image_n/nCD012841-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD012841-sec-0048"> <h4 class="title">Data extraction and management</h4> <p>We collected all association data reported between the prognostic factor and outcomes, with details on any adjustment factors used. Where necessary, we extracted raw data that would allow calculation of association measures. </p> <p>We extracted and recorded data from included studies using an Excel‐based data extraction sheet, which we piloted initially on a few studies. We based the Items extracted on the CHARMS guidance (<a href="./references#CD012841-bbs2-0200" title="MoonsKG , DeGrootJA , BouwmeesterW , VergouweY , MallettS , AltmanDG , et al. Critical appraisal and data extraction for systematic reviews of prediction modelling studies: the CHARMS checklist. PLoS Medicine2014;11(10):e1001744. ">Moons 2014</a>). One review author extracted data, which was then checked by a second review author. We did not contact the study authors if key data were missing from reports, because the overall risk of bias was too high. </p> <p>We extracted the following data for the prespecified prognostic factors and outcomes in this review. We collected outcome data as described in the 'Types of outcome measures' section: </p> <p> <ul id="CD012841-list-0007"> <li> <p>country and setting in which study was conducted;</p> </li> <li> <p>study design;</p> </li> <li> <p>eligibility criteria;</p> </li> <li> <p>participant details;</p> </li> <li> <p>ulcer details, including duration of ulcer, ulcer size, number of ulcers and ulcer history, and ulcer severity (with the system used to classify this) as reported by the study authors; </p> </li> <li> <p>treatment details, including compression and debridement (including type and frequency);</p> </li> <li> <p>method of obtaining wound fluid for prognostic factor measurement, including duration of collection; </p> </li> <li> <p>method of measurement of protease activity (e.g. Gelatin zymography);</p> </li> <li> <p>details of each prognostic factor: type of protease/combination of factors, measurement of prognostic factor (including time of measurement), type of data (e.g. continuous/any cut‐off points and if so, whether they were predefined and what the justification was for that cut‐off point); </p> </li> <li> <p>details of each outcome: measurement, type of data (e.g. continuous/any cut‐off points);</p> </li> <li> <p>duration of follow‐up;</p> </li> <li> <p>type of analysis: explanatory/confirmatory (including the presence of a predefined protocol and study registration); logistic regression/Cox regression; </p> </li> <li> <p>any adjustment factors considered in the analysis;</p> </li> <li> <p>association statistics for each prognostic factor for primary and secondary outcomes (e.g. odds ratios (ORs), hazard ratios (HRs) and their CIs/variances/standard errors); </p> </li> <li> <p>loss to follow‐up and reasons.</p> </li> </ul> </p> <p>We extracted minimal data where there were no association data reported.</p> </section> <section id="CD012841-sec-0049"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors independently appraised the included studies using a standardised approach. In the case of discrepancies, the review authors attempted to reach consensus; if necessary, a third review author resolved any disagreements. The review authors were not blinded to study authors, institution or journal of publication because this was not feasible. </p> <p>We planned to assess risk of bias using an approach based on the Quality In Prognosis Studies (QUIPS) tool, which is appropriate for prognostic factor review questions (<a href="./references#CD012841-bbs2-0174" title="HaydenJA , Van derWindtDA , CartwrightJL , CôtéP , BombardierC . Assessing bias in studies of prognostic factors. Annals of Internal Medicine2013;158(4):280‐6. ">Hayden 2013</a>; <a href="./references#CD012841-bbs2-0175" title="HaydenJA , TougasME , RileyR , IlesR , PincusT . Individual recovery expectations and prognosis of outcomes in non‐specific low back pain: prognostic factor exemplar review. Cochrane Database of Systematic Reviews2014, Issue 9. [DOI: 10.1002/14651858.CD011284] ">Hayden 2014</a>), also drawing on ROBINS I tool (<a href="./references#CD012841-bbs2-0220" title="The ROBINS‐I tool (Risk Of Bias In Non‐randomized Studies ‐ of Interventions). sites.google.com/site/riskofbiastool/welcome/home (accessed 31 January 2018). ">ROBINS‐I 2017</a>), which assesses the risk of bias for non‐randomised intervention studies (<a href="./references#CD012841-bbs2-0233" title="SterneJA , HernánMA , ReevesBC , SavovićJ , BerkmanND , ViswanathanM , et al. ROBINS‐I: a tool for assessing risk of bias in non‐randomised studies of interventions. BMJ2016;355:i4919. [DOI: 10.1136/bmj.i4919] ">Sterne 2016</a>). However, because of the absence of multivariable analyses in all studies. we modified the approach (see below). </p> <section id="CD012841-sec-0050"> <h5 class="title">Original approach</h5> <p>Our original approach to risk of bias assessment is described fully in <a href="./appendices#CD012841-sec-0096">Appendix 2</a>. This approach assesses risk of bias per study for each prognostic factor–outcome combination, considering six domains: study participation (selection bias), study attrition, prognostic factor measurement, outcome measurement, adjustment, and statistical analysis and reporting. To assess the adjustment bias domain, we identified key adjustment factors, both from review of the literature and in discussion with clinicians (<a href="./appendices#CD012841-sec-0122">Appendix 3</a>). </p> <p>Each domain is rated as having high, moderate or low risk of bias. We defined an all‐domain risk of bias per study for each prognostic factor–outcome combination, taking into account all the above domains, but especially focusing on the key domains of selection bias, study attrition, adjustment, and statistical analysis and reporting. As a guide, we assigned risk of bias as follows: low risk of bias if all (or all key) domains had low risk of bias; moderate risk of bias if there was high risk of bias for one key domain or moderate risk of bias for at least two key domains (with the rest as low risk of bias); high risk of bias if there was high risk of bias for at least two key domains. We planned to perform sensitivity analysis considering only studies at low all‐domain risk of bias (<a href="./references#CD012841-bbs2-0174" title="HaydenJA , Van derWindtDA , CartwrightJL , CôtéP , BombardierC . Assessing bias in studies of prognostic factors. Annals of Internal Medicine2013;158(4):280‐6. ">Hayden 2013</a>). </p> </section> <section id="CD012841-sec-0051"> <h5 class="title">Post‐hoc modified approach</h5> <p>In view of the lack of multivariable analysis in all the studies, we modified post‐hoc the QUIPS risk of bias assessment for domain 6 (statistical analysis and reporting) to avoid 'triple‐counting' the univariate features of the studies which are also addressed in the GRADE approach and in QUIPS domain 5 (adjustment factors) (see <a href="./appendices#CD012841-sec-0096">Appendix 2</a>; <a href="./appendices#CD012841-sec-0125">Appendix 4</a>). The GRADE approach to prognostic factor reviews assigns a moderate rating to phase 1 exploratory studies or other studies reporting univariable associations or having sufficient data to calculate associations. Domain 5 of QUIPS (adjustment) assigns high risk of bias if key adjustment factors were not taken into account in the design or the analysis. We modified the assessment of risk of bias for domain 6 so that if a well‐designed, appropriately analysed and well‐reported exploratory (univariate) study was described, a low risk of bias was assigned for this domain. For all other studies, we assigned moderate or high risk of bias to that domain, taking into account the aim of the study and the impact of interventions, as well as the other factors in <a href="./appendices#CD012841-sec-0096">Appendix 2</a>. </p> </section> </section> <section id="CD012841-sec-0052"> <h4 class="title">Measures of association</h4> <p>We planned to extract all unadjusted and adjusted measures of association from included studies and to convert effect sizes, as necessary, to avoid possible selection bias, thus allowing us to use data from as many studies as possible. </p> <p>We had anticipated that results from multivariable analyses would have been reported as ORs, RRs and HRs and, if so, we would have used ORs as the common measure of the association, using RRs and HRs to estimate ORs at a particular time point (<a href="./references#CD012841-bbs2-0236" title="SymonsMJ , MooreDT . Hazard rate ratio and prospective epidemiological studies. Journal of Clinical Epidemiology2002;55(9):893‐9. ">Symons 2002</a>). However, none of the included studies reported adjusted measures for binary healing outcomes, but some studies provided sufficient raw data to allow us to calculate associations. </p> <p> <ul id="CD012841-list-0008"> <li> <p>Where both the healing outcomes and prognostic factors were reported as dichotomous variables (e.g. elevated and non‐elevated protease activities for complete healing), we formed 2 × 2 tables and analysed these data as the RR. </p> </li> <li> <p>Where the prognostic factors were reported as continuous variables and individual participant data (IPD) were given and the outcome was dichotomous, we conducted a univariate regression analysis in STATA (<a href="./references#CD012841-bbs2-0231" title="StataCorp LLC. Stata data analysis and statistical software. Version 13. College Station, TX: StataCorp LLC, 2013. ">STATA 2013</a>). </p> </li> <li> <p>Where there were summary data, we extracted the mean and standard deviation protease activity for each healing outcome state. To obtain an indication of possible associations between protease activity and healing, we conducted a t‐test to record associations between healing at the follow‐up time (as an independent variable) and protease levels at baseline (as the dependent variable) (i.e. we investigated the reverse association). </p> </li> </ul> </p> <p>Where the outcomes were reported as continuous measures (e.g. change in ulcer size) and the prognostic factor was a dichotomous variable, we planned to analyse the regression coefficients with their standard errors or to conduct a simple t‐test. If both outcome and prognostic factor were continuous variables, we extracted (or calculated) Pearson correlation coefficients and P values and calculated CIs (<a href="./references#CD012841-bbs2-0190" title="LowryR . The confidence interval of rho. vassarstats.net/rho.html (accessed 31 January 2018). ">Lowry 2018</a>). </p> <p>For consistency, we recalculated associations to be in the same direction, as necessary, with associations above 1 indicating better prognosis for positive binary outcomes (e.g. a healed wound). We did not contact study authors regarding missing or unusable data. </p> </section> <section id="CD012841-sec-0053"> <h4 class="title">Unit of analysis issues</h4> <p>The prognostic factor (protease activity) and outcome (complete wound healing) were both considered at the ulcer level. A possible unit of analysis issue could have arisen when there was more than one ulcer per person and multivariable analysis was conducted with adjustment factors measured at the individual level (e.g. age). This represents clustered data and analyses should be conducted using hierarchical methods. Where studies included clustered data of this type, we planned to report this, noting whether data were analysed correctly, recording this as part of the risk of bias assessment. We planned to consider including such studies in any meta‐analysis, taking into account the associated risk of bias. No studies clearly included more than one wound per participant. </p> </section> <section id="CD012841-sec-0054"> <h4 class="title">Dealing with missing data</h4> <p>We included studies that investigated the relationship between protease activity and healing regardless of whether there were missing data and even if limited evidence was provided about the size of the effect (e.g. if the factor was mentioned only as being ’non‐significant’ in the analyses). We did not contact study authors to attempt to retrieve any missing information. </p> </section> <section id="CD012841-sec-0055"> <h4 class="title">Assessment of heterogeneity</h4> <p>We considered the clinical heterogeneity of included studies based on the population, measure of the prognostic factor, cut‐off points used, outcome measurement and methodological heterogeneity due to study design/potential biases. We planned to synthesise associations as appropriate within clinically relevant subgroups, grouping studies regardless of type of protease, duration of ulcer and presence of infection. We planned to examine the duration of ulcer and presence of infection in subgroup analyses where there was heterogeneity. </p> </section> <section id="CD012841-sec-0056"> <h4 class="title">Assessment of reporting deficiencies</h4> <p>We planned to examine publication bias for each meta‐analysis, provided there were 10 or more studies, by visually examining asymmetry on funnel plots and testing for asymmetry at the 10% level, using Egger's test for HRs, and Peters' test for ORs (<a href="./references#CD012841-bbs2-0154" title="DebrayTP , MoonsCG , RileyRD . Detecting small‐study effects and funnel plot asymmetry in meta‐analysis of survival data: a comparison of new and existing tests. Research Synthesis Methods.2018;9:41–50. ">Debray 2018</a>; <a href="./references#CD012841-bbs2-0232" title="SterneJA , EggerM , MoherD . Chapter 10: Addressing reporting biases. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Sterne 2011</a>). </p> </section> <section id="CD012841-sec-0057"> <h4 class="title">Data synthesis</h4> <p>Synthesising data in prognostic factor studies requires us to recognise the many different ways of reporting and analysing results, and, where possible, to request alternative data or to transform results to a common format (see 'Measures of association' section). We planned to consider the impact of data transformations using sensitivity analyses. </p> <p>We had expected that most studies would present data in the format of dichotomous outcome data and continuous prognostic factor data (e.g. protease activity), which may have been dichotomised or categorised using cut‐off values . </p> <p>After carrying out any appropriate transformations, where possible we grouped together studies with similar prognostic factor cut‐off points/similar analytical approaches, and represented the data on forest plots. We had planned to conduct meta‐analyses if valid data were available assessing associations between individual prognostic factors and an outcome of interest for sufficiently homogeneous subgroups of studies. We defined 'sufficiently homogeneous' subgroups according to population, measures of the prognostic factor and outcome measurement. However, we considered all data to be at too high a risk of bias to pool. We had planned to include in the forest plots details of any adjustment factors considered in the study analyses, but instead gave other relevant details in the footnotes. </p> <p>We planned to combine the data for all proteases, regardless of the source or type of protease mainly because of a lack of evidence to inform stratification. For prognostic factors analysed as dichotomous measures, we planned additionally to take cut‐off points into consideration as described above. We planned to analyse separately ratios of proteases and their inhibitors. </p> <p>If meta‐analysis had been conducted, we would have analysed HRs and ORs separately (at similar follow‐up points). We also planned to transform the measures, where possible, so that a single analysis (OR) could have been conducted. We planned to conduct meta‐regression analysis if there were more than 10 studies providing sufficient data (<a href="./references#CD012841-bbs2-0142" title="BerkeyCS , HoaglinDC , MostellerF , ColditzGA . A random‐effects regression model for meta‐analysis. Statistics in Medicine1995;14:395‐411. ">Berkey 1995</a>). We planned to conduct meta‐analyses using STATA (StataCorp version 14) with a random‐effects restricted maximum likelihood (REML) meta‐analysis model, which accounts for any between‐study heterogeneity in the prognostic effect (<a href="./references#CD012841-bbs2-0149" title="CornellJE , MulrowCD , LocalioR , StackCB , MeibohmAR , GuallarE , et al. Random‐effects meta‐analysis of inconsistent effects: a time for change. Annals of Internal Medicine2014;160(4):267‐70. ">Cornell 2014</a>; <a href="./references#CD012841-bbs2-0217" title="RileyRD , SteyerbergEW . Meta‐analysis of a binary outcome using individual participant data and aggregate data. Research Synthesis Methods2010;1:2‐19. ">Riley 2010</a>). Such heterogeneity is common in prognostic factor studies. Unless the heterogeneity (as assessed above) was too extensive for appropriate pooling, we planned to summarise the meta‐analysis by the pooled estimate (the average prognostic factor effect), the Hartung‐Knapp 95% CI, the estimate of Tau² (between‐study variance) and a 95% prediction interval for the prognostic effect in a single population (<a href="./references#CD012841-bbs2-0218" title="RileyRD , HigginsJP , DeeksJJ . Interpretation of random effects meta‐analyses. BMJ2011;342:d549. ">Riley 2011</a>). </p> </section> <section id="CD012841-sec-0058"> <h4 class="title">'Summary of findings' table and GRADE assessment</h4> <p>We used an approach modified from the GRADE framework (<a href="./references#CD012841-bbs2-0166" title="GuyattGH , OxmanAD , SchünemannHJ , TugwellP , KnottnerusA . GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. Journal of Clinical Epidemiology2011;64(4):380‐2. ">Guyatt 2011a</a>) to assess the certainty of the summarised evidence for each prognostic factor–outcome combination (<a href="./references#CD012841-bbs2-0175" title="HaydenJA , TougasME , RileyR , IlesR , PincusT . Individual recovery expectations and prognosis of outcomes in non‐specific low back pain: prognostic factor exemplar review. Cochrane Database of Systematic Reviews2014, Issue 9. [DOI: 10.1002/14651858.CD011284] ">Hayden 2014</a>; <a href="./references#CD012841-bbs2-0180" title="HuguetA , HaydenJA , StinsonJ , McGrathPJ , ChambersCT , TougasME . Judging the quality of evidence in reviews of prognostic factor research: adapting the GRADE framework. Systematic Reviews2013;2:71. ">Huguet 2013</a>; <a href="./references#CD012841-bbs2-0182" title="IorioA , SpencerFA , FalavignaM , AlbaC , LangE , BurnandB , et al. Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients. BMJ2015;350:h870. [DOI: 10.1136/bmj.h870] ">Iorio 2015</a>). We rated the overall strength of evidence as high, moderate, low or very low considering the phase of prognostic study (confirmatory/explanatory or exploratory), the within‐study risk of bias, the directness of evidence, heterogeneity, precision of effect estimates and risk of publication bias (<a href="./references#CD012841-bbs2-0182" title="IorioA , SpencerFA , FalavignaM , AlbaC , LangE , BurnandB , et al. Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients. BMJ2015;350:h870. [DOI: 10.1136/bmj.h870] ">Iorio 2015</a>; <a href="./references#CD012841-bbs2-0221" title="SchünemannHJ , OxmanAD , HigginsJP , VistGE , GlasziouP , GuyattGH . Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Schünemann 2011a</a>). We also considered two 'upgrading' factors, large effect and dose effect, although we noted that high risk of bias may artificially lead to large effects (see <a href="./appendices#CD012841-sec-0125">Appendix 4</a> for further details). </p> <p>We did not present the main results of the review in formal 'Summary of findings' tables because the vast majority of the evidence was at high risk of bias and this, together with the study design, meant that the evidence was of very low certainty throughout. Instead we summarised the findings in the text. 'Summary of findings' tables present key information concerning the certainty of the evidence, the magnitude of the associations examined and the sum of the available data (<a href="./references#CD012841-bbs2-0222" title="SchünemannHJ , OxmanAD , HigginsJP , DeeksJJ , GlasziouP , GuyattGH . Chapter 12: Interpreting results and drawing conclusions. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Schünemann 2011b</a>), and include an overall grading of the evidence. This defines the certainty of a body of evidence as the extent to which one can be confident that an estimate of effect or association is close to the true quantity of specific interest. </p> <p>If it was not appropriate to combine results using a meta‐analysis (due to excess clinical heterogeneity), we planned to present the results qualitatively, considering the strength and consistency of results using the following schema: </p> <p> <ul id="CD012841-list-0009"> <li> <p>strong evidence of effect: consistent findings (defined as greater than 75% of studies showing the same direction of effect) in multiple low risk of bias studies; </p> </li> <li> <p>moderate evidence of effect: consistent findings in multiple high risk of bias or one study with low risk of bias (or both); </p> </li> <li> <p>limited evidence of effect: one study available;</p> </li> <li> <p>conflicting evidence of effect: inconsistent findings across studies;</p> </li> <li> <p>no effect: no association between participant expectations and the outcome of interest.</p> </li> </ul> </p> <p>We planned to calculate absolute risk differences for the effect of the prognostic factor using estimates of baseline risk from the literature where possible. </p> </section> <section id="CD012841-sec-0059"> <h4 class="title">Subgroup and sensitivity analyses</h4> <p>We planned to use sensitivity analyses to explore the impact of study level all‐domain risk of bias, first restricting the analysis to studies rated as having low risk of bias, and if this was not feasible, to restrict to low or moderate risk of bias. </p> <p>If there was heterogeneity, we planned to investigate it using the following prespecified subgroup analyses, provided there were at least two studies per subgroup: </p> <p> <ul id="CD012841-list-0010"> <li> <p>baseline duration of ulcer (up to 24 weeks; 24 weeks or greater); duration may be a proxy for a non‐healing wound, in which protease activity may be associated differently with healing; </p> </li> <li> <p>presence or absence of infection.</p> </li> </ul> </p> <p>We did not plan to conduct subgroup analyses by type of protease because this would have introduced too high a level of complexity for this review, but we recorded the type of protease measured. </p> <p>We planned to consider subgroup or sensitivity analyses to explore the impact of types of measurement approaches for assessing prognostic factors. </p> <p>This <a href="#CD012841-sec-0036">Methods</a> section was based on the exemplar Cochrane prognosis review protocol for prognostic factors (<a href="./references#CD012841-bbs2-0175" title="HaydenJA , TougasME , RileyR , IlesR , PincusT . Individual recovery expectations and prognosis of outcomes in non‐specific low back pain: prognostic factor exemplar review. Cochrane Database of Systematic Reviews2014, Issue 9. [DOI: 10.1002/14651858.CD011284] ">Hayden 2014</a>) and the general protocol template of the Cochrane Prognosis Methods Group (<a href="./references#CD012841-bbs2-0147" title="Cochrane Prognosis Methods Group. Review tools. https://methods.cochrane.org/prognosis/sites/methods.cochrane.org.prognosis/files/public/uploads/protocol_template_prognosis_reviews.doc (accessed 13 July 2018). ">Cochrane Prognosis Methods Group 2018</a>). In conducting the review, we carried out a number of modifications to the methods, as described above. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD012841-sec-0060" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD012841-sec-0060"></div> <section id="CD012841-sec-0061"> <h3 class="title" id="CD012841-sec-0061">Description of studies</h3> <section id="CD012841-sec-0062"> <h4 class="title">Results of the search</h4> <p>The search generated 1493 records and one of the review authors identified an additional paper separately: we obtained 153 full papers (<a href="#CD012841-fig-0001">Figure 1</a>); some of these were reviews ordered for bibliographic checks and background material; we excluded 110 studies with reasons (<a href="./references#CD012841-sec-0144" title="">Characteristics of excluded studies</a> table). We included 19 studies described in 21 reports (see 'Included studies' for explanation). One study was placed in the <a href="./references#CD012841-sec-0145" title="">Characteristics of studies awaiting classification</a> section (<a href="./references#CD012841-bbs2-0132" title="CullenB , NisbetL , EsslerL , SilcockD , LalikosJ , DunnR . The ability of collagen/ORC to correct biochemical imbalances in venous leg ulcers. Wound Repair and Regeneration2009;17(4):A55. ">Cullen 2009</a>); this was a conference abstract and gave too little information. </p> </section> </section> <section id="CD012841-sec-0063"> <h3 class="title" id="CD012841-sec-0063">Included studies</h3> <p>Studies are described in detail in the <a href="./references#CD012841-sec-0143" title="">Characteristics of included studies</a> table. In this table, we report two studies twice because they were RCTs with different risks of bias for each treatment group: we report each trial arm as a separate cohort (<a href="./references#CD012841-bbs2-0011" title="MoffattCJ , StantonJ , MurrayS , DoodyV , DavisPJ , FranksPJ . A randomised trial to compare the performance of Oxyzyme and Iodozyme with standard care in the treatment of patients with venous and mixed venous/arterial ulceration. Wound Medicine2014;6:1‐10. ">Moffatt 2014a</a>; <a href="./references#CD012841-bbs2-0012" title="MoffattCJ , StantonJ , MurrayS , DoodyV , DavisPJ , FranksPJ . A randomised trial to compare the performance of Oxyzyme and Iodozyme with standard care in the treatment of patients with venous and mixed venous/arterial ulceration. Wound Medicine2014;6:1‐10. ">Moffatt 2014b</a>; <a href="./references#CD012841-bbs2-0016" title="SerraR , GallelliL , BuffoneG , MolinariV , StillitanoDM , PalmieriC , et al. Doxycycline speeds up healing of chronic venous ulcers. International Wound Journal2015;12(2):179‐84. ">Serra 2015a</a>; <a href="./references#CD012841-bbs2-0017" title="SerraR , GallelliL , BuffoneG , MolinariV , StillitanoDM , PalmieriC , et al. Doxycycline speeds up healing of chronic venous ulcers. International Wound Journal2015;12(2):179‐84. ">Serra 2015b</a>). </p> <p>Nineteen studies (involving 21 cohorts), with 646 participants, met the inclusion criteria for the review (<a href="./references#CD012841-bbs2-0001" title="AhmadA , SahaP , EvansC , ThurisonT , Hoyer‐HansenG , PatelA , et al. The soluble urokinase plasminogen activator receptor and its fragments in venous ulcers. Journal of Vascular Surgery: Venous and Lymphatic Disorders2015;3(2):190‐7. ">Ahmad 2015</a>; <a href="./references#CD012841-bbs2-0002" title="CullenB , GibsonM , NisbetL . Targeted use of collagen/ORC improves clinical outcomes. Wound Repair and Regeneration2012;20(5):A93. ">Cullen 2012</a>; <a href="./references#CD012841-bbs2-0003" title="FrankovaJ , DiamantovaD , VrbkovaJ , UlrichovaJ . Influence of hydrogencalcium salts of oxidized cellulose on MMP‐2, MMP‐9 and TNF‐alpha production and wound healing in non‐healing wounds. Acta Dermatovenerologica Croatica2013;21(4):219‐23. ">Frankova 2013</a>; <a href="./references#CD012841-bbs2-0004" title="GohelMS , WindhaberRA , TarltonJF , WhymanMR , PoskittKR . The relationship between cytokine concentrations and wound healing in chronic venous ulceration. Journal of Vascular Surgery2008;48(5):1272‐7. ">Gohel 2008</a>; <a href="./references#CD012841-bbs2-0005" title="GrzelaT , Niderla‐BielinskaJ , LitwiniukM , WhiteR . The direct inhibition of MMP‐2 and MMP‐9 by an enzyme alginogel: a possible mechanism of healing support for venous leg ulcers. Journal of Wound Care2014;23(5):278, 280‐2, 284. ">Grzela 2014</a>; <a href="./references#CD012841-bbs2-0006" title="HarrisIR , YeeKC , WaltersCE , CunliffeWJ , KearneyJN , WoodEJ , et al. Cytokine and protease levels in healing and non‐healing chronic venous leg ulcers. Experimental Dermatology1995;4(6):342‐9. ">Harris 1995</a>; <a href="./references#CD012841-bbs2-0007" title="HoffmanR , NobleJ , EagleM . The use of proteases as prognostic markers for the healing of venous leg ulcers. Journal of Wound Care1999;8(6):273‐6. ">Hoffman 1999</a>; <a href="./references#CD012841-bbs2-0008" title="JamesTJ , HughesMA , CherryGW , TaylorRP . Evidence of oxidative stress in chronic venous ulcers. Wound Repair and Regeneration2003;11(3):172‐6. ">James 2003</a>; <a href="./references#CD012841-bbs2-0009" title="LitwiniukM , BikowskaB , Niderla‐BielinskaJ , JozwiakJ , KaminskiA , SkopinskiP , et al. Potential role of metalloproteinase inhibitors from radiation‐sterilized amnion dressings in the healing of venous leg ulcers. Molecular Medicine Reports2012;6(4):723‐8. ">Litwiniuk 2012</a>; <a href="./references#CD012841-bbs2-0010" title="McDanielJC , SzalachaL , SalesM , RoyS , ChafeeS , ParinandiN . EPA + DHA supplementation reduces PMN activation in microenvironment of chronic venous leg ulcers: a randomized, double‐blind, controlled study. Wound Repair and Regeneration2017;25(4):680‐90. ">McDaniel 2017</a>; <a href="./references#CD012841-bbs2-0011" title="MoffattCJ , StantonJ , MurrayS , DoodyV , DavisPJ , FranksPJ . A randomised trial to compare the performance of Oxyzyme and Iodozyme with standard care in the treatment of patients with venous and mixed venous/arterial ulceration. Wound Medicine2014;6:1‐10. ">Moffatt 2014a</a>; <a href="./references#CD012841-bbs2-0012" title="MoffattCJ , StantonJ , MurrayS , DoodyV , DavisPJ , FranksPJ . A randomised trial to compare the performance of Oxyzyme and Iodozyme with standard care in the treatment of patients with venous and mixed venous/arterial ulceration. Wound Medicine2014;6:1‐10. ">Moffatt 2014b</a>; <a href="./references#CD012841-bbs2-0013" title="MwauraB , MahendranB , HynesN , DefreitasD , AvalosG , AdegbolaT , et al. The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase‐2, tissue inhibitor of matrix metalloproteinase‐2 and PDGF‐AA on the chronicity of venous leg ulcers. European Journal of Vascular and Endovascular Surgery2006;31(3):306‐10. ">Mwaura 2006</a>; <a href="./references#CD012841-bbs2-0014" title="RaffettoJD , MostiG , SantiM , LigiD , MannelloF . Matrix metalloproteinase profiles in chronic venous ulcer wound fluid of inflammatory and granulating venous leg ulcers. Journal of Vascular Surgery: Venous and Lymphatic Disorders2015;3(1):119‐20. ">Raffetto 2015</a>; <a href="./references#CD012841-bbs2-0015" title="SerraR , BuffoneG , FalconeD , MolinariV , ScaramuzzinoM , GallelliL , et al. Chronic venous leg ulcers are associated with high levels of metalloproteinases‐9 and neutrophil gelatinase‐associated lipocalin. Wound Repair and Regeneration2013;21(3):395‐401. ">Serra 2013</a>; <a href="./references#CD012841-bbs2-0016" title="SerraR , GallelliL , BuffoneG , MolinariV , StillitanoDM , PalmieriC , et al. Doxycycline speeds up healing of chronic venous ulcers. International Wound Journal2015;12(2):179‐84. ">Serra 2015a</a>; <a href="./references#CD012841-bbs2-0017" title="SerraR , GallelliL , BuffoneG , MolinariV , StillitanoDM , PalmieriC , et al. Doxycycline speeds up healing of chronic venous ulcers. International Wound Journal2015;12(2):179‐84. ">Serra 2015b</a>; <a href="./references#CD012841-bbs2-0018" title="SmeetsR , UlrichD , UnglaubF , WoltjeM , PalluaN . Effect of oxidised regenerated cellulose/collagen matrix on proteases in wound exudate of patients with chronic venous ulceration. International Wound Journal2008;5(2):195‐203. ">Smeets 2008</a>; <a href="./references#CD012841-bbs2-0019" title="TrengoveNJ , StaceyMC , MacauleyS , BennettN , GibsonJ , BurslemF , et al. Analysis of the acute and chronic would environments: the role of proteases and their inhibitors. Wound Repair and Regeneration1999;7(6):442‐52. ">Trengove 1999</a>; <a href="./references#CD012841-bbs2-0020" title="TrøstrupH , LundquistR , ChristensenLH , JorgensenLN , KarlsmarkT , HaabBB , et al. S100A8/A9 deficiency in nonhealing venous leg ulcers uncovered by multiplexed antibody microarray profiling. British Journal of Dermatology2011;165(2):292‐301. TrøstrupH , LundquistR , JorgensenL , KarlmarkT , HaabB , AgrenMS . Antibody microarray profiling uncovers molecular anomalies in chronic venous leg ulcers. Wound Repair and Regeneration2010;18(2):A14. TrøstrupH , LundquistR , JorgensenL , KarlsmarkT , HaabB , AgrenM . Antibody‐based microarray profiling of acute and chronic wound fluids. Wound Repair and Regeneration2010;18(6):A95. ">Trøstrup 2011</a>; <a href="./references#CD012841-bbs2-0021" title="WysockiAB , KusakabeAO , ChangS , TuanTL . Temporal expression of urokinase plasminogen activator, plasminogen activator inhibitor and gelatinase‐B in chronic wound fluid switches from a chronic to acute wound profile with progression to healing. Wound Repair and Regeneration1999;7(3):154‐65. ">Wysocki 1999</a>). The size of the cohorts was small, with a median (range) of 30 (7 to 80) participants. Two studies were reported only as conference abstracts or posters (<a href="./references#CD012841-bbs2-0002" title="CullenB , GibsonM , NisbetL . Targeted use of collagen/ORC improves clinical outcomes. Wound Repair and Regeneration2012;20(5):A93. ">Cullen 2012</a>; <a href="./references#CD012841-bbs2-0014" title="RaffettoJD , MostiG , SantiM , LigiD , MannelloF . Matrix metalloproteinase profiles in chronic venous ulcer wound fluid of inflammatory and granulating venous leg ulcers. Journal of Vascular Surgery: Venous and Lymphatic Disorders2015;3(1):119‐20. ">Raffetto 2015</a>). </p> <p>Most included studies had a cohort study design and two were a type of case‐control study. Eleven studies reported a prospective longitudinal design (<a href="./references#CD012841-bbs2-0001" title="AhmadA , SahaP , EvansC , ThurisonT , Hoyer‐HansenG , PatelA , et al. The soluble urokinase plasminogen activator receptor and its fragments in venous ulcers. Journal of Vascular Surgery: Venous and Lymphatic Disorders2015;3(2):190‐7. ">Ahmad 2015</a>; <a href="./references#CD012841-bbs2-0003" title="FrankovaJ , DiamantovaD , VrbkovaJ , UlrichovaJ . Influence of hydrogencalcium salts of oxidized cellulose on MMP‐2, MMP‐9 and TNF‐alpha production and wound healing in non‐healing wounds. Acta Dermatovenerologica Croatica2013;21(4):219‐23. ">Frankova 2013</a>; <a href="./references#CD012841-bbs2-0004" title="GohelMS , WindhaberRA , TarltonJF , WhymanMR , PoskittKR . The relationship between cytokine concentrations and wound healing in chronic venous ulceration. Journal of Vascular Surgery2008;48(5):1272‐7. ">Gohel 2008</a>; <a href="./references#CD012841-bbs2-0007" title="HoffmanR , NobleJ , EagleM . The use of proteases as prognostic markers for the healing of venous leg ulcers. Journal of Wound Care1999;8(6):273‐6. ">Hoffman 1999</a>; <a href="./references#CD012841-bbs2-0008" title="JamesTJ , HughesMA , CherryGW , TaylorRP . Evidence of oxidative stress in chronic venous ulcers. Wound Repair and Regeneration2003;11(3):172‐6. ">James 2003</a>; <a href="./references#CD012841-bbs2-0009" title="LitwiniukM , BikowskaB , Niderla‐BielinskaJ , JozwiakJ , KaminskiA , SkopinskiP , et al. Potential role of metalloproteinase inhibitors from radiation‐sterilized amnion dressings in the healing of venous leg ulcers. Molecular Medicine Reports2012;6(4):723‐8. ">Litwiniuk 2012</a>; <a href="./references#CD012841-bbs2-0013" title="MwauraB , MahendranB , HynesN , DefreitasD , AvalosG , AdegbolaT , et al. The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase‐2, tissue inhibitor of matrix metalloproteinase‐2 and PDGF‐AA on the chronicity of venous leg ulcers. European Journal of Vascular and Endovascular Surgery2006;31(3):306‐10. ">Mwaura 2006</a>; <a href="./references#CD012841-bbs2-0015" title="SerraR , BuffoneG , FalconeD , MolinariV , ScaramuzzinoM , GallelliL , et al. Chronic venous leg ulcers are associated with high levels of metalloproteinases‐9 and neutrophil gelatinase‐associated lipocalin. Wound Repair and Regeneration2013;21(3):395‐401. ">Serra 2013</a>; <a href="./references#CD012841-bbs2-0019" title="TrengoveNJ , StaceyMC , MacauleyS , BennettN , GibsonJ , BurslemF , et al. Analysis of the acute and chronic would environments: the role of proteases and their inhibitors. Wound Repair and Regeneration1999;7(6):442‐52. ">Trengove 1999</a>; <a href="./references#CD012841-bbs2-0020" title="TrøstrupH , LundquistR , ChristensenLH , JorgensenLN , KarlsmarkT , HaabBB , et al. S100A8/A9 deficiency in nonhealing venous leg ulcers uncovered by multiplexed antibody microarray profiling. British Journal of Dermatology2011;165(2):292‐301. TrøstrupH , LundquistR , JorgensenL , KarlmarkT , HaabB , AgrenMS . Antibody microarray profiling uncovers molecular anomalies in chronic venous leg ulcers. Wound Repair and Regeneration2010;18(2):A14. TrøstrupH , LundquistR , JorgensenL , KarlsmarkT , HaabB , AgrenM . Antibody‐based microarray profiling of acute and chronic wound fluids. Wound Repair and Regeneration2010;18(6):A95. ">Trøstrup 2011</a>; <a href="./references#CD012841-bbs2-0021" title="WysockiAB , KusakabeAO , ChangS , TuanTL . Temporal expression of urokinase plasminogen activator, plasminogen activator inhibitor and gelatinase‐B in chronic wound fluid switches from a chronic to acute wound profile with progression to healing. Wound Repair and Regeneration1999;7(3):154‐65. ">Wysocki 1999</a>), of which three had 10 or fewer participants (<a href="./references#CD012841-bbs2-0007" title="HoffmanR , NobleJ , EagleM . The use of proteases as prognostic markers for the healing of venous leg ulcers. Journal of Wound Care1999;8(6):273‐6. ">Hoffman 1999</a>; <a href="./references#CD012841-bbs2-0008" title="JamesTJ , HughesMA , CherryGW , TaylorRP . Evidence of oxidative stress in chronic venous ulcers. Wound Repair and Regeneration2003;11(3):172‐6. ">James 2003</a>; <a href="./references#CD012841-bbs2-0020" title="TrøstrupH , LundquistR , ChristensenLH , JorgensenLN , KarlsmarkT , HaabBB , et al. S100A8/A9 deficiency in nonhealing venous leg ulcers uncovered by multiplexed antibody microarray profiling. British Journal of Dermatology2011;165(2):292‐301. TrøstrupH , LundquistR , JorgensenL , KarlmarkT , HaabB , AgrenMS . Antibody microarray profiling uncovers molecular anomalies in chronic venous leg ulcers. Wound Repair and Regeneration2010;18(2):A14. TrøstrupH , LundquistR , JorgensenL , KarlsmarkT , HaabB , AgrenM . Antibody‐based microarray profiling of acute and chronic wound fluids. Wound Repair and Regeneration2010;18(6):A95. ">Trøstrup 2011</a>). There were six RCTs, two of which reported results separately for each arm (<a href="./references#CD012841-bbs2-0011" title="MoffattCJ , StantonJ , MurrayS , DoodyV , DavisPJ , FranksPJ . A randomised trial to compare the performance of Oxyzyme and Iodozyme with standard care in the treatment of patients with venous and mixed venous/arterial ulceration. Wound Medicine2014;6:1‐10. ">Moffatt 2014a</a>; <a href="./references#CD012841-bbs2-0012" title="MoffattCJ , StantonJ , MurrayS , DoodyV , DavisPJ , FranksPJ . A randomised trial to compare the performance of Oxyzyme and Iodozyme with standard care in the treatment of patients with venous and mixed venous/arterial ulceration. Wound Medicine2014;6:1‐10. ">Moffatt 2014b</a>; <a href="./references#CD012841-bbs2-0016" title="SerraR , GallelliL , BuffoneG , MolinariV , StillitanoDM , PalmieriC , et al. Doxycycline speeds up healing of chronic venous ulcers. International Wound Journal2015;12(2):179‐84. ">Serra 2015a</a>; <a href="./references#CD012841-bbs2-0017" title="SerraR , GallelliL , BuffoneG , MolinariV , StillitanoDM , PalmieriC , et al. Doxycycline speeds up healing of chronic venous ulcers. International Wound Journal2015;12(2):179‐84. ">Serra 2015b</a>); two of which reported relevant results for the study as a whole (<a href="./references#CD012841-bbs2-0002" title="CullenB , GibsonM , NisbetL . Targeted use of collagen/ORC improves clinical outcomes. Wound Repair and Regeneration2012;20(5):A93. ">Cullen 2012</a>; <a href="./references#CD012841-bbs2-0010" title="McDanielJC , SzalachaL , SalesM , RoyS , ChafeeS , ParinandiN . EPA + DHA supplementation reduces PMN activation in microenvironment of chronic venous leg ulcers: a randomized, double‐blind, controlled study. Wound Repair and Regeneration2017;25(4):680‐90. ">McDaniel 2017</a>); and two did not give any useable results (<a href="./references#CD012841-bbs2-0005" title="GrzelaT , Niderla‐BielinskaJ , LitwiniukM , WhiteR . The direct inhibition of MMP‐2 and MMP‐9 by an enzyme alginogel: a possible mechanism of healing support for venous leg ulcers. Journal of Wound Care2014;23(5):278, 280‐2, 284. ">Grzela 2014</a>; <a href="./references#CD012841-bbs2-0018" title="SmeetsR , UlrichD , UnglaubF , WoltjeM , PalluaN . Effect of oxidised regenerated cellulose/collagen matrix on proteases in wound exudate of patients with chronic venous ulceration. International Wound Journal2008;5(2):195‐203. ">Smeets 2008</a>). The remaining two studies had a type of case‐control design nested in a cross‐sectional study (<a href="./references#CD012841-bbs2-0006" title="HarrisIR , YeeKC , WaltersCE , CunliffeWJ , KearneyJN , WoodEJ , et al. Cytokine and protease levels in healing and non‐healing chronic venous leg ulcers. Experimental Dermatology1995;4(6):342‐9. ">Harris 1995</a>; <a href="./references#CD012841-bbs2-0014" title="RaffettoJD , MostiG , SantiM , LigiD , MannelloF . Matrix metalloproteinase profiles in chronic venous ulcer wound fluid of inflammatory and granulating venous leg ulcers. Journal of Vascular Surgery: Venous and Lymphatic Disorders2015;3(1):119‐20. ">Raffetto 2015</a>): we have interpreted these studies as having a longitudinal component that occurred before the study started. </p> <p>Eight included studies did not provide sufficient useable results data in the published report (<a href="./references#CD012841-bbs2-0003" title="FrankovaJ , DiamantovaD , VrbkovaJ , UlrichovaJ . Influence of hydrogencalcium salts of oxidized cellulose on MMP‐2, MMP‐9 and TNF‐alpha production and wound healing in non‐healing wounds. Acta Dermatovenerologica Croatica2013;21(4):219‐23. ">Frankova 2013</a>; <a href="./references#CD012841-bbs2-0005" title="GrzelaT , Niderla‐BielinskaJ , LitwiniukM , WhiteR . The direct inhibition of MMP‐2 and MMP‐9 by an enzyme alginogel: a possible mechanism of healing support for venous leg ulcers. Journal of Wound Care2014;23(5):278, 280‐2, 284. ">Grzela 2014</a>; <a href="./references#CD012841-bbs2-0008" title="JamesTJ , HughesMA , CherryGW , TaylorRP . Evidence of oxidative stress in chronic venous ulcers. Wound Repair and Regeneration2003;11(3):172‐6. ">James 2003</a>; <a href="./references#CD012841-bbs2-0009" title="LitwiniukM , BikowskaB , Niderla‐BielinskaJ , JozwiakJ , KaminskiA , SkopinskiP , et al. Potential role of metalloproteinase inhibitors from radiation‐sterilized amnion dressings in the healing of venous leg ulcers. Molecular Medicine Reports2012;6(4):723‐8. ">Litwiniuk 2012</a>; <a href="./references#CD012841-bbs2-0018" title="SmeetsR , UlrichD , UnglaubF , WoltjeM , PalluaN . Effect of oxidised regenerated cellulose/collagen matrix on proteases in wound exudate of patients with chronic venous ulceration. International Wound Journal2008;5(2):195‐203. ">Smeets 2008</a>; <a href="./references#CD012841-bbs2-0019" title="TrengoveNJ , StaceyMC , MacauleyS , BennettN , GibsonJ , BurslemF , et al. Analysis of the acute and chronic would environments: the role of proteases and their inhibitors. Wound Repair and Regeneration1999;7(6):442‐52. ">Trengove 1999</a>; <a href="./references#CD012841-bbs2-0020" title="TrøstrupH , LundquistR , ChristensenLH , JorgensenLN , KarlsmarkT , HaabBB , et al. S100A8/A9 deficiency in nonhealing venous leg ulcers uncovered by multiplexed antibody microarray profiling. British Journal of Dermatology2011;165(2):292‐301. TrøstrupH , LundquistR , JorgensenL , KarlmarkT , HaabB , AgrenMS . Antibody microarray profiling uncovers molecular anomalies in chronic venous leg ulcers. Wound Repair and Regeneration2010;18(2):A14. TrøstrupH , LundquistR , JorgensenL , KarlsmarkT , HaabB , AgrenM . Antibody‐based microarray profiling of acute and chronic wound fluids. Wound Repair and Regeneration2010;18(6):A95. ">Trøstrup 2011</a>; <a href="./references#CD012841-bbs2-0021" title="WysockiAB , KusakabeAO , ChangS , TuanTL . Temporal expression of urokinase plasminogen activator, plasminogen activator inhibitor and gelatinase‐B in chronic wound fluid switches from a chronic to acute wound profile with progression to healing. Wound Repair and Regeneration1999;7(3):154‐65. ">Wysocki 1999</a>). One study reported association statistics only for an intermediate biomarker for both the prognostic factor and the outcome (<a href="./references#CD012841-bbs2-0008" title="JamesTJ , HughesMA , CherryGW , TaylorRP . Evidence of oxidative stress in chronic venous ulcers. Wound Repair and Regeneration2003;11(3):172‐6. ">James 2003</a>); the other studies reported both the prognostic factor and the outcome as continuous variables, generally giving summary statistics for each, but no association statistics. To have useable data for the review, we would have had to request further analyses from the authors. Therefore, we included these studies for completeness, noted the lack of useable results and only extracted data for a minimal set of characteristics (see <a href="./references#CD012841-sec-0143" title="">Characteristics of included studies</a> table). We did not formally conduct 'Risk of bias' assessments and did not include these studies in the 'Risk of bias' figures (see 'Risk of bias' section). </p> <p>The remaining 11 studies involving 13 cohorts are summarised in this section and analysed in the results section (<a href="./references#CD012841-bbs2-0001" title="AhmadA , SahaP , EvansC , ThurisonT , Hoyer‐HansenG , PatelA , et al. The soluble urokinase plasminogen activator receptor and its fragments in venous ulcers. Journal of Vascular Surgery: Venous and Lymphatic Disorders2015;3(2):190‐7. ">Ahmad 2015</a>; <a href="./references#CD012841-bbs2-0002" title="CullenB , GibsonM , NisbetL . Targeted use of collagen/ORC improves clinical outcomes. Wound Repair and Regeneration2012;20(5):A93. ">Cullen 2012</a>; <a href="./references#CD012841-bbs2-0004" title="GohelMS , WindhaberRA , TarltonJF , WhymanMR , PoskittKR . The relationship between cytokine concentrations and wound healing in chronic venous ulceration. Journal of Vascular Surgery2008;48(5):1272‐7. ">Gohel 2008</a>; <a href="./references#CD012841-bbs2-0006" title="HarrisIR , YeeKC , WaltersCE , CunliffeWJ , KearneyJN , WoodEJ , et al. Cytokine and protease levels in healing and non‐healing chronic venous leg ulcers. Experimental Dermatology1995;4(6):342‐9. ">Harris 1995</a>; <a href="./references#CD012841-bbs2-0007" title="HoffmanR , NobleJ , EagleM . The use of proteases as prognostic markers for the healing of venous leg ulcers. Journal of Wound Care1999;8(6):273‐6. ">Hoffman 1999</a>; <a href="./references#CD012841-bbs2-0010" title="McDanielJC , SzalachaL , SalesM , RoyS , ChafeeS , ParinandiN . EPA + DHA supplementation reduces PMN activation in microenvironment of chronic venous leg ulcers: a randomized, double‐blind, controlled study. Wound Repair and Regeneration2017;25(4):680‐90. ">McDaniel 2017</a>; <a href="./references#CD012841-bbs2-0011" title="MoffattCJ , StantonJ , MurrayS , DoodyV , DavisPJ , FranksPJ . A randomised trial to compare the performance of Oxyzyme and Iodozyme with standard care in the treatment of patients with venous and mixed venous/arterial ulceration. Wound Medicine2014;6:1‐10. ">Moffatt 2014a</a>; <a href="./references#CD012841-bbs2-0012" title="MoffattCJ , StantonJ , MurrayS , DoodyV , DavisPJ , FranksPJ . A randomised trial to compare the performance of Oxyzyme and Iodozyme with standard care in the treatment of patients with venous and mixed venous/arterial ulceration. Wound Medicine2014;6:1‐10. ">Moffatt 2014b</a>; <a href="./references#CD012841-bbs2-0013" title="MwauraB , MahendranB , HynesN , DefreitasD , AvalosG , AdegbolaT , et al. The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase‐2, tissue inhibitor of matrix metalloproteinase‐2 and PDGF‐AA on the chronicity of venous leg ulcers. European Journal of Vascular and Endovascular Surgery2006;31(3):306‐10. ">Mwaura 2006</a>; <a href="./references#CD012841-bbs2-0014" title="RaffettoJD , MostiG , SantiM , LigiD , MannelloF . Matrix metalloproteinase profiles in chronic venous ulcer wound fluid of inflammatory and granulating venous leg ulcers. Journal of Vascular Surgery: Venous and Lymphatic Disorders2015;3(1):119‐20. ">Raffetto 2015</a>; <a href="./references#CD012841-bbs2-0015" title="SerraR , BuffoneG , FalconeD , MolinariV , ScaramuzzinoM , GallelliL , et al. Chronic venous leg ulcers are associated with high levels of metalloproteinases‐9 and neutrophil gelatinase‐associated lipocalin. Wound Repair and Regeneration2013;21(3):395‐401. ">Serra 2013</a>; <a href="./references#CD012841-bbs2-0016" title="SerraR , GallelliL , BuffoneG , MolinariV , StillitanoDM , PalmieriC , et al. Doxycycline speeds up healing of chronic venous ulcers. International Wound Journal2015;12(2):179‐84. ">Serra 2015a</a>; <a href="./references#CD012841-bbs2-0017" title="SerraR , GallelliL , BuffoneG , MolinariV , StillitanoDM , PalmieriC , et al. Doxycycline speeds up healing of chronic venous ulcers. International Wound Journal2015;12(2):179‐84. ">Serra 2015b</a>). There were 522 participants in these studies, with a median of 40 participants (range 7 to 80). </p> <p>Six studies were conducted in the UK (<a href="./references#CD012841-bbs2-0001" title="AhmadA , SahaP , EvansC , ThurisonT , Hoyer‐HansenG , PatelA , et al. The soluble urokinase plasminogen activator receptor and its fragments in venous ulcers. Journal of Vascular Surgery: Venous and Lymphatic Disorders2015;3(2):190‐7. ">Ahmad 2015</a>; <a href="./references#CD012841-bbs2-0002" title="CullenB , GibsonM , NisbetL . Targeted use of collagen/ORC improves clinical outcomes. Wound Repair and Regeneration2012;20(5):A93. ">Cullen 2012</a>; <a href="./references#CD012841-bbs2-0004" title="GohelMS , WindhaberRA , TarltonJF , WhymanMR , PoskittKR . The relationship between cytokine concentrations and wound healing in chronic venous ulceration. Journal of Vascular Surgery2008;48(5):1272‐7. ">Gohel 2008</a>; <a href="./references#CD012841-bbs2-0006" title="HarrisIR , YeeKC , WaltersCE , CunliffeWJ , KearneyJN , WoodEJ , et al. Cytokine and protease levels in healing and non‐healing chronic venous leg ulcers. Experimental Dermatology1995;4(6):342‐9. ">Harris 1995</a>; <a href="./references#CD012841-bbs2-0007" title="HoffmanR , NobleJ , EagleM . The use of proteases as prognostic markers for the healing of venous leg ulcers. Journal of Wound Care1999;8(6):273‐6. ">Hoffman 1999</a>; <a href="./references#CD012841-bbs2-0011" title="MoffattCJ , StantonJ , MurrayS , DoodyV , DavisPJ , FranksPJ . A randomised trial to compare the performance of Oxyzyme and Iodozyme with standard care in the treatment of patients with venous and mixed venous/arterial ulceration. Wound Medicine2014;6:1‐10. ">Moffatt 2014a</a>/<a href="./references#CD012841-bbs2-0012" title="MoffattCJ , StantonJ , MurrayS , DoodyV , DavisPJ , FranksPJ . A randomised trial to compare the performance of Oxyzyme and Iodozyme with standard care in the treatment of patients with venous and mixed venous/arterial ulceration. Wound Medicine2014;6:1‐10. ">Moffatt 2014b</a>); two in Italy (<a href="./references#CD012841-bbs2-0015" title="SerraR , BuffoneG , FalconeD , MolinariV , ScaramuzzinoM , GallelliL , et al. Chronic venous leg ulcers are associated with high levels of metalloproteinases‐9 and neutrophil gelatinase‐associated lipocalin. Wound Repair and Regeneration2013;21(3):395‐401. ">Serra 2013</a>; <a href="./references#CD012841-bbs2-0016" title="SerraR , GallelliL , BuffoneG , MolinariV , StillitanoDM , PalmieriC , et al. Doxycycline speeds up healing of chronic venous ulcers. International Wound Journal2015;12(2):179‐84. ">Serra 2015a</a>/<a href="./references#CD012841-bbs2-0017" title="SerraR , GallelliL , BuffoneG , MolinariV , StillitanoDM , PalmieriC , et al. Doxycycline speeds up healing of chronic venous ulcers. International Wound Journal2015;12(2):179‐84. ">Serra 2015b</a>); one in the USA (<a href="./references#CD012841-bbs2-0010" title="McDanielJC , SzalachaL , SalesM , RoyS , ChafeeS , ParinandiN . EPA + DHA supplementation reduces PMN activation in microenvironment of chronic venous leg ulcers: a randomized, double‐blind, controlled study. Wound Repair and Regeneration2017;25(4):680‐90. ">McDaniel 2017</a>); one in Ireland (<a href="./references#CD012841-bbs2-0013" title="MwauraB , MahendranB , HynesN , DefreitasD , AvalosG , AdegbolaT , et al. The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase‐2, tissue inhibitor of matrix metalloproteinase‐2 and PDGF‐AA on the chronicity of venous leg ulcers. European Journal of Vascular and Endovascular Surgery2006;31(3):306‐10. ">Mwaura 2006</a>); and one abstract did not report the country (<a href="./references#CD012841-bbs2-0014" title="RaffettoJD , MostiG , SantiM , LigiD , MannelloF . Matrix metalloproteinase profiles in chronic venous ulcer wound fluid of inflammatory and granulating venous leg ulcers. Journal of Vascular Surgery: Venous and Lymphatic Disorders2015;3(1):119‐20. ">Raffetto 2015</a>). </p> <p>Of the longitudinal studies, two had a follow‐up time of substantially less than two months (four weeks: <a href="./references#CD012841-bbs2-0002" title="CullenB , GibsonM , NisbetL . Targeted use of collagen/ORC improves clinical outcomes. Wound Repair and Regeneration2012;20(5):A93. ">Cullen 2012</a>; five weeks: <a href="./references#CD012841-bbs2-0004" title="GohelMS , WindhaberRA , TarltonJF , WhymanMR , PoskittKR . The relationship between cytokine concentrations and wound healing in chronic venous ulceration. Journal of Vascular Surgery2008;48(5):1272‐7. ">Gohel 2008</a>). The other studies ranged from eight weeks (<a href="./references#CD012841-bbs2-0013" title="MwauraB , MahendranB , HynesN , DefreitasD , AvalosG , AdegbolaT , et al. The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase‐2, tissue inhibitor of matrix metalloproteinase‐2 and PDGF‐AA on the chronicity of venous leg ulcers. European Journal of Vascular and Endovascular Surgery2006;31(3):306‐10. ">Mwaura 2006</a>; <a href="./references#CD012841-bbs2-0010" title="McDanielJC , SzalachaL , SalesM , RoyS , ChafeeS , ParinandiN . EPA + DHA supplementation reduces PMN activation in microenvironment of chronic venous leg ulcers: a randomized, double‐blind, controlled study. Wound Repair and Regeneration2017;25(4):680‐90. ">McDaniel 2017</a>; <a href="./references#CD012841-bbs2-0015" title="SerraR , BuffoneG , FalconeD , MolinariV , ScaramuzzinoM , GallelliL , et al. Chronic venous leg ulcers are associated with high levels of metalloproteinases‐9 and neutrophil gelatinase‐associated lipocalin. Wound Repair and Regeneration2013;21(3):395‐401. ">Serra 2013</a>) to 36 weeks (<a href="./references#CD012841-bbs2-0007" title="HoffmanR , NobleJ , EagleM . The use of proteases as prognostic markers for the healing of venous leg ulcers. Journal of Wound Care1999;8(6):273‐6. ">Hoffman 1999</a>); one of these gave correlation coefficients between protease levels measured at four weeks and follow‐up at eight weeks (<a href="./references#CD012841-bbs2-0010" title="McDanielJC , SzalachaL , SalesM , RoyS , ChafeeS , ParinandiN . EPA + DHA supplementation reduces PMN activation in microenvironment of chronic venous leg ulcers: a randomized, double‐blind, controlled study. Wound Repair and Regeneration2017;25(4):680‐90. ">McDaniel 2017</a>). </p> <section id="CD012841-sec-0064"> <h4 class="title">Participant characteristics</h4> <p>In 10 studies, all the participants had VLUs. In the remaining study, 56% of participants had VLU and 44% had mixed arterial‐venous leg ulcers (<a href="./references#CD012841-bbs2-0011" title="MoffattCJ , StantonJ , MurrayS , DoodyV , DavisPJ , FranksPJ . A randomised trial to compare the performance of Oxyzyme and Iodozyme with standard care in the treatment of patients with venous and mixed venous/arterial ulceration. Wound Medicine2014;6:1‐10. ">Moffatt 2014a</a>/<a href="./references#CD012841-bbs2-0012" title="MoffattCJ , StantonJ , MurrayS , DoodyV , DavisPJ , FranksPJ . A randomised trial to compare the performance of Oxyzyme and Iodozyme with standard care in the treatment of patients with venous and mixed venous/arterial ulceration. Wound Medicine2014;6:1‐10. ">Moffatt 2014b</a>). Three studies had similar numbers of males and females (<a href="./references#CD012841-bbs2-0001" title="AhmadA , SahaP , EvansC , ThurisonT , Hoyer‐HansenG , PatelA , et al. The soluble urokinase plasminogen activator receptor and its fragments in venous ulcers. Journal of Vascular Surgery: Venous and Lymphatic Disorders2015;3(2):190‐7. ">Ahmad 2015</a>; <a href="./references#CD012841-bbs2-0004" title="GohelMS , WindhaberRA , TarltonJF , WhymanMR , PoskittKR . The relationship between cytokine concentrations and wound healing in chronic venous ulceration. Journal of Vascular Surgery2008;48(5):1272‐7. ">Gohel 2008</a>; <a href="./references#CD012841-bbs2-0011" title="MoffattCJ , StantonJ , MurrayS , DoodyV , DavisPJ , FranksPJ . A randomised trial to compare the performance of Oxyzyme and Iodozyme with standard care in the treatment of patients with venous and mixed venous/arterial ulceration. Wound Medicine2014;6:1‐10. ">Moffatt 2014a</a>/<a href="./references#CD012841-bbs2-0012" title="MoffattCJ , StantonJ , MurrayS , DoodyV , DavisPJ , FranksPJ . A randomised trial to compare the performance of Oxyzyme and Iodozyme with standard care in the treatment of patients with venous and mixed venous/arterial ulceration. Wound Medicine2014;6:1‐10. ">Moffatt 2014b</a>); one was about two‐thirds male (<a href="./references#CD012841-bbs2-0010" title="McDanielJC , SzalachaL , SalesM , RoyS , ChafeeS , ParinandiN . EPA + DHA supplementation reduces PMN activation in microenvironment of chronic venous leg ulcers: a randomized, double‐blind, controlled study. Wound Repair and Regeneration2017;25(4):680‐90. ">McDaniel 2017</a>); three studies had about twice as many females as males (<a href="./references#CD012841-bbs2-0013" title="MwauraB , MahendranB , HynesN , DefreitasD , AvalosG , AdegbolaT , et al. The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase‐2, tissue inhibitor of matrix metalloproteinase‐2 and PDGF‐AA on the chronicity of venous leg ulcers. European Journal of Vascular and Endovascular Surgery2006;31(3):306‐10. ">Mwaura 2006</a>; <a href="./references#CD012841-bbs2-0015" title="SerraR , BuffoneG , FalconeD , MolinariV , ScaramuzzinoM , GallelliL , et al. Chronic venous leg ulcers are associated with high levels of metalloproteinases‐9 and neutrophil gelatinase‐associated lipocalin. Wound Repair and Regeneration2013;21(3):395‐401. ">Serra 2013</a>; <a href="./references#CD012841-bbs2-0016" title="SerraR , GallelliL , BuffoneG , MolinariV , StillitanoDM , PalmieriC , et al. Doxycycline speeds up healing of chronic venous ulcers. International Wound Journal2015;12(2):179‐84. ">Serra 2015a</a>/<a href="./references#CD012841-bbs2-0017" title="SerraR , GallelliL , BuffoneG , MolinariV , StillitanoDM , PalmieriC , et al. Doxycycline speeds up healing of chronic venous ulcers. International Wound Journal2015;12(2):179‐84. ">Serra 2015b</a>); and four did not report on sex (<a href="./references#CD012841-bbs2-0002" title="CullenB , GibsonM , NisbetL . Targeted use of collagen/ORC improves clinical outcomes. Wound Repair and Regeneration2012;20(5):A93. ">Cullen 2012</a>; <a href="./references#CD012841-bbs2-0006" title="HarrisIR , YeeKC , WaltersCE , CunliffeWJ , KearneyJN , WoodEJ , et al. Cytokine and protease levels in healing and non‐healing chronic venous leg ulcers. Experimental Dermatology1995;4(6):342‐9. ">Harris 1995</a>; <a href="./references#CD012841-bbs2-0007" title="HoffmanR , NobleJ , EagleM . The use of proteases as prognostic markers for the healing of venous leg ulcers. Journal of Wound Care1999;8(6):273‐6. ">Hoffman 1999</a>; <a href="./references#CD012841-bbs2-0014" title="RaffettoJD , MostiG , SantiM , LigiD , MannelloF . Matrix metalloproteinase profiles in chronic venous ulcer wound fluid of inflammatory and granulating venous leg ulcers. Journal of Vascular Surgery: Venous and Lymphatic Disorders2015;3(1):119‐20. ">Raffetto 2015</a>). Where reported, mean ages ranged from 51 to 75 years. Two studies reported that wounds were not infected (<a href="./references#CD012841-bbs2-0004" title="GohelMS , WindhaberRA , TarltonJF , WhymanMR , PoskittKR . The relationship between cytokine concentrations and wound healing in chronic venous ulceration. Journal of Vascular Surgery2008;48(5):1272‐7. ">Gohel 2008</a>; <a href="./references#CD012841-bbs2-0006" title="HarrisIR , YeeKC , WaltersCE , CunliffeWJ , KearneyJN , WoodEJ , et al. Cytokine and protease levels in healing and non‐healing chronic venous leg ulcers. Experimental Dermatology1995;4(6):342‐9. ">Harris 1995</a>). The mean/median duration of wounds ranged from three months (<a href="./references#CD012841-bbs2-0004" title="GohelMS , WindhaberRA , TarltonJF , WhymanMR , PoskittKR . The relationship between cytokine concentrations and wound healing in chronic venous ulceration. Journal of Vascular Surgery2008;48(5):1272‐7. ">Gohel 2008</a>) to 14 years (<a href="./references#CD012841-bbs2-0006" title="HarrisIR , YeeKC , WaltersCE , CunliffeWJ , KearneyJN , WoodEJ , et al. Cytokine and protease levels in healing and non‐healing chronic venous leg ulcers. Experimental Dermatology1995;4(6):342‐9. ">Harris 1995</a>). </p> </section> <section id="CD012841-sec-0065"> <h4 class="title">Prognostic factors</h4> <p>The studies investigated the following protease biomarkers; some studies examined more than one biomarker: </p> <p> <ul id="CD012841-list-0011"> <li> <p>MMP‐1 (<a href="./references#CD012841-bbs2-0014" title="RaffettoJD , MostiG , SantiM , LigiD , MannelloF . Matrix metalloproteinase profiles in chronic venous ulcer wound fluid of inflammatory and granulating venous leg ulcers. Journal of Vascular Surgery: Venous and Lymphatic Disorders2015;3(1):119‐20. ">Raffetto 2015</a>); </p> </li> <li> <p>MMP‐2 (<a href="./references#CD012841-bbs2-0004" title="GohelMS , WindhaberRA , TarltonJF , WhymanMR , PoskittKR . The relationship between cytokine concentrations and wound healing in chronic venous ulceration. Journal of Vascular Surgery2008;48(5):1272‐7. ">Gohel 2008</a>; <a href="./references#CD012841-bbs2-0013" title="MwauraB , MahendranB , HynesN , DefreitasD , AvalosG , AdegbolaT , et al. The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase‐2, tissue inhibitor of matrix metalloproteinase‐2 and PDGF‐AA on the chronicity of venous leg ulcers. European Journal of Vascular and Endovascular Surgery2006;31(3):306‐10. ">Mwaura 2006</a>; <a href="./references#CD012841-bbs2-0014" title="RaffettoJD , MostiG , SantiM , LigiD , MannelloF . Matrix metalloproteinase profiles in chronic venous ulcer wound fluid of inflammatory and granulating venous leg ulcers. Journal of Vascular Surgery: Venous and Lymphatic Disorders2015;3(1):119‐20. ">Raffetto 2015</a>); </p> </li> <li> <p>MMP‐3 (<a href="./references#CD012841-bbs2-0014" title="RaffettoJD , MostiG , SantiM , LigiD , MannelloF . Matrix metalloproteinase profiles in chronic venous ulcer wound fluid of inflammatory and granulating venous leg ulcers. Journal of Vascular Surgery: Venous and Lymphatic Disorders2015;3(1):119‐20. ">Raffetto 2015</a>); </p> </li> <li> <p>MMP‐7 (<a href="./references#CD012841-bbs2-0014" title="RaffettoJD , MostiG , SantiM , LigiD , MannelloF . Matrix metalloproteinase profiles in chronic venous ulcer wound fluid of inflammatory and granulating venous leg ulcers. Journal of Vascular Surgery: Venous and Lymphatic Disorders2015;3(1):119‐20. ">Raffetto 2015</a>); </p> </li> <li> <p>MMP‐8 (<a href="./references#CD012841-bbs2-0010" title="McDanielJC , SzalachaL , SalesM , RoyS , ChafeeS , ParinandiN . EPA + DHA supplementation reduces PMN activation in microenvironment of chronic venous leg ulcers: a randomized, double‐blind, controlled study. Wound Repair and Regeneration2017;25(4):680‐90. ">McDaniel 2017</a>; <a href="./references#CD012841-bbs2-0014" title="RaffettoJD , MostiG , SantiM , LigiD , MannelloF . Matrix metalloproteinase profiles in chronic venous ulcer wound fluid of inflammatory and granulating venous leg ulcers. Journal of Vascular Surgery: Venous and Lymphatic Disorders2015;3(1):119‐20. ">Raffetto 2015</a>); </p> </li> <li> <p>MMP‐9 (<a href="./references#CD012841-bbs2-0004" title="GohelMS , WindhaberRA , TarltonJF , WhymanMR , PoskittKR . The relationship between cytokine concentrations and wound healing in chronic venous ulceration. Journal of Vascular Surgery2008;48(5):1272‐7. ">Gohel 2008</a>; <a href="./references#CD012841-bbs2-0014" title="RaffettoJD , MostiG , SantiM , LigiD , MannelloF . Matrix metalloproteinase profiles in chronic venous ulcer wound fluid of inflammatory and granulating venous leg ulcers. Journal of Vascular Surgery: Venous and Lymphatic Disorders2015;3(1):119‐20. ">Raffetto 2015</a>; <a href="./references#CD012841-bbs2-0015" title="SerraR , BuffoneG , FalconeD , MolinariV , ScaramuzzinoM , GallelliL , et al. Chronic venous leg ulcers are associated with high levels of metalloproteinases‐9 and neutrophil gelatinase‐associated lipocalin. Wound Repair and Regeneration2013;21(3):395‐401. ">Serra 2013</a>; <a href="./references#CD012841-bbs2-0016" title="SerraR , GallelliL , BuffoneG , MolinariV , StillitanoDM , PalmieriC , et al. Doxycycline speeds up healing of chronic venous ulcers. International Wound Journal2015;12(2):179‐84. ">Serra 2015a</a>/<a href="./references#CD012841-bbs2-0017" title="SerraR , GallelliL , BuffoneG , MolinariV , StillitanoDM , PalmieriC , et al. Doxycycline speeds up healing of chronic venous ulcers. International Wound Journal2015;12(2):179‐84. ">Serra 2015b</a>); </p> </li> <li> <p>MMP‐10 (<a href="./references#CD012841-bbs2-0014" title="RaffettoJD , MostiG , SantiM , LigiD , MannelloF . Matrix metalloproteinase profiles in chronic venous ulcer wound fluid of inflammatory and granulating venous leg ulcers. Journal of Vascular Surgery: Venous and Lymphatic Disorders2015;3(1):119‐20. ">Raffetto 2015</a>); </p> </li> <li> <p>MMP‐12 (<a href="./references#CD012841-bbs2-0014" title="RaffettoJD , MostiG , SantiM , LigiD , MannelloF . Matrix metalloproteinase profiles in chronic venous ulcer wound fluid of inflammatory and granulating venous leg ulcers. Journal of Vascular Surgery: Venous and Lymphatic Disorders2015;3(1):119‐20. ">Raffetto 2015</a>); </p> </li> <li> <p>MMP‐13 (<a href="./references#CD012841-bbs2-0014" title="RaffettoJD , MostiG , SantiM , LigiD , MannelloF . Matrix metalloproteinase profiles in chronic venous ulcer wound fluid of inflammatory and granulating venous leg ulcers. Journal of Vascular Surgery: Venous and Lymphatic Disorders2015;3(1):119‐20. ">Raffetto 2015</a>); </p> </li> <li> <p>MMP‐unspecified (<a href="./references#CD012841-bbs2-0006" title="HarrisIR , YeeKC , WaltersCE , CunliffeWJ , KearneyJN , WoodEJ , et al. Cytokine and protease levels in healing and non‐healing chronic venous leg ulcers. Experimental Dermatology1995;4(6):342‐9. ">Harris 1995</a>; <a href="./references#CD012841-bbs2-0011" title="MoffattCJ , StantonJ , MurrayS , DoodyV , DavisPJ , FranksPJ . A randomised trial to compare the performance of Oxyzyme and Iodozyme with standard care in the treatment of patients with venous and mixed venous/arterial ulceration. Wound Medicine2014;6:1‐10. ">Moffatt 2014a</a>/<a href="./references#CD012841-bbs2-0012" title="MoffattCJ , StantonJ , MurrayS , DoodyV , DavisPJ , FranksPJ . A randomised trial to compare the performance of Oxyzyme and Iodozyme with standard care in the treatment of patients with venous and mixed venous/arterial ulceration. Wound Medicine2014;6:1‐10. ">Moffatt 2014b</a>); </p> </li> <li> <p>HNE (<a href="./references#CD012841-bbs2-0002" title="CullenB , GibsonM , NisbetL . Targeted use of collagen/ORC improves clinical outcomes. Wound Repair and Regeneration2012;20(5):A93. ">Cullen 2012</a>; <a href="./references#CD012841-bbs2-0007" title="HoffmanR , NobleJ , EagleM . The use of proteases as prognostic markers for the healing of venous leg ulcers. Journal of Wound Care1999;8(6):273‐6. ">Hoffman 1999</a>; <a href="./references#CD012841-bbs2-0010" title="McDanielJC , SzalachaL , SalesM , RoyS , ChafeeS , ParinandiN . EPA + DHA supplementation reduces PMN activation in microenvironment of chronic venous leg ulcers: a randomized, double‐blind, controlled study. Wound Repair and Regeneration2017;25(4):680‐90. ">McDaniel 2017</a>); </p> </li> <li> <p>uPA (<a href="./references#CD012841-bbs2-0001" title="AhmadA , SahaP , EvansC , ThurisonT , Hoyer‐HansenG , PatelA , et al. The soluble urokinase plasminogen activator receptor and its fragments in venous ulcers. Journal of Vascular Surgery: Venous and Lymphatic Disorders2015;3(2):190‐7. ">Ahmad 2015</a>). </p> </li> </ul> </p> <p>No study clearly measured bacteria‐specific proteases and no studies reported ratios of biomarkers and their inhibitors. </p> <p>Studies reported different methods for extracting wound fluid for analysis of protease activity: occlusive dressings (<a href="./references#CD012841-bbs2-0001" title="AhmadA , SahaP , EvansC , ThurisonT , Hoyer‐HansenG , PatelA , et al. The soluble urokinase plasminogen activator receptor and its fragments in venous ulcers. Journal of Vascular Surgery: Venous and Lymphatic Disorders2015;3(2):190‐7. ">Ahmad 2015</a>; <a href="./references#CD012841-bbs2-0004" title="GohelMS , WindhaberRA , TarltonJF , WhymanMR , PoskittKR . The relationship between cytokine concentrations and wound healing in chronic venous ulceration. Journal of Vascular Surgery2008;48(5):1272‐7. ">Gohel 2008</a>; <a href="./references#CD012841-bbs2-0006" title="HarrisIR , YeeKC , WaltersCE , CunliffeWJ , KearneyJN , WoodEJ , et al. Cytokine and protease levels in healing and non‐healing chronic venous leg ulcers. Experimental Dermatology1995;4(6):342‐9. ">Harris 1995</a>; <a href="./references#CD012841-bbs2-0010" title="McDanielJC , SzalachaL , SalesM , RoyS , ChafeeS , ParinandiN . EPA + DHA supplementation reduces PMN activation in microenvironment of chronic venous leg ulcers: a randomized, double‐blind, controlled study. Wound Repair and Regeneration2017;25(4):680‐90. ">McDaniel 2017</a>; <a href="./references#CD012841-bbs2-0015" title="SerraR , BuffoneG , FalconeD , MolinariV , ScaramuzzinoM , GallelliL , et al. Chronic venous leg ulcers are associated with high levels of metalloproteinases‐9 and neutrophil gelatinase‐associated lipocalin. Wound Repair and Regeneration2013;21(3):395‐401. ">Serra 2013</a>); entrapment in dressings (<a href="./references#CD012841-bbs2-0007" title="HoffmanR , NobleJ , EagleM . The use of proteases as prognostic markers for the healing of venous leg ulcers. Journal of Wound Care1999;8(6):273‐6. ">Hoffman 1999</a>; <a href="./references#CD012841-bbs2-0013" title="MwauraB , MahendranB , HynesN , DefreitasD , AvalosG , AdegbolaT , et al. The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase‐2, tissue inhibitor of matrix metalloproteinase‐2 and PDGF‐AA on the chronicity of venous leg ulcers. European Journal of Vascular and Endovascular Surgery2006;31(3):306‐10. ">Mwaura 2006</a>; <a href="./references#CD012841-bbs2-0014" title="RaffettoJD , MostiG , SantiM , LigiD , MannelloF . Matrix metalloproteinase profiles in chronic venous ulcer wound fluid of inflammatory and granulating venous leg ulcers. Journal of Vascular Surgery: Venous and Lymphatic Disorders2015;3(1):119‐20. ">Raffetto 2015</a>), with two of these studies using dressings already used for treatment (<a href="./references#CD012841-bbs2-0007" title="HoffmanR , NobleJ , EagleM . The use of proteases as prognostic markers for the healing of venous leg ulcers. Journal of Wound Care1999;8(6):273‐6. ">Hoffman 1999</a>; <a href="./references#CD012841-bbs2-0013" title="MwauraB , MahendranB , HynesN , DefreitasD , AvalosG , AdegbolaT , et al. The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase‐2, tissue inhibitor of matrix metalloproteinase‐2 and PDGF‐AA on the chronicity of venous leg ulcers. European Journal of Vascular and Endovascular Surgery2006;31(3):306‐10. ">Mwaura 2006</a>); swabs (<a href="./references#CD012841-bbs2-0011" title="MoffattCJ , StantonJ , MurrayS , DoodyV , DavisPJ , FranksPJ . A randomised trial to compare the performance of Oxyzyme and Iodozyme with standard care in the treatment of patients with venous and mixed venous/arterial ulceration. Wound Medicine2014;6:1‐10. ">Moffatt 2014a</a>/<a href="./references#CD012841-bbs2-0012" title="MoffattCJ , StantonJ , MurrayS , DoodyV , DavisPJ , FranksPJ . A randomised trial to compare the performance of Oxyzyme and Iodozyme with standard care in the treatment of patients with venous and mixed venous/arterial ulceration. Wound Medicine2014;6:1‐10. ">Moffatt 2014b</a>); and not stated (<a href="./references#CD012841-bbs2-0002" title="CullenB , GibsonM , NisbetL . Targeted use of collagen/ORC improves clinical outcomes. Wound Repair and Regeneration2012;20(5):A93. ">Cullen 2012</a>; <a href="./references#CD012841-bbs2-0016" title="SerraR , GallelliL , BuffoneG , MolinariV , StillitanoDM , PalmieriC , et al. Doxycycline speeds up healing of chronic venous ulcers. International Wound Journal2015;12(2):179‐84. ">Serra 2015a</a>/<a href="./references#CD012841-bbs2-0017" title="SerraR , GallelliL , BuffoneG , MolinariV , StillitanoDM , PalmieriC , et al. Doxycycline speeds up healing of chronic venous ulcers. International Wound Journal2015;12(2):179‐84. ">Serra 2015b</a>). </p> <p>Studies measured protease using ELISA techniques (<a href="./references#CD012841-bbs2-0001" title="AhmadA , SahaP , EvansC , ThurisonT , Hoyer‐HansenG , PatelA , et al. The soluble urokinase plasminogen activator receptor and its fragments in venous ulcers. Journal of Vascular Surgery: Venous and Lymphatic Disorders2015;3(2):190‐7. ">Ahmad 2015</a>; <a href="./references#CD012841-bbs2-0010" title="McDanielJC , SzalachaL , SalesM , RoyS , ChafeeS , ParinandiN . EPA + DHA supplementation reduces PMN activation in microenvironment of chronic venous leg ulcers: a randomized, double‐blind, controlled study. Wound Repair and Regeneration2017;25(4):680‐90. ">McDaniel 2017</a>; <a href="./references#CD012841-bbs2-0013" title="MwauraB , MahendranB , HynesN , DefreitasD , AvalosG , AdegbolaT , et al. The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase‐2, tissue inhibitor of matrix metalloproteinase‐2 and PDGF‐AA on the chronicity of venous leg ulcers. European Journal of Vascular and Endovascular Surgery2006;31(3):306‐10. ">Mwaura 2006</a>; <a href="./references#CD012841-bbs2-0014" title="RaffettoJD , MostiG , SantiM , LigiD , MannelloF . Matrix metalloproteinase profiles in chronic venous ulcer wound fluid of inflammatory and granulating venous leg ulcers. Journal of Vascular Surgery: Venous and Lymphatic Disorders2015;3(1):119‐20. ">Raffetto 2015</a>; <a href="./references#CD012841-bbs2-0015" title="SerraR , BuffoneG , FalconeD , MolinariV , ScaramuzzinoM , GallelliL , et al. Chronic venous leg ulcers are associated with high levels of metalloproteinases‐9 and neutrophil gelatinase‐associated lipocalin. Wound Repair and Regeneration2013;21(3):395‐401. ">Serra 2013</a>; <a href="./references#CD012841-bbs2-0016" title="SerraR , GallelliL , BuffoneG , MolinariV , StillitanoDM , PalmieriC , et al. Doxycycline speeds up healing of chronic venous ulcers. International Wound Journal2015;12(2):179‐84. ">Serra 2015a</a>/<a href="./references#CD012841-bbs2-0017" title="SerraR , GallelliL , BuffoneG , MolinariV , StillitanoDM , PalmieriC , et al. Doxycycline speeds up healing of chronic venous ulcers. International Wound Journal2015;12(2):179‐84. ">Serra 2015b</a>); fluorogenic substrate assay (<a href="./references#CD012841-bbs2-0002" title="CullenB , GibsonM , NisbetL . Targeted use of collagen/ORC improves clinical outcomes. Wound Repair and Regeneration2012;20(5):A93. ">Cullen 2012</a>); gelatin zymography (<a href="./references#CD012841-bbs2-0004" title="GohelMS , WindhaberRA , TarltonJF , WhymanMR , PoskittKR . The relationship between cytokine concentrations and wound healing in chronic venous ulceration. Journal of Vascular Surgery2008;48(5):1272‐7. ">Gohel 2008</a>); and other activity assays (<a href="./references#CD012841-bbs2-0006" title="HarrisIR , YeeKC , WaltersCE , CunliffeWJ , KearneyJN , WoodEJ , et al. Cytokine and protease levels in healing and non‐healing chronic venous leg ulcers. Experimental Dermatology1995;4(6):342‐9. ">Harris 1995</a>; <a href="./references#CD012841-bbs2-0007" title="HoffmanR , NobleJ , EagleM . The use of proteases as prognostic markers for the healing of venous leg ulcers. Journal of Wound Care1999;8(6):273‐6. ">Hoffman 1999</a>; <a href="./references#CD012841-bbs2-0010" title="McDanielJC , SzalachaL , SalesM , RoyS , ChafeeS , ParinandiN . EPA + DHA supplementation reduces PMN activation in microenvironment of chronic venous leg ulcers: a randomized, double‐blind, controlled study. Wound Repair and Regeneration2017;25(4):680‐90. ">McDaniel 2017</a>; <a href="./references#CD012841-bbs2-0011" title="MoffattCJ , StantonJ , MurrayS , DoodyV , DavisPJ , FranksPJ . A randomised trial to compare the performance of Oxyzyme and Iodozyme with standard care in the treatment of patients with venous and mixed venous/arterial ulceration. Wound Medicine2014;6:1‐10. ">Moffatt 2014a</a>/<a href="./references#CD012841-bbs2-0012" title="MoffattCJ , StantonJ , MurrayS , DoodyV , DavisPJ , FranksPJ . A randomised trial to compare the performance of Oxyzyme and Iodozyme with standard care in the treatment of patients with venous and mixed venous/arterial ulceration. Wound Medicine2014;6:1‐10. ">Moffatt 2014b</a>). One study reported measurement only of pro‐MMP (and this was not cleaved to give the active form; <a href="./references#CD012841-bbs2-0004" title="GohelMS , WindhaberRA , TarltonJF , WhymanMR , PoskittKR . The relationship between cytokine concentrations and wound healing in chronic venous ulceration. Journal of Vascular Surgery2008;48(5):1272‐7. ">Gohel 2008</a>); another study (<a href="./references#CD012841-bbs2-0001" title="AhmadA , SahaP , EvansC , ThurisonT , Hoyer‐HansenG , PatelA , et al. The soluble urokinase plasminogen activator receptor and its fragments in venous ulcers. Journal of Vascular Surgery: Venous and Lymphatic Disorders2015;3(2):190‐7. ">Ahmad 2015</a>) measured total uPA including bound and complexed forms, with the active form level being below the level of the bioassay; <a href="./references#CD012841-bbs2-0006" title="HarrisIR , YeeKC , WaltersCE , CunliffeWJ , KearneyJN , WoodEJ , et al. Cytokine and protease levels in healing and non‐healing chronic venous leg ulcers. Experimental Dermatology1995;4(6):342‐9. ">Harris 1995</a> separately reported total, active and latent forms of MMP; three studies reported 'activity' (<a href="./references#CD012841-bbs2-0002" title="CullenB , GibsonM , NisbetL . Targeted use of collagen/ORC improves clinical outcomes. Wound Repair and Regeneration2012;20(5):A93. ">Cullen 2012</a>; <a href="./references#CD012841-bbs2-0007" title="HoffmanR , NobleJ , EagleM . The use of proteases as prognostic markers for the healing of venous leg ulcers. Journal of Wound Care1999;8(6):273‐6. ">Hoffman 1999</a>; <a href="./references#CD012841-bbs2-0011" title="MoffattCJ , StantonJ , MurrayS , DoodyV , DavisPJ , FranksPJ . A randomised trial to compare the performance of Oxyzyme and Iodozyme with standard care in the treatment of patients with venous and mixed venous/arterial ulceration. Wound Medicine2014;6:1‐10. ">Moffatt 2014a</a>/<a href="./references#CD012841-bbs2-0012" title="MoffattCJ , StantonJ , MurrayS , DoodyV , DavisPJ , FranksPJ . A randomised trial to compare the performance of Oxyzyme and Iodozyme with standard care in the treatment of patients with venous and mixed venous/arterial ulceration. Wound Medicine2014;6:1‐10. ">Moffatt 2014b</a>); one study appeared to measure total MMP (<a href="./references#CD012841-bbs2-0013" title="MwauraB , MahendranB , HynesN , DefreitasD , AvalosG , AdegbolaT , et al. The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase‐2, tissue inhibitor of matrix metalloproteinase‐2 and PDGF‐AA on the chronicity of venous leg ulcers. European Journal of Vascular and Endovascular Surgery2006;31(3):306‐10. ">Mwaura 2006</a>); and the other studies reported concentrations (<a href="./references#CD012841-bbs2-0010" title="McDanielJC , SzalachaL , SalesM , RoyS , ChafeeS , ParinandiN . EPA + DHA supplementation reduces PMN activation in microenvironment of chronic venous leg ulcers: a randomized, double‐blind, controlled study. Wound Repair and Regeneration2017;25(4):680‐90. ">McDaniel 2017</a>; <a href="./references#CD012841-bbs2-0014" title="RaffettoJD , MostiG , SantiM , LigiD , MannelloF . Matrix metalloproteinase profiles in chronic venous ulcer wound fluid of inflammatory and granulating venous leg ulcers. Journal of Vascular Surgery: Venous and Lymphatic Disorders2015;3(1):119‐20. ">Raffetto 2015</a>; <a href="./references#CD012841-bbs2-0015" title="SerraR , BuffoneG , FalconeD , MolinariV , ScaramuzzinoM , GallelliL , et al. Chronic venous leg ulcers are associated with high levels of metalloproteinases‐9 and neutrophil gelatinase‐associated lipocalin. Wound Repair and Regeneration2013;21(3):395‐401. ">Serra 2013</a>; <a href="./references#CD012841-bbs2-0016" title="SerraR , GallelliL , BuffoneG , MolinariV , StillitanoDM , PalmieriC , et al. Doxycycline speeds up healing of chronic venous ulcers. International Wound Journal2015;12(2):179‐84. ">Serra 2015a</a>/<a href="./references#CD012841-bbs2-0017" title="SerraR , GallelliL , BuffoneG , MolinariV , StillitanoDM , PalmieriC , et al. Doxycycline speeds up healing of chronic venous ulcers. International Wound Journal2015;12(2):179‐84. ">Serra 2015b</a>), but it was unclear whether this meant total MMPs (active and pro‐MMP forms). </p> <p>Two studies used a cut‐off point for the prognostic factor: <a href="./references#CD012841-bbs2-0002" title="CullenB , GibsonM , NisbetL . Targeted use of collagen/ORC improves clinical outcomes. Wound Repair and Regeneration2012;20(5):A93. ">Cullen 2012</a> used greater than 25 mU/110 µL for elastase (taken from their work in diagnostic studies (<a href="./references#CD012841-bbs2-0224" title="SerenaT , CullenB , BayliffS , GibsonM , DeMarcoD , GalbraithJ , et al. Protease activity levels associated with healing status of chronic wounds. 2011. www.woundchek.com/uploads/downloads/posters_articles/Protease‐Activity‐Levels‐Associated‐with‐Healing‐Status‐of‐Chronic‐Wounds.pdf (accessed 31 January 2018). ">Serena 2011</a>)) and <a href="./references#CD012841-bbs2-0011" title="MoffattCJ , StantonJ , MurrayS , DoodyV , DavisPJ , FranksPJ . A randomised trial to compare the performance of Oxyzyme and Iodozyme with standard care in the treatment of patients with venous and mixed venous/arterial ulceration. Wound Medicine2014;6:1‐10. ">Moffatt 2014a</a>/<a href="./references#CD012841-bbs2-0012" title="MoffattCJ , StantonJ , MurrayS , DoodyV , DavisPJ , FranksPJ . A randomised trial to compare the performance of Oxyzyme and Iodozyme with standard care in the treatment of patients with venous and mixed venous/arterial ulceration. Wound Medicine2014;6:1‐10. ">Moffatt 2014b</a> used an activity score of 5 or more to define high activity on a scale of 0 to 10 for MMPs (unspecified). The other studies reported the prognostic factor as a continuous measure, sometimes in relation to a standard (<a href="./references#CD012841-bbs2-0001" title="AhmadA , SahaP , EvansC , ThurisonT , Hoyer‐HansenG , PatelA , et al. The soluble urokinase plasminogen activator receptor and its fragments in venous ulcers. Journal of Vascular Surgery: Venous and Lymphatic Disorders2015;3(2):190‐7. ">Ahmad 2015</a>; <a href="./references#CD012841-bbs2-0004" title="GohelMS , WindhaberRA , TarltonJF , WhymanMR , PoskittKR . The relationship between cytokine concentrations and wound healing in chronic venous ulceration. Journal of Vascular Surgery2008;48(5):1272‐7. ">Gohel 2008</a>; <a href="./references#CD012841-bbs2-0007" title="HoffmanR , NobleJ , EagleM . The use of proteases as prognostic markers for the healing of venous leg ulcers. Journal of Wound Care1999;8(6):273‐6. ">Hoffman 1999</a>), or per total protein in the sample (<a href="./references#CD012841-bbs2-0010" title="McDanielJC , SzalachaL , SalesM , RoyS , ChafeeS , ParinandiN . EPA + DHA supplementation reduces PMN activation in microenvironment of chronic venous leg ulcers: a randomized, double‐blind, controlled study. Wound Repair and Regeneration2017;25(4):680‐90. ">McDaniel 2017</a>; <a href="./references#CD012841-bbs2-0015" title="SerraR , BuffoneG , FalconeD , MolinariV , ScaramuzzinoM , GallelliL , et al. Chronic venous leg ulcers are associated with high levels of metalloproteinases‐9 and neutrophil gelatinase‐associated lipocalin. Wound Repair and Regeneration2013;21(3):395‐401. ">Serra 2013</a>; <a href="./references#CD012841-bbs2-0016" title="SerraR , GallelliL , BuffoneG , MolinariV , StillitanoDM , PalmieriC , et al. Doxycycline speeds up healing of chronic venous ulcers. International Wound Journal2015;12(2):179‐84. ">Serra 2015a</a>/<a href="./references#CD012841-bbs2-0017" title="SerraR , GallelliL , BuffoneG , MolinariV , StillitanoDM , PalmieriC , et al. Doxycycline speeds up healing of chronic venous ulcers. International Wound Journal2015;12(2):179‐84. ">Serra 2015b</a>), or as a concentration (<a href="./references#CD012841-bbs2-0005" title="GrzelaT , Niderla‐BielinskaJ , LitwiniukM , WhiteR . The direct inhibition of MMP‐2 and MMP‐9 by an enzyme alginogel: a possible mechanism of healing support for venous leg ulcers. Journal of Wound Care2014;23(5):278, 280‐2, 284. ">Grzela 2014</a>; <a href="./references#CD012841-bbs2-0013" title="MwauraB , MahendranB , HynesN , DefreitasD , AvalosG , AdegbolaT , et al. The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase‐2, tissue inhibitor of matrix metalloproteinase‐2 and PDGF‐AA on the chronicity of venous leg ulcers. European Journal of Vascular and Endovascular Surgery2006;31(3):306‐10. ">Mwaura 2006</a>; <a href="./references#CD012841-bbs2-0014" title="RaffettoJD , MostiG , SantiM , LigiD , MannelloF . Matrix metalloproteinase profiles in chronic venous ulcer wound fluid of inflammatory and granulating venous leg ulcers. Journal of Vascular Surgery: Venous and Lymphatic Disorders2015;3(1):119‐20. ">Raffetto 2015</a>). </p> <p>This variability in sampling, measurement techniques and use of standards meant that analyses of continuous outcomes were conducted using standardised mean differences. </p> </section> <section id="CD012841-sec-0066"> <h4 class="title">Outcome measures</h4> <p>Studies measured healing in several ways: only three studies reported complete healing as a dichotomous outcome (<a href="./references#CD012841-bbs2-0001" title="AhmadA , SahaP , EvansC , ThurisonT , Hoyer‐HansenG , PatelA , et al. The soluble urokinase plasminogen activator receptor and its fragments in venous ulcers. Journal of Vascular Surgery: Venous and Lymphatic Disorders2015;3(2):190‐7. ">Ahmad 2015</a>; <a href="./references#CD012841-bbs2-0007" title="HoffmanR , NobleJ , EagleM . The use of proteases as prognostic markers for the healing of venous leg ulcers. Journal of Wound Care1999;8(6):273‐6. ">Hoffman 1999</a>; <a href="./references#CD012841-bbs2-0011" title="MoffattCJ , StantonJ , MurrayS , DoodyV , DavisPJ , FranksPJ . A randomised trial to compare the performance of Oxyzyme and Iodozyme with standard care in the treatment of patients with venous and mixed venous/arterial ulceration. Wound Medicine2014;6:1‐10. ">Moffatt 2014a</a>/<a href="./references#CD012841-bbs2-0012" title="MoffattCJ , StantonJ , MurrayS , DoodyV , DavisPJ , FranksPJ . A randomised trial to compare the performance of Oxyzyme and Iodozyme with standard care in the treatment of patients with venous and mixed venous/arterial ulceration. Wound Medicine2014;6:1‐10. ">Moffatt 2014b</a>). Five studies reported partial healing (other dichotomous measures of 'healing'), compared with 'no healing,' defined as follows: </p> <p> <ul id="CD012841-list-0012"> <li> <p>reduction in area of 30% or greater over four weeks versus no healing (<a href="./references#CD012841-bbs2-0002" title="CullenB , GibsonM , NisbetL . Targeted use of collagen/ORC improves clinical outcomes. Wound Repair and Regeneration2012;20(5):A93. ">Cullen 2012</a>); </p> </li> <li> <p>decreased size (greater than 20%), decrease in slough and development of healthy granulation tissue versus no healing (<a href="./references#CD012841-bbs2-0013" title="MwauraB , MahendranB , HynesN , DefreitasD , AvalosG , AdegbolaT , et al. The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase‐2, tissue inhibitor of matrix metalloproteinase‐2 and PDGF‐AA on the chronicity of venous leg ulcers. European Journal of Vascular and Endovascular Surgery2006;31(3):306‐10. ">Mwaura 2006</a>); </p> </li> <li> <p>categorical healing: high healing (1 cm²/week or greater); low healing (less than 1 cm²/week) and no healing (<a href="./references#CD012841-bbs2-0015" title="SerraR , BuffoneG , FalconeD , MolinariV , ScaramuzzinoM , GallelliL , et al. Chronic venous leg ulcers are associated with high levels of metalloproteinases‐9 and neutrophil gelatinase‐associated lipocalin. Wound Repair and Regeneration2013;21(3):395‐401. ">Serra 2013</a>); </p> </li> <li> <p>granulating wounds versus non‐granulating/inflammatory wounds (<a href="./references#CD012841-bbs2-0006" title="HarrisIR , YeeKC , WaltersCE , CunliffeWJ , KearneyJN , WoodEJ , et al. Cytokine and protease levels in healing and non‐healing chronic venous leg ulcers. Experimental Dermatology1995;4(6):342‐9. ">Harris 1995</a>; <a href="./references#CD012841-bbs2-0014" title="RaffettoJD , MostiG , SantiM , LigiD , MannelloF . Matrix metalloproteinase profiles in chronic venous ulcer wound fluid of inflammatory and granulating venous leg ulcers. Journal of Vascular Surgery: Venous and Lymphatic Disorders2015;3(1):119‐20. ">Raffetto 2015</a>). </p> </li> </ul> </p> <p>Two studies compared different degrees of healing:</p> <p> <ul id="CD012841-list-0013"> <li> <p>high healing (1 cm²/week or greater) versus low healing (less than 1 cm²/week) (<a href="./references#CD012841-bbs2-0015" title="SerraR , BuffoneG , FalconeD , MolinariV , ScaramuzzinoM , GallelliL , et al. Chronic venous leg ulcers are associated with high levels of metalloproteinases‐9 and neutrophil gelatinase‐associated lipocalin. Wound Repair and Regeneration2013;21(3):395‐401. ">Serra 2013</a>; <a href="./references#CD012841-bbs2-0016" title="SerraR , GallelliL , BuffoneG , MolinariV , StillitanoDM , PalmieriC , et al. Doxycycline speeds up healing of chronic venous ulcers. International Wound Journal2015;12(2):179‐84. ">Serra 2015a</a>/<a href="./references#CD012841-bbs2-0017" title="SerraR , GallelliL , BuffoneG , MolinariV , StillitanoDM , PalmieriC , et al. Doxycycline speeds up healing of chronic venous ulcers. International Wound Journal2015;12(2):179‐84. ">Serra 2015b</a>). </p> </li> </ul> </p> <p>Three studies reported the outcome as a continuous measure: one measured the change in size (<a href="./references#CD012841-bbs2-0004" title="GohelMS , WindhaberRA , TarltonJF , WhymanMR , PoskittKR . The relationship between cytokine concentrations and wound healing in chronic venous ulceration. Journal of Vascular Surgery2008;48(5):1272‐7. ">Gohel 2008</a>), and the others the percentage change in size from baseline (<a href="./references#CD012841-bbs2-0007" title="HoffmanR , NobleJ , EagleM . The use of proteases as prognostic markers for the healing of venous leg ulcers. Journal of Wound Care1999;8(6):273‐6. ">Hoffman 1999</a>; <a href="./references#CD012841-bbs2-0010" title="McDanielJC , SzalachaL , SalesM , RoyS , ChafeeS , ParinandiN . EPA + DHA supplementation reduces PMN activation in microenvironment of chronic venous leg ulcers: a randomized, double‐blind, controlled study. Wound Repair and Regeneration2017;25(4):680‐90. ">McDaniel 2017</a>). </p> </section> <section id="CD012841-sec-0067"> <h4 class="title">Interventions</h4> <p>Nine studies reported that the participants received compression therapy (<a href="./references#CD012841-bbs2-0001" title="AhmadA , SahaP , EvansC , ThurisonT , Hoyer‐HansenG , PatelA , et al. The soluble urokinase plasminogen activator receptor and its fragments in venous ulcers. Journal of Vascular Surgery: Venous and Lymphatic Disorders2015;3(2):190‐7. ">Ahmad 2015</a>; <a href="./references#CD012841-bbs2-0002" title="CullenB , GibsonM , NisbetL . Targeted use of collagen/ORC improves clinical outcomes. Wound Repair and Regeneration2012;20(5):A93. ">Cullen 2012</a>; <a href="./references#CD012841-bbs2-0004" title="GohelMS , WindhaberRA , TarltonJF , WhymanMR , PoskittKR . The relationship between cytokine concentrations and wound healing in chronic venous ulceration. Journal of Vascular Surgery2008;48(5):1272‐7. ">Gohel 2008</a>; <a href="./references#CD012841-bbs2-0007" title="HoffmanR , NobleJ , EagleM . The use of proteases as prognostic markers for the healing of venous leg ulcers. Journal of Wound Care1999;8(6):273‐6. ">Hoffman 1999</a>; <a href="./references#CD012841-bbs2-0010" title="McDanielJC , SzalachaL , SalesM , RoyS , ChafeeS , ParinandiN . EPA + DHA supplementation reduces PMN activation in microenvironment of chronic venous leg ulcers: a randomized, double‐blind, controlled study. Wound Repair and Regeneration2017;25(4):680‐90. ">McDaniel 2017</a>; <a href="./references#CD012841-bbs2-0011" title="MoffattCJ , StantonJ , MurrayS , DoodyV , DavisPJ , FranksPJ . A randomised trial to compare the performance of Oxyzyme and Iodozyme with standard care in the treatment of patients with venous and mixed venous/arterial ulceration. Wound Medicine2014;6:1‐10. ">Moffatt 2014a</a>/<a href="./references#CD012841-bbs2-0012" title="MoffattCJ , StantonJ , MurrayS , DoodyV , DavisPJ , FranksPJ . A randomised trial to compare the performance of Oxyzyme and Iodozyme with standard care in the treatment of patients with venous and mixed venous/arterial ulceration. Wound Medicine2014;6:1‐10. ">Moffatt 2014b</a>; <a href="./references#CD012841-bbs2-0013" title="MwauraB , MahendranB , HynesN , DefreitasD , AvalosG , AdegbolaT , et al. The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase‐2, tissue inhibitor of matrix metalloproteinase‐2 and PDGF‐AA on the chronicity of venous leg ulcers. European Journal of Vascular and Endovascular Surgery2006;31(3):306‐10. ">Mwaura 2006</a>; <a href="./references#CD012841-bbs2-0015" title="SerraR , BuffoneG , FalconeD , MolinariV , ScaramuzzinoM , GallelliL , et al. Chronic venous leg ulcers are associated with high levels of metalloproteinases‐9 and neutrophil gelatinase‐associated lipocalin. Wound Repair and Regeneration2013;21(3):395‐401. ">Serra 2013</a>; <a href="./references#CD012841-bbs2-0016" title="SerraR , GallelliL , BuffoneG , MolinariV , StillitanoDM , PalmieriC , et al. Doxycycline speeds up healing of chronic venous ulcers. International Wound Journal2015;12(2):179‐84. ">Serra 2015a</a>/<a href="./references#CD012841-bbs2-0017" title="SerraR , GallelliL , BuffoneG , MolinariV , StillitanoDM , PalmieriC , et al. Doxycycline speeds up healing of chronic venous ulcers. International Wound Journal2015;12(2):179‐84. ">Serra 2015b</a>). Two studies gave no information on compression interventions (<a href="./references#CD012841-bbs2-0006" title="HarrisIR , YeeKC , WaltersCE , CunliffeWJ , KearneyJN , WoodEJ , et al. Cytokine and protease levels in healing and non‐healing chronic venous leg ulcers. Experimental Dermatology1995;4(6):342‐9. ">Harris 1995</a>; <a href="./references#CD012841-bbs2-0014" title="RaffettoJD , MostiG , SantiM , LigiD , MannelloF . Matrix metalloproteinase profiles in chronic venous ulcer wound fluid of inflammatory and granulating venous leg ulcers. Journal of Vascular Surgery: Venous and Lymphatic Disorders2015;3(1):119‐20. ">Raffetto 2015</a>). </p> <p>In addition to compression, two studies received vein surgery, as appropriate (<a href="./references#CD012841-bbs2-0015" title="SerraR , BuffoneG , FalconeD , MolinariV , ScaramuzzinoM , GallelliL , et al. Chronic venous leg ulcers are associated with high levels of metalloproteinases‐9 and neutrophil gelatinase‐associated lipocalin. Wound Repair and Regeneration2013;21(3):395‐401. ">Serra 2013</a>; <a href="./references#CD012841-bbs2-0016" title="SerraR , GallelliL , BuffoneG , MolinariV , StillitanoDM , PalmieriC , et al. Doxycycline speeds up healing of chronic venous ulcers. International Wound Journal2015;12(2):179‐84. ">Serra 2015a</a>/<a href="./references#CD012841-bbs2-0017" title="SerraR , GallelliL , BuffoneG , MolinariV , StillitanoDM , PalmieriC , et al. Doxycycline speeds up healing of chronic venous ulcers. International Wound Journal2015;12(2):179‐84. ">Serra 2015b</a>). Six studies received other treatments, some of which were likely or possible protease‐modulating dressings: </p> <p> <ul id="CD012841-list-0014"> <li> <p>likely protease modulating: <a href="./references#CD012841-bbs2-0002" title="CullenB , GibsonM , NisbetL . Targeted use of collagen/ORC improves clinical outcomes. Wound Repair and Regeneration2012;20(5):A93. ">Cullen 2012</a> (randomised to collagen/oxidised regenerated cellulose (ORC) matrix with or without silver); </p> </li> <li> <p>possible protease modulating: <a href="./references#CD012841-bbs2-0011" title="MoffattCJ , StantonJ , MurrayS , DoodyV , DavisPJ , FranksPJ . A randomised trial to compare the performance of Oxyzyme and Iodozyme with standard care in the treatment of patients with venous and mixed venous/arterial ulceration. Wound Medicine2014;6:1‐10. ">Moffatt 2014a</a> (oxyzyme or iodozyme plus basic treatment); <a href="./references#CD012841-bbs2-0016" title="SerraR , GallelliL , BuffoneG , MolinariV , StillitanoDM , PalmieriC , et al. Doxycycline speeds up healing of chronic venous ulcers. International Wound Journal2015;12(2):179‐84. ">Serra 2015a</a> (doxycycline); <a href="./references#CD012841-bbs2-0010" title="McDanielJC , SzalachaL , SalesM , RoyS , ChafeeS , ParinandiN . EPA + DHA supplementation reduces PMN activation in microenvironment of chronic venous leg ulcers: a randomized, double‐blind, controlled study. Wound Repair and Regeneration2017;25(4):680‐90. ">McDaniel 2017</a> (oral n‐3 eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) plus silver dressing); </p> </li> <li> <p>unlikely to be protease modulating: <a href="./references#CD012841-bbs2-0004" title="GohelMS , WindhaberRA , TarltonJF , WhymanMR , PoskittKR . The relationship between cytokine concentrations and wound healing in chronic venous ulceration. Journal of Vascular Surgery2008;48(5):1272‐7. ">Gohel 2008</a> (non‐adherent); <a href="./references#CD012841-bbs2-0007" title="HoffmanR , NobleJ , EagleM . The use of proteases as prognostic markers for the healing of venous leg ulcers. Journal of Wound Care1999;8(6):273‐6. ">Hoffman 1999</a> (non‐adherent, wool padding, etc.); <a href="./references#CD012841-bbs2-0012" title="MoffattCJ , StantonJ , MurrayS , DoodyV , DavisPJ , FranksPJ . A randomised trial to compare the performance of Oxyzyme and Iodozyme with standard care in the treatment of patients with venous and mixed venous/arterial ulceration. Wound Medicine2014;6:1‐10. ">Moffatt 2014b</a> (usual care continued); <a href="./references#CD012841-bbs2-0017" title="SerraR , GallelliL , BuffoneG , MolinariV , StillitanoDM , PalmieriC , et al. Doxycycline speeds up healing of chronic venous ulcers. International Wound Journal2015;12(2):179‐84. ">Serra 2015b</a> ('most appropriate treatment' ‐ basic treatment). </p> </li> </ul> </p> </section> </section> <section id="CD012841-sec-0068"> <h3 class="title" id="CD012841-sec-0068">Excluded studies</h3> <p>We excluded 110 studies from the review for the following main reasons (see <a href="./references#CD012841-sec-0144" title="">Characteristics of excluded studies</a> table): 13 studies had an ineligible population (<a href="./references#CD012841-bbs2-0032" title="Budzyn‐NapieralaM , IskraM , KrasinskiZ , TurkiewiczW , GryszczynskaB , KasprzakM , et al. Altered elastase‐alpha1‐antitrypsin balance in the blood of patients with chronic venous disease. Phlebology2016;31(2):125‐32. ">Budzyn‐Napierala 2016</a>; <a href="./references#CD012841-bbs2-0037" title="CullenB , WattPW , LundqvistC , SilcockD , SchmidtRJ , BoganD , et al. The role of oxidised regenerated cellulose/collagen in chronic wound repair and its potential mechanism of action. International Journal of Biochemistry &amp; Cell Biology2002;34(12):1544‐56. ">Cullen 2002b</a>; <a href="./references#CD012841-bbs2-0059" title="HondaK , OkamotoK , MochidaY , IshiokaK , OkaM , MaesatoK , et al. A novel mechanism in maggot debridement therapy: protease in excretion/secretion promotes hepatocyte growth factor production. American Journal of Physiology: Cell Physiology2011;301(6):C1423‐30. ">Honda 2011</a>; <a href="./references#CD012841-bbs2-0062" title="HuttunenM , HarvimaIT . Mast cell tryptase and chymase in chronic leg ulcers: chymase is potentially destructive to epithelium and is controlled by proteinase inhibitors. British Journal of Dermatology2005;152(6):1149‐60. ">Huttunen 2005</a>; <a href="./references#CD012841-bbs2-0066" title="KaratepeO , UnalO , UgurlucanM , KemikA , KarahanS , AksoyM , et al. The impact of valvular oxidative stress on the development of venous stasis ulcer valvular oxidative stress and venous ulcers. Angiology2010;61(3):283‐8. ">Karatepe 2010</a>; <a href="./references#CD012841-bbs2-0070" title="KucukguvenA , KhalilRA . Matrix metalloproteinases as potential targets in the venous dilation associated with varicose veins. Current Drug Targets2013;14(3):287‐324. ">Kucukguven 2013</a>; <a href="./references#CD012841-bbs2-0078" title="MirastschijskiU , ImpolaU , JahkolaT , KarlsmarkT , MsAG , Saarialho‐KereU . Ectopic localization of matrix metalloproteinase‐9 in chronic cutaneous wounds. Human Pathology2002;33(3):355‐64. ">Mirastschijski 2002</a>; <a href="./references#CD012841-bbs2-0099" title="SchultzG . Commentary on mechanism of action of PROMOGRAN, a protease modulating matrix, for the treatment of diabetic foot ulcers. Foot and Ankle Quarterly: the Seminar Journal2004;16(2):84. ">Schultz 2004</a>; <a href="./references#CD012841-bbs2-0102" title="SerraR , GallelliL , ContiA , DeCaridiG , MassaraM , SpinelliF , et al. The effects of sulodexide on both clinical and molecular parameters in patients with mixed arterial and venous ulcers of lower limbs. Drug Design, Development and Therapy2014;8:519‐27. ">Serra 2014</a>; <a href="./references#CD012841-bbs2-0107" title="ShieldsDA , AndazSK , SarinS , ScurrJH , Coleridge SmithPD . Plasma elastase in venous disease. British Journal of Surgery1994;81(10):1496‐9. ">Shields 1994</a>; <a href="./references#CD012841-bbs2-0121" title="VareliasA , HughesH , CowinA , CowledP , CooterR , HarriesR . Detection and modulation of matrix metalloproteinases in patients with chronic leg ulcers treated with whey‐derived growth factors. Fourth Australian Wound Management Association Conference; 2002 Mar 7‐10; Adelaide, South Australia. 2002:334. ">Varelias 2002</a>; <a href="./references#CD012841-bbs2-0122" title="VareliasA , CowinAJ , AdamsD , Harries RH CooterRD , BelfordD , et al. Mitogenic bovine whey extract modulates matrix metalloproteinase‐2, ‐9, and tissue inhibitor of matrix metalloproteinase‐2 levels in chronic leg ulcers. Wound Repair and Regeneration2006;14(1):28‐37. ">Varelias 2006</a>; <a href="./references#CD012841-bbs2-0129" title="ZamboniP , ScapoliG , LanzaraV , IzzoM , FortiniP , LegnaroR , et al. Serum iron and matrix metalloproteinase‐9 variations in limbs affected by chronic venous disease and venous leg ulcers. Dermatologic Surgery2005;31(6):644‐9. ">Zamboni 2005</a>); five did not assess a relevant prognostic factor (<a href="./references#CD012841-bbs2-0036" title="CookH , StephensP , DaviesKJ , HardingKG , ThomasDW . Phenotypic differences in wound healing responses are reflected by differences in ECM reorganisation and MMP‐2 activation. Journal of Gastroenterology and Hepatology2009;24:A88. ">Cook 2009</a>; <a href="./references#CD012841-bbs2-0063" title="IbbotsonSH , LaytonAM , DaviesJA , GoodfieldMJ . Plasminogen activator inhibitor 1 (PAI‐1) levels in patients with chronic venous leg ulceration. British Journal of Dermatology1994;131(5):738‐9. ">Ibbotson 1994</a>; <a href="./references#CD012841-bbs2-0100" title="SenetP , BonFX , BenbunanM , BusselA , TraineauR , CalvoF , et al. Randomized trial and local biological effect of autologous platelets used as adjuvant therapy for chronic venous leg ulcers. Journal of Vascular Surgery2003;38(6):1342‐8. ">Senet 2003</a>; <a href="./references#CD012841-bbs2-0111" title="StojadinovicO , RamirezH , PatelS , YinN , BollenbachT , GoldenP , et al. Genomic insight into molecular mechanisms of action of bilayered living cellular construct nonhealing venous leg ulcers. Wound Repair and Regeneration2014;22(2):A60. ">Stojadinovic 2014</a>; <a href="./references#CD012841-bbs2-0126" title="WlaschekM , PeusD , AchterbergV , Meyer‐IngoldW , Scharffetter‐KochanekK . Protease inhibitors protect growth factor activity in chronic wounds. British Journal of Dermatology1997;137(4):646. ">Wlaschek 1997</a>); 18 did not report an eligible healing outcome (<a href="./references#CD012841-bbs2-0028" title="BernatchezSF , StoffelJJ , WaltersSH , LindroosWE , CrosslandMC , ShawlerLG , et al. Nitric oxide levels in wound fluid may reflect the healing trajectory. Wound Repair and Regeneration2012;20(2):A15. ">Bernatchez 2012</a>; <a href="./references#CD012841-bbs2-0038" title="DaltonSJ , MitchellDC , WhitingCV , TarltonJF . Abnormal extracellular matrix metabolism in chronically ischemic skin: a mechanism for dermal failure in leg ulcers. Journal of Investigative Dermatology2005;125(2):373‐9. ">Dalton 2005</a>; <a href="./references#CD012841-bbs2-0043" title="EmingS , SmolaH , HartmannB , MalchauG , WegnerR , KriegT , et al. The inhibition of matrix metalloproteinase activity in chronic wounds by a polyacrylate superabsorber. Biomaterials2008;29(19):2932‐40. ">Eming 2008</a>; <a href="./references#CD012841-bbs2-0044" title="FaillaG , CampoS , ArditaG , FinocchiaroP , MugnoF , AttanasioL , et al. Proteases and chronic leg ulcers. Minerva Cardioangiologica2008;56(4):409‐15. ">Failla 2008</a>; <a href="./references#CD012841-bbs2-0051" title="GrinnellF , ZhuM , ParksWC . Collagenase‐1 complexes with alpha2‐macroglobulin in the acute and chronic wound environments. Journal of Investigative Dermatology1998;110(5):771‐6. ">Grinnell 1998</a>; <a href="./references#CD012841-bbs2-0060" title="HuttunenM , AaltoML , HarvimaRJ , HorsmanheimoM , HarvimaIT . Alterations in mast cells showing tryptase and chymase activity in epithelializating and chronic wounds. Experimental Dermatology2000;9(4):258‐65. ">Huttunen 2000</a>; <a href="./references#CD012841-bbs2-0061" title="HuttunenM . Mast cells in cutaneous wound healing. Forum for Nordic Dermato‐Venerology2004;9(2):37‐8. ">Huttunen 2004</a>; <a href="./references#CD012841-bbs2-0064" title="ImpolaU , JeskanenL , RavantiL , SyrjanenS , BaldurssonB , KahariVM , et al. Expression of matrix metalloproteinase (MMP)‐7 and MMP‐13 and loss of MMP‐19 and p16 are associated with malignant progression in chronic wounds. British Journal of Dermatology2005;152(4):720‐6. ">Impola 2005</a>; <a href="./references#CD012841-bbs2-0067" title="KarimRB , BritoBL , DutrieuxRP , LassanceFP , HageJJ . MMP‐2 assessment as an indicator of wound healing: a feasibility study. Advances in Skin &amp; Wound Care2006;19(6):324‐7. ">Karim 2006</a>; <a href="./references#CD012841-bbs2-0077" title="McInnesRL , CullenBM , HillKE , PricePE , HardingKG , ThomasDW , et al. Contrasting host immuno‐inflammatory responses to bacterial challenge within venous and diabetic ulcers. Wound Repair and Regeneration2014;22(1):58‐69. ">McInnes 2014</a>; <a href="./references#CD012841-bbs2-0080" title="MoorAN , VachonDJ , GouldLJ . Proteolytic activity in wound fluids and tissues derived from chronic venous leg ulcers. Wound Repair and Regeneration2009;17(6):832‐9. ">Moor 2009</a>; <a href="./references#CD012841-bbs2-0086" title="PalolahtiM , LauharantaJ , StephensRW , KuuselaP , VaheriA . Proteolytic activity in leg ulcer exudate. Experimental Dermatology1993;2(1):29‐37. ">Palolahti 1993</a>; <a href="./references#CD012841-bbs2-0090" title="RaymentEA , Upton , Z , ShooterGK . Increased matrix metalloproteinase‐9 (MMP‐9) activity observed in chronic wound fluid is related to the clinical severity of the ulcer. Clinical and Laboratory Investigations2008;158:951‐61. ">Rayment 2008</a>; <a href="./references#CD012841-bbs2-0096" title="SchmidP , ItinP , CoxD . Proteolytic inactivation of transforming growth factor beta3 by elastase in venous leg ulcers: implications for clinical trials using topically‐applied peptide growth factors. British Journal of Dermatology1999;140(6):1170‐2. ">Schmid 1999</a>; <a href="./references#CD012841-bbs2-0097" title="SchmidtchenA . Degradation of antiproteinases, complement and fibronectin in chronic leg ulcers. Acta Dermato‐Venereologica2000;80(3):179‐84. ">Schmidtchen 2000</a>; <a href="./references#CD012841-bbs2-0127" title="WysockiAB , Staiano‐CoicoL , GrinnellF . Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP‐2 and MMP‐9. Journal of Investigative Dermatology1993;101(1):64‐8. ">Wysocki 1993</a>; <a href="./references#CD012841-bbs2-0128" title="WysockiAB . Wound fluids and the pathogenesis of chronic wounds. Journal of Wound, Ostomy &amp; Continence Nursing1996;23(6):283‐90. ">Wysocki 1996</a>; <a href="./references#CD012841-bbs2-0131" title="ZillmerR , TrøstrupH , KarlsmarkT , IfversenP , ÅgrenMS . Duration of wound fluid secretion from chronic venous leg ulcers is critical for interleukin‐1α, interleukin‐1β, interleukin‐8 levels and fibroblast activation. Archives of Dermatological Research2011;303(8):601‐6. ">Zillmer 2011</a>); 38 studies where the study design was not longitudinal (<a href="./references#CD012841-bbs2-0022" title="AhmadA , WalthamM , Hooyer‐HansenG , SoorensenTT , MattockK , SahaP , et al. Reduced expression of soluble urokinase receptor fragment DII‐III predicts venous ulcers that fail to heal. Journal of Vascular Surgery2011;53(1):256. ">Ahmad 2011</a>; <a href="./references#CD012841-bbs2-0024" title="AmatoB , CorettiG , CompagnaR , AmatoM , BuffoneG , GigliottiD , et al. Role of matrix metalloproteinases in non‐healing venous ulcers. International Wound Journal2015;12(6):641‐5. ">Amato 2015</a>; <a href="./references#CD012841-bbs2-0025" title="Anonymous . A stimulating approach to hard‐to‐heal wounds. Wounds UK2008;4(1 Suppl):1‐5. ">Anon 2008</a>; <a href="./references#CD012841-bbs2-0026" title="AyukSM , AbrahamseH , HoureldNN . The role of matrix metalloproteinases in diabetic wound healing in relation to photobiomodulation. Journal of Diabetes Research2016;2016:2897656. ">Ayuk 2016</a>; <a href="./references#CD012841-bbs2-0030" title="BogaczewiczJ , ChodorowskaG , KrasowskaD . The role of matrix metalloproteinases and tissue inhibitors of metalloproteinases in cutaneous wound healing. Przeglad Dermatologiczny2004;91(3):253‐61. ">Bogaczewicz 2004</a>; <a href="./references#CD012841-bbs2-0031" title="Bohórquez‐SierraJC . Matrix metalloproteases: their involvement in peripheral vascular diseases [Metaloproteinasas de matriz: su implicación en las enfermedades vasculares periféricas]. Angiologia2006;58(4):269‐77. ">Bohórquez‐Sierra 2006</a>; <a href="./references#CD012841-bbs2-0034" title="ClarkRA . Fibrin and wound healing. Annals of the New York Academy of Sciences2001;936:355‐67. ">Clark 2001</a>; <a href="./references#CD012841-bbs2-0035" title="CookH , StephensP , DaviesKJ , HardingKG , ThomasDW . Defective extracellular matrix reorganization by chronic wound fibroblasts is associated with alterations in TIMP‐1, TIMP‐2, and MMP‐2 activity. Journal of Investigative Dermatology2000;115(2):225‐33. ">Cook 2000</a>; <a href="./references#CD012841-bbs2-0039" title="DaSilvaFS , AraujoDN , LimaJP , DeRezendeAA , DaGraca Azevedo AbreuBJ , DiasFA . Enzymatic activity analysis of MMP‐2 and 9 collected by swab from lower limb venous ulcers. Jornal Vascular Brasileiro2014;13(3):229‐34. ">Da Silva 2014</a>; <a href="./references#CD012841-bbs2-0040" title="DerbyshireA . A case study to demonstrate the role of proteases in wound healing. Professional Nurse2003;19(2):108‐11. ">Derbyshire 2003</a>; <a href="./references#CD012841-bbs2-0041" title="DuffyD . Serum iron and matrix metalloproteinase‐9 variations in limbs affected by chronic venous disease and venous leg ulcers: commentary. Dermatologic Surgery2005;31(6):649. ">Duffy 2005</a>; <a href="./references#CD012841-bbs2-0046" title="FisherDA , GrossmanD , HealdPW , RinderHM . Activated protein C resistance and anticardiolipin antibodies in patients with venous leg ulcers. Journal of the American Academy of Dermatology1998;39(2 Pt 1):299‐300. ">Fisher 1998</a>; <a href="./references#CD012841-bbs2-0049" title="GordonB . The use of topical proteolytic enzymes in the treatment of post‐thrombotic leg ulcers. British Journal of Clinical Practice1975;29(6):143‐6. ">Gordon 1975</a>; <a href="./references#CD012841-bbs2-0054" title="HerouyY , TrefzerD , HellsternMO , StarkGB , VanscheidtW , SchopfE , et al. Plasminogen activation in venous leg ulcers. British Journal of Dermatology2000;143(5):930‐6. ">Herouy 2000a</a>; <a href="./references#CD012841-bbs2-0055" title="HerouyY , TrefzerD , ZimpferU , SchopfE , WanscheidtW , NorgauerJ . Matrix metalloproteinases and venous leg ulceration. European Journal of Dermatology2000;10(3):173‐80. ">Herouy 2000b</a>; <a href="./references#CD012841-bbs2-0065" title="IvinsN . Evaluation of the mode of action of a new gel wound dressing. Wounds UK2014;10(2):86‐95. ">Ivins 2014</a>; <a href="./references#CD012841-bbs2-0068" title="KörberA , FreiseJ , GrabbeS , DissemondJ . Reduction of pH values in chronic leg ulcers by cadesorb. Zeitschrift fur Wundheilung2006;11(5):230‐4. ">Körber 2006</a>; <a href="./references#CD012841-bbs2-0069" title="KucharzewskiM . Matrix metalloproteinases and venous leg ulcer. Przeglad Flebologiczny2005;13(6):269‐74. ">Kucharzewski 2005</a>; <a href="./references#CD012841-bbs2-0072" title="LigiD , MostiG , CroceL , RaffettoJD , MannelloF . Chronic venous disease ‐ part II: proteolytic biomarkers in wound healing. Biochimica et Biophysica Acta2016;1862(10):1900‐8. ">Ligi 2016</a>; <a href="./references#CD012841-bbs2-0073" title="LimCS , ShalhoubJ , GohelMS , ShepherdAC , DaviesAH . Matrix metalloproteinases in vascular disease: a potential therapeutic target?. Current Vascular Pharmacology2010;8(1):75‐85. ">Lim 2010</a>; <a href="./references#CD012841-bbs2-0075" title="McCartySM , CochraneCA , CleggPD , PercivalSL . The role of endogenous and exogenous enzymes in chronic wounds: a focus on the implications of aberrant levels of both host and bacterial proteases in wound healing. Wound Repair and Regeneration2012;20(2):125‐36. ">McCarty 2012</a>; <a href="./references#CD012841-bbs2-0076" title="McCartySM , PercivalSL . Proteases and delayed wound healing. Advances in Wound Care2013;2(8):438‐47. ">McCarty 2013</a>; <a href="./references#CD012841-bbs2-0081" title="MooreK , HuddlestonE , StaceyMC , HardingKG . Venous leg ulcers ‐ the search for a prognostic indicator. International Wound Journal2007;4(2):163‐72. ">Moore 2007</a>; <a href="./references#CD012841-bbs2-0084" title="NwomehBC , LiangHX , CohenIK , YagerDR . MMP‐8 is the predominant collagenase in healing wounds and nonhealing ulcers. Journal of Surgical Research1999;81(2):189‐95. ">Nwomeh 1999</a>; <a href="./references#CD012841-bbs2-0085" title="OvingtonLG . Matrix metalloproteases: the newest initials in would healing are MMP. Podiatry Management2001;20(6):107‐12. ">Ovington 2001</a>; <a href="./references#CD012841-bbs2-0087" title="PhillipsLJ , SarkarR . Molecular characterization of post‐thrombotic syndrome. Journal of Vascular Surgery2007;45(Suppl A):A116‐22. ">Phillips 2007</a>; <a href="./references#CD012841-bbs2-0089" title="RaffettoJD . Which dressings reduce inflammation and improve venous leg ulcer healing. Phlebology2014;29(1 Suppl):157‐64. ">Raffetto 2014</a>; <a href="./references#CD012841-bbs2-0091" title="RaymentEA , UptonZ . Finding the culprit: a review of the influences of proteases on the chronic wound environment. International Journal of Lower Extremity Wounds2009;8(1):19‐27. ">Rayment 2009</a>; <a href="./references#CD012841-bbs2-0093" title="RogersAA , BurnettS , LindholmC , BjellerupM , ChristensenOB , ZederfeldtB , et al. Expression of tissue‐type and urokinase‐type plasminogen activator activities in chronic venous leg ulcers. Vasa1999;28(2):101‐5. ">Rogers 1999</a>; <a href="./references#CD012841-bbs2-0098" title="SchmidtchenA , WolffH , RydengardV , HanssonC . Detection of serine proteases secreted by Lucilia sericata in vitro and during treatment of a chronic leg ulcer. Acta Dermato‐Venereologica2003;83(4):310‐1. ">Schmidtchen 2003</a>; <a href="./references#CD012841-bbs2-0101" title="SerenaTE , CullenB , BayliffS , GibsonM , DeMarcoD , GalbraithJ , et al. Protease activity levels associated with non‐healing chronic wounds. Wound Repair and Regeneration2012;20(5):A93. SerenaTE , CullenBM , BayliffSW , GibsonMC , CarterMJ , ChenL , et al. Defining a new diagnostic assessment parameter for wound care: elevated protease activity, an indicator of nonhealing, for targeted protease‐modulating treatment. Wound Repair and Regeneration2016;24(3):589‐95. ">Serena 2016</a>; <a href="./references#CD012841-bbs2-0103" title="SerraR , ButricoL , RuggieroM , RossiA , BuffoneG , FugettoF , et al. Epidemiology, diagnosis and treatment of chronic leg ulcers: a systematic review. Acta Phlebologica2015;16(1):9‐18. ">Serra 2015c</a>; <a href="./references#CD012841-bbs2-0104" title="SerraR , GrandeR , BuffoneG , MolinariV , PerriP , PerriA , et al. Extracellular matrix assessment of infected chronic venous leg ulcers: role of metalloproteinases and inflammatory cytokines. International Wound Journal2016;13(1):53‐8. ">Serra 2016a</a>; <a href="./references#CD012841-bbs2-0108" title="SinghAV , SubhashreeL , MilaniP , GemmatiD , ZamboniP . Interplay of iron metallobiology, metalloproteinases, and FXIII, and role of their gene variants in venous leg ulcer. International Journal of Lower Extremity Wounds2010;9(4):166‐79. ">Singh 2010</a>; <a href="./references#CD012841-bbs2-0112" title="TarltonJF , BaileyAJ , CrawfordE , JonesD , MooreK , HardingKD . Prognostic value of markers of collagen remodeling in venous ulcers. Wound Repair and Regeneration1999;7(5):347‐55. ">Tarlton 1999</a>; <a href="./references#CD012841-bbs2-0119" title="VahlquistA . Markers of skin inflammation and wound healing. Acta Dermato‐venereologica2000;80(3):161. ">Vahlquist 2000</a>; <a href="./references#CD012841-bbs2-0123" title="WeckrothM , VaheriA , LauharantaJ , SorsaT , KonttinenYT . Matrix metalloproteinases, gelatinase and collagenase, in chronic leg ulcers. Journal of Investigative Dermatology1996;106(5):1119‐24. ">Weckroth 1996</a>; <a href="./references#CD012841-bbs2-0125" title="WidgerowAD . Chronic wound fluid ‐ thinking outside the box. Wound Repair and Regeneration2011;19(3):287‐91. ">Widgerow 2011</a>); and 34 studies where the samples were not obtained from wound fluids or were not obtained by an eligible method (<a href="./references#CD012841-bbs2-0023" title="AlexewiczP , Gosk‐BierskaI , MaleckiR , AdamiecR . Plasma protein S level in patients with venous ulcers secondary to post‐thrombotic syndrome. Przeglad Flebologiczny2007;15(3):117‐9. ">Alexewicz 2007</a>; <a href="./references#CD012841-bbs2-0027" title="BarrosSC , MartinsJA , MarcosJC , Cavaco‐PauloA . Influence of secretory leukocyte protease inhibitor‐based peptides on elastase activity and their incorporation in hyaluronic acid hydrogels for chronic wound therapy. Biopolymers2012;98(6):576‐90. ">Barros 2012</a>; <a href="./references#CD012841-bbs2-0033" title="CaimiG , FerraraF , MontanaM , MuratoriI , AmatoC , CaninoB , et al. Behaviour of the plasma concentration of gelatinases and their tissue inhibitors in subjects with venous leg ulcers. Clinical Hemorheology and Microcirculation2015;60(3):309‐16. ">Caimi 2015</a>; <a href="./references#CD012841-bbs2-0042" title="EmingSA , Smola‐HessS , KurschatP , HircheD , KriegT , SmolaH . A novel property of povidon‐iodine: inhibition of excessive protease levels in chronic non‐healing wounds. Journal of Investigative Dermatology2006;126(12):2731‐3. ">Eming 2006</a>; <a href="./references#CD012841-bbs2-0045" title="FernandezML , BroadbentJA , ShooterGK , MaldaJ , UptonZ . Development of an enhanced proteomic method to detect prognostic and diagnostic markers of healing in chronic wound fluid. British Journal of Dermatology2008;158(2):281‐90. ">Fernandez 2008</a>; <a href="./references#CD012841-bbs2-0048" title="GackaM , MastejK , AdamiecR . Thrombotic and fibrinolitic activity in patients with venous ulcer during sulodexide treatment. Przeglad Flebologiczny2004;12(3):97‐100. ">Gacka 2004</a>; <a href="./references#CD012841-bbs2-0050" title="GrinnellF , HoCH , WysockiA . Degradation of fibronectin and vitronectin in chronic wound fluid: analysis by cell blotting, immunoblotting, and cell adhesion assays. Journal of Investigative Dermatology1992;98(4):410‐6. ">Grinnell 1992</a>; <a href="./references#CD012841-bbs2-0052" title="HasmannA , GewesslerU , HullaE , SchneiderKP , BinderB , FranceskoA , et al. Sensor materials for the detection of human neutrophil elastase and cathepsin G activity in wound fluid. Experimental Dermatology2011;20(6):508‐13. ">Hasmann 2011</a>; <a href="./references#CD012841-bbs2-0053" title="HeC , HughesMA , CherryGW , ArnoldF . Effects of chronic wound fluid on the bioactivity of platelet‐derived growth factor in serum‐free medium and its direct effect on fibroblast growth. Wound Repair and Regeneration1999;7(2):97‐105. ">He 1999</a>; <a href="./references#CD012841-bbs2-0056" title="HerouyY , KahleB , IdzkoM , HildenbrandT , AliMY , ClementJ , et al. Venous leg ulcers and apoptosis: a TIMP‐3‐mediated pathway?. Journal of Investigative Dermatology2004;123(6):1210‐2. ">Herouy 2004</a>; <a href="./references#CD012841-bbs2-0057" title="HerrickS , AshcroftG , IrelandG , HoranM , McCollumC , FergusonM . Up‐regulation of elastase in acute wounds of healthy aged humans and chronic venous leg ulcers are associated with matrix degradation. Laboratory Investigation1997;77(3):281‐8. ">Herrick 1997</a>; <a href="./references#CD012841-bbs2-0058" title="HoffmanR , StarkeyS , CoadJ . Wound fluid from venous leg ulcers degrades plasminogen and reduces plasmin generation by keratinocytes. Journal of Investigative Dermatology1998;111(6):1140‐4. ">Hoffman 1998</a>; <a href="./references#CD012841-bbs2-0071" title="LantisJ2nd , TheoharidesT , FullerA , GendicsC . Analysis of mast cell tryptase in hard to heal venous leg ulcers. Wound Repair and Regeneration2011;19(5):A76. ">Lantis 2011</a>; <a href="./references#CD012841-bbs2-0074" title="LottiT , BenciM . Plasminogen activators, venous leg ulcers and reepithelialization. International Journal of Dermatology1995;34(10):696‐9. ">Lotti 1995</a>; <a href="./references#CD012841-bbs2-0079" title="MirshahiS , SoriaJ , MirshahiM , SoriaC , LenobleM , VasmantD , et al. Expression of elastase and fibrin in venous leg ulcer biopsies: a pilot study of pentoxifylline versus placebo. Journal of Cardiovascular Pharmacology1995;25(Suppl 2):S101‐5. ">Mirshahi 1995</a>; <a href="./references#CD012841-bbs2-0082" title="NielsenJA , BundgaardD , SchmidtEB . Fibrinolysis in patients with venous ulcers before and after ulcer healing induced by an unelastic bandage. European Journal of Internal Medicine1992;3(1):23‐6. ">Nielsen 1992</a>; <a href="./references#CD012841-bbs2-0083" title="NorgauerJ , HildenbrandT , IdzkoM , PantherE , BandemirE , HartmannM , et al. Elevated expression of extracellular matrix metalloproteinase inducer (CD147) and membrane‐type matrix metalloproteinases in venous leg ulcers. British Journal of Dermatology2002;147(6):1180‐6. ">Norgauer 2002</a><a href="./references#CD012841-bbs2-0088" title="PirilaE , KorpiJT , KorkiamakiT , JahkolaT , Gutierrez‐FernandezA , Lopez‐OtinC , et al. Collagenase‐2 (MMP‐8) and matrilysin‐2 (MMP‐26) expression in human wounds of different etiologies. Wound Repair and Regeneration2007;15(1):47‐57. ">Pirila 2007</a>; <a href="./references#CD012841-bbs2-0092" title="RechardtO , ElomaaO , VaalamoM , PaakkonenK , JahkolaT , Hook‐NikanneJ , et al. Stromelysin‐2 is upregulated during normal wound repair and is induced by cytokines. Journal of Investigative Dermatology2000;115(5):778‐87. ">Rechardt 2000</a>; <a href="./references#CD012841-bbs2-0094" title="Saarialho‐KereUK . Patterns of matrix metalloproteinase and TIMP expression in chronic ulcers. Archives of Dermatological Research1998;290(Suppl):S47‐54. ">Saarialho‐Kere 1998</a>; <a href="./references#CD012841-bbs2-0095" title="SalgadoR , Cruz‐CastanedaO , Elizondo‐VazquezF , PatL , De laGarzaA , Cano‐ColínS , et al. Maltodextrin/ascorbic acid stimulates wound closure by increasing collagen turnover and TGF‐β1 expression in vitro and changing the stage of inflammation from chronic to acute in vivo. Journal of Tissue Viability2017;26(2):131‐7. ">Salgado 2017</a>; <a href="./references#CD012841-bbs2-0105" title="SerraR , GrandeR , ButricoL , BuffoneG , CalioFG , SquillaceA , et al. Effects of a new nutraceutical substance on clinical and molecular parameters in patients with chronic venous ulceration. International Wound Journal2016;13(1):88‐96. ">Serra 2016b</a>; <a href="./references#CD012841-bbs2-0106" title="SerraR , GallelliL , ButricoL , BuffoneG , CalioFG , DeCaridiG , et al. From varices to venous ulceration: the story of chronic venous disease described by metalloproteinases. International Wound Journal2017;14(1):233‐40. ">Serra 2017</a>; <a href="./references#CD012841-bbs2-0109" title="StaceyMC , BurnandKG , Mahmoud‐AlexandroniM , GaffneyPJ , BhogalBS . Tissue and urokinase plasminogen activators in the environs of venous and ischaemic leg ulcers. British Journal of Surgery1993;80(5):596‐9. ">Stacey 1993</a>; <a href="./references#CD012841-bbs2-0110" title="StaceyMC , MataSD . Lower levels of PAI‐2 may contribute to impaired healing in venous ulcers ‐ a preliminary study. Cardiovascular Surgery2000;8(5):381‐5. ">Stacey 2000</a>; <a href="./references#CD012841-bbs2-0113" title="TauzinH , RobinS , HumbertP , ViennetC , SaasP , Courderot‐MasuyerC , et al. Can leg ulcer fibroblasts phenotype be influenced by human amniotic membrane extract?. Cell and Tissue Banking2014;15(2):251‐5. ">Tauzin 2014</a>; <a href="./references#CD012841-bbs2-0114" title="TurioE , AvvenenteA , EvangelistiL , PanicucciE , GiordaniR , SagripantiA , et al. Measurement of coagulation and fibrinolysis plasma parameters in patients with post‐phlebitic and non post‐phlebitic venous leg ulcers. Giornale Italiano di Dermatologia e Venereologia2002;137(1):25‐30. ">Turio 2002</a>; <a href="./references#CD012841-bbs2-0115" title="UlrichD , LichteneggerF , UnglaubF , SmeetsR , PalluaN . Effect of chronic wound exudates and MMP‐2/‐9 inhibitor on angiogenesis in vitro. Plastic and Reconstructive Surgery2005;116(2):539‐45. ">Ulrich 2005</a>; <a href="./references#CD012841-bbs2-0116" title="VaalamoM , WeckrothM , PuolakkainenP , KereJ , SaarinenP , LauharantaJ , et al. Patterns of matrix metalloproteinase and TIMP‐1 expression in chronic and normally healing human cutaneous wounds. British Journal of Dermatology1996;135(1):52‐9. ">Vaalamo 1996</a>; <a href="./references#CD012841-bbs2-0117" title="VaalamoM , MattilaL , JohanssonN , KariniemiAL , Karjalainen‐LindsbergML , KahariVM , et al. Distinct populations of stromal cells express collagenase‐3 (MMP‐13) and collagenase‐1 (MMP‐1) in chronic ulcers but not in normally healing wounds. Journal of Investigative Dermatology1997;109(1):96‐101. ">Vaalamo 1997</a>; <a href="./references#CD012841-bbs2-0118" title="VaalamoM , LeivoT , Saarialho‐KereU . Differential expression of tissue inhibitors of metalloproteinases (TIMP‐1, ‐2, ‐3, and ‐4) in normal and aberrant wound healing. Human Pathology1999;30(7):795‐802. ">Vaalamo 1999</a>; <a href="./references#CD012841-bbs2-0120" title="VanBergenBH , AndriessenMP , SpruijtKI , Van deKerkhofPC , SchalkwijkJ . Expression of SKALP/elafin during wound healing in human skin. Archives of Dermatological Research1996;288(8):458‐62. ">Van Bergen 1996</a>; <a href="./references#CD012841-bbs2-0124" title="WeckrothM , VaheriA , VirolainenS , Saarialho‐KereU , JahkolaT , SirenV . Epithelial tissue‐type plasminogen activator expression, unlike that of urokinase, its receptor, and plasminogen activator inhibitor‐1, is increased in chronic venous ulcers. British Journal of Dermatology2004;151(6):1189‐96. ">Weckroth 2004</a>; <a href="./references#CD012841-bbs2-0130" title="ZeegelaarJE , VerheijenJH , KerckhaertJA , JankowskiI , FaberWR . Local treatment of venous ulcers with tissue type plasminogen activator containing ointment. Vasa1997;26(2):81‐4. ">Zeegelaar 1997)</a>. </p> <p>One excluded study, <a href="./references#CD012841-bbs2-0101" title="SerenaTE , CullenB , BayliffS , GibsonM , DeMarcoD , GalbraithJ , et al. Protease activity levels associated with non‐healing chronic wounds. Wound Repair and Regeneration2012;20(5):A93. SerenaTE , CullenBM , BayliffSW , GibsonMC , CarterMJ , ChenL , et al. Defining a new diagnostic assessment parameter for wound care: elevated protease activity, an indicator of nonhealing, for targeted protease‐modulating treatment. Wound Repair and Regeneration2016;24(3):589‐95. ">Serena 2016</a>, had similarities with two of the included studies (<a href="./references#CD012841-bbs2-0006" title="HarrisIR , YeeKC , WaltersCE , CunliffeWJ , KearneyJN , WoodEJ , et al. Cytokine and protease levels in healing and non‐healing chronic venous leg ulcers. Experimental Dermatology1995;4(6):342‐9. ">Harris 1995</a>; <a href="./references#CD012841-bbs2-0014" title="RaffettoJD , MostiG , SantiM , LigiD , MannelloF . Matrix metalloproteinase profiles in chronic venous ulcer wound fluid of inflammatory and granulating venous leg ulcers. Journal of Vascular Surgery: Venous and Lymphatic Disorders2015;3(1):119‐20. ">Raffetto 2015</a>), in that healing trajectories were analysed within a cross‐sectional study. However, the trajectories (healing and non‐healing) were derived from measurements of healing rate before the start of the study, rather than clinical assessment of the phase of the wound in the study. Therefore, we considered the study to be cross‐sectional and measuring diagnosis rather than prognosis. Additionally, <a href="./references#CD012841-bbs2-0101" title="SerenaTE , CullenB , BayliffS , GibsonM , DeMarcoD , GalbraithJ , et al. Protease activity levels associated with non‐healing chronic wounds. Wound Repair and Regeneration2012;20(5):A93. SerenaTE , CullenBM , BayliffSW , GibsonMC , CarterMJ , ChenL , et al. Defining a new diagnostic assessment parameter for wound care: elevated protease activity, an indicator of nonhealing, for targeted protease‐modulating treatment. Wound Repair and Regeneration2016;24(3):589‐95. ">Serena 2016</a> had only 32% VLUs and it would have been necessary to write to the authors. </p> </section> <section id="CD012841-sec-0069"> <h3 class="title" id="CD012841-sec-0069">Studies awaiting classification</h3> <p>We identified one study that is awaiting classification (<a href="./references#CD012841-bbs2-0132" title="CullenB , NisbetL , EsslerL , SilcockD , LalikosJ , DunnR . The ability of collagen/ORC to correct biochemical imbalances in venous leg ulcers. Wound Repair and Regeneration2009;17(4):A55. ">Cullen 2009</a>). This was a conference abstract and gave too little information. </p> </section> <section id="CD012841-sec-0070"> <h3 class="title" id="CD012841-sec-0070">Ongoing studies</h3> <p>We found no ongoing studies.</p> </section> <section id="CD012841-sec-0071"> <h3 class="title" id="CD012841-sec-0071">Risk of bias in included studies</h3> <p>No study conducted multivariable analyses, but all 11 studies (13 cohorts) with useable results either had sufficient data to calculate univariate associations or reported correlations between protease measurements and a measure of healing. We did not report risk of bias assessments for studies with non‐useable results. However, all these studies were at high risk of bias due to inadequate analyses and lack of adjustment. </p> <p><a href="#CD012841-fig-0002">Figure 2</a> shows risk of bias judgements for each cohort. Judgements for each domain across studies are shown in <a href="#CD012841-fig-0003">Figure 3</a>. These figures also included studies that did not have useable results and did not have risk of bias assessments, and these appear blank. </p> <div class="figure" id="CD012841-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies with results. Studies without useable results do not have risk of bias assessments, and these appear blank." data-id="CD012841-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/image_n/nCD012841-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies with results. Studies without useable results do not have risk of bias assessments, and these appear blank. </p> </div> </div> </div> <div class="figure" id="CD012841-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study with results. Studies without useable results do not have risk of bias assessments, and these appear blank." data-id="CD012841-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/image_n/nCD012841-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study with results. Studies without useable results do not have risk of bias assessments, and these appear blank. </p> </div> </div> </div> <p>Overall, all studies (and all cohorts) except <a href="./references#CD012841-bbs2-0013" title="MwauraB , MahendranB , HynesN , DefreitasD , AvalosG , AdegbolaT , et al. The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase‐2, tissue inhibitor of matrix metalloproteinase‐2 and PDGF‐AA on the chronicity of venous leg ulcers. European Journal of Vascular and Endovascular Surgery2006;31(3):306‐10. ">Mwaura 2006</a> were at high risk of bias (they had high risk of bias for at least two domains): this was commonly due to high risk of selection bias (five of 12 cohorts), outcome measurement bias (nine cohorts) and adjustment factor bias (11 cohorts). <a href="./references#CD012841-bbs2-0013" title="MwauraB , MahendranB , HynesN , DefreitasD , AvalosG , AdegbolaT , et al. The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase‐2, tissue inhibitor of matrix metalloproteinase‐2 and PDGF‐AA on the chronicity of venous leg ulcers. European Journal of Vascular and Endovascular Surgery2006;31(3):306‐10. ">Mwaura 2006</a> was at moderate risk of bias overall. </p> </section> <section id="CD012841-sec-0072"> <h3 class="title" id="CD012841-sec-0072">Results</h3> <p>At the outset of this results section, we must stress that no reliable associations could be identified from the data presented here because all the evidence in this review was of very low certainty (see Certainty of the evidence section below). However, as this is a new type of review in the wounds field, we have presented the full set of (very low‐certainty) results in order to indicate possible factors that should inform future research and systematic review methodology in this area. We have not generally reported the numerical findings in the main text, but these can be seen in the forest plots as indicated. </p> <section id="CD012841-sec-0073"> <h4 class="title">Associations of protease activity (continuous data) with complete healing and partial healing </h4> <section id="CD012841-sec-0074"> <h5 class="title">Healing as dichotomous data (versus no healing)</h5> <p>We used individual participant data (IPD) from one study including seven participants to conduct a univariate logistic regression analysis (<a href="./references#CD012841-bbs2-0007" title="HoffmanR , NobleJ , EagleM . The use of proteases as prognostic markers for the healing of venous leg ulcers. Journal of Wound Care1999;8(6):273‐6. ">Hoffman 1999</a>). The OR per unit increase in elastase activity at baseline was 0.96 (95% CI 0.88 to 1.04). This was very low‐certainty evidence. </p> <p>We used the data from each of six studies including 174 participants to carry out a 'reverse' t‐test of associations between healing and protease activity (<a href="./references#CD012841-bbs2-0001" title="AhmadA , SahaP , EvansC , ThurisonT , Hoyer‐HansenG , PatelA , et al. The soluble urokinase plasminogen activator receptor and its fragments in venous ulcers. Journal of Vascular Surgery: Venous and Lymphatic Disorders2015;3(2):190‐7. ">Ahmad 2015</a>; <a href="./references#CD012841-bbs2-0006" title="HarrisIR , YeeKC , WaltersCE , CunliffeWJ , KearneyJN , WoodEJ , et al. Cytokine and protease levels in healing and non‐healing chronic venous leg ulcers. Experimental Dermatology1995;4(6):342‐9. ">Harris 1995</a>; <a href="./references#CD012841-bbs2-0007" title="HoffmanR , NobleJ , EagleM . The use of proteases as prognostic markers for the healing of venous leg ulcers. Journal of Wound Care1999;8(6):273‐6. ">Hoffman 1999</a>; <a href="./references#CD012841-bbs2-0013" title="MwauraB , MahendranB , HynesN , DefreitasD , AvalosG , AdegbolaT , et al. The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase‐2, tissue inhibitor of matrix metalloproteinase‐2 and PDGF‐AA on the chronicity of venous leg ulcers. European Journal of Vascular and Endovascular Surgery2006;31(3):306‐10. ">Mwaura 2006</a>; <a href="./references#CD012841-bbs2-0014" title="RaffettoJD , MostiG , SantiM , LigiD , MannelloF . Matrix metalloproteinase profiles in chronic venous ulcer wound fluid of inflammatory and granulating venous leg ulcers. Journal of Vascular Surgery: Venous and Lymphatic Disorders2015;3(1):119‐20. ">Raffetto 2015</a>; <a href="./references#CD012841-bbs2-0015" title="SerraR , BuffoneG , FalconeD , MolinariV , ScaramuzzinoM , GallelliL , et al. Chronic venous leg ulcers are associated with high levels of metalloproteinases‐9 and neutrophil gelatinase‐associated lipocalin. Wound Repair and Regeneration2013;21(3):395‐401. ">Serra 2013</a>). The (theoretical) interpretation of this was that a negative SMD indicated that lower baseline levels of protease were associated with higher proportions of healing wounds at follow‐up (compared with non‐healing). </p> <p>Results from all studies are shown on the same forest plot to visually display the findings and to allow possible influencing factors to be considered (<a href="./references#CD012841-fig-0008" title="">Analysis 1.1</a>; <a href="#CD012841-fig-0004">Figure 4</a>). </p> <div class="figure" id="CD012841-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Protease activity continuous, outcome: 1.1 t‐test assocation of protease level and healing (dichotomous)." data-id="CD012841-fig-0004" src="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/image_n/nCD012841-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Protease activity continuous, outcome: 1.1 t‐test assocation of protease level and healing (dichotomous). </p> </div> </div> </div> <p>Two studies including 37 participants reported <b>complete healing</b> (versus no healing) (<a href="./references#CD012841-bbs2-0001" title="AhmadA , SahaP , EvansC , ThurisonT , Hoyer‐HansenG , PatelA , et al. The soluble urokinase plasminogen activator receptor and its fragments in venous ulcers. Journal of Vascular Surgery: Venous and Lymphatic Disorders2015;3(2):190‐7. ">Ahmad 2015</a>; <a href="./references#CD012841-bbs2-0007" title="HoffmanR , NobleJ , EagleM . The use of proteases as prognostic markers for the healing of venous leg ulcers. Journal of Wound Care1999;8(6):273‐6. ">Hoffman 1999</a>). Both studies investigated serine proteases. This very low‐certainty evidence illustrated inconsistency in the point estimates regarding the direction of the association, high risk of bias and very wide CIs; in other words, it is completely unclear whether serine protease activity is associated with leg ulcer healing. <a href="./references#CD012841-bbs2-0001" title="AhmadA , SahaP , EvansC , ThurisonT , Hoyer‐HansenG , PatelA , et al. The soluble urokinase plasminogen activator receptor and its fragments in venous ulcers. Journal of Vascular Surgery: Venous and Lymphatic Disorders2015;3(2):190‐7. ">Ahmad 2015</a> measured mainly bound and complexed forms of uPA protease and <a href="./references#CD012841-bbs2-0007" title="HoffmanR , NobleJ , EagleM . The use of proteases as prognostic markers for the healing of venous leg ulcers. Journal of Wound Care1999;8(6):273‐6. ">Hoffman 1999</a> appeared to measure the active form of neutrophil elastase. </p> <p>Four studies including 137 participants reported <b>partial healing</b> (versus no healing) (<a href="./references#CD012841-bbs2-0006" title="HarrisIR , YeeKC , WaltersCE , CunliffeWJ , KearneyJN , WoodEJ , et al. Cytokine and protease levels in healing and non‐healing chronic venous leg ulcers. Experimental Dermatology1995;4(6):342‐9. ">Harris 1995</a>; <a href="./references#CD012841-bbs2-0013" title="MwauraB , MahendranB , HynesN , DefreitasD , AvalosG , AdegbolaT , et al. The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase‐2, tissue inhibitor of matrix metalloproteinase‐2 and PDGF‐AA on the chronicity of venous leg ulcers. European Journal of Vascular and Endovascular Surgery2006;31(3):306‐10. ">Mwaura 2006</a>; <a href="./references#CD012841-bbs2-0014" title="RaffettoJD , MostiG , SantiM , LigiD , MannelloF . Matrix metalloproteinase profiles in chronic venous ulcer wound fluid of inflammatory and granulating venous leg ulcers. Journal of Vascular Surgery: Venous and Lymphatic Disorders2015;3(1):119‐20. ">Raffetto 2015</a>; <a href="./references#CD012841-bbs2-0015" title="SerraR , BuffoneG , FalconeD , MolinariV , ScaramuzzinoM , GallelliL , et al. Chronic venous leg ulcers are associated with high levels of metalloproteinases‐9 and neutrophil gelatinase‐associated lipocalin. Wound Repair and Regeneration2013;21(3):395‐401. ">Serra 2013</a>), with <a href="./references#CD012841-bbs2-0006" title="HarrisIR , YeeKC , WaltersCE , CunliffeWJ , KearneyJN , WoodEJ , et al. Cytokine and protease levels in healing and non‐healing chronic venous leg ulcers. Experimental Dermatology1995;4(6):342‐9. ">Harris 1995</a> comparing granulating/epithelialising ('healing') wounds with non‐granulating ('non‐healing') wounds in a type of case‐control study; <a href="./references#CD012841-bbs2-0013" title="MwauraB , MahendranB , HynesN , DefreitasD , AvalosG , AdegbolaT , et al. The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase‐2, tissue inhibitor of matrix metalloproteinase‐2 and PDGF‐AA on the chronicity of venous leg ulcers. European Journal of Vascular and Endovascular Surgery2006;31(3):306‐10. ">Mwaura 2006</a> reporting a 'healing wound' as one with more than 20% decrease in wound size, decrease in slough and development of granulation tissue; and <a href="./references#CD012841-bbs2-0015" title="SerraR , BuffoneG , FalconeD , MolinariV , ScaramuzzinoM , GallelliL , et al. Chronic venous leg ulcers are associated with high levels of metalloproteinases‐9 and neutrophil gelatinase‐associated lipocalin. Wound Repair and Regeneration2013;21(3):395‐401. ">Serra 2013</a> comparing 'high healing' (1 cm²/week or greater decrease in size) and 'low healing' (less than 1 cm²/week) versus no healing. <a href="./references#CD012841-bbs2-0014" title="RaffettoJD , MostiG , SantiM , LigiD , MannelloF . Matrix metalloproteinase profiles in chronic venous ulcer wound fluid of inflammatory and granulating venous leg ulcers. Journal of Vascular Surgery: Venous and Lymphatic Disorders2015;3(1):119‐20. ">Raffetto 2015</a> reported protease levels for wounds in granulating versus inflammatory phases in a type of case‐control study, with protease levels given for a number of different proteases. </p> <p><a href="./references#CD012841-bbs2-0014" title="RaffettoJD , MostiG , SantiM , LigiD , MannelloF . Matrix metalloproteinase profiles in chronic venous ulcer wound fluid of inflammatory and granulating venous leg ulcers. Journal of Vascular Surgery: Venous and Lymphatic Disorders2015;3(1):119‐20. ">Raffetto 2015</a> (a conference abstract) suggested there may be two types of protease involved in wound healing, which they described as 'degrading' MMPs and 'reparative' MMPs. We explored this proposed differentiation of proteases in <a href="./references#CD012841-fig-0008" title="">Analysis 1.1</a> (<a href="#CD012841-fig-0004">Figure 4</a>). The degrading and reparative MMPs in <a href="./references#CD012841-bbs2-0014" title="RaffettoJD , MostiG , SantiM , LigiD , MannelloF . Matrix metalloproteinase profiles in chronic venous ulcer wound fluid of inflammatory and granulating venous leg ulcers. Journal of Vascular Surgery: Venous and Lymphatic Disorders2015;3(1):119‐20. ">Raffetto 2015</a> appeared to have different directions of association with healing, and the other studies may have supported this interpretation (<a href="./references#CD012841-bbs2-0006" title="HarrisIR , YeeKC , WaltersCE , CunliffeWJ , KearneyJN , WoodEJ , et al. Cytokine and protease levels in healing and non‐healing chronic venous leg ulcers. Experimental Dermatology1995;4(6):342‐9. ">Harris 1995</a>; <a href="./references#CD012841-bbs2-0013" title="MwauraB , MahendranB , HynesN , DefreitasD , AvalosG , AdegbolaT , et al. The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase‐2, tissue inhibitor of matrix metalloproteinase‐2 and PDGF‐AA on the chronicity of venous leg ulcers. European Journal of Vascular and Endovascular Surgery2006;31(3):306‐10. ">Mwaura 2006</a>; <a href="./references#CD012841-bbs2-0015" title="SerraR , BuffoneG , FalconeD , MolinariV , ScaramuzzinoM , GallelliL , et al. Chronic venous leg ulcers are associated with high levels of metalloproteinases‐9 and neutrophil gelatinase‐associated lipocalin. Wound Repair and Regeneration2013;21(3):395‐401. ">Serra 2013</a>). However, this was very low‐certainty evidence, dominated by a single study which identified healing and non‐healing wounds in the same cohort, and there may well be confounding and bias (<a href="./references#CD012841-bbs2-0014" title="RaffettoJD , MostiG , SantiM , LigiD , MannelloF . Matrix metalloproteinase profiles in chronic venous ulcer wound fluid of inflammatory and granulating venous leg ulcers. Journal of Vascular Surgery: Venous and Lymphatic Disorders2015;3(1):119‐20. ">Raffetto 2015</a>). </p> </section> <section id="CD012841-sec-0075"> <h5 class="title">Healing as dichotomous data ('high healing' versus 'low healing' chronic wounds)</h5> <p>Two studies including 95 participants examined the association of protease levels with 'high healing' versus 'low healing' chronic wounds (<a href="./references#CD012841-bbs2-0015" title="SerraR , BuffoneG , FalconeD , MolinariV , ScaramuzzinoM , GallelliL , et al. Chronic venous leg ulcers are associated with high levels of metalloproteinases‐9 and neutrophil gelatinase‐associated lipocalin. Wound Repair and Regeneration2013;21(3):395‐401. ">Serra 2013</a>; <a href="./references#CD012841-bbs2-0016" title="SerraR , GallelliL , BuffoneG , MolinariV , StillitanoDM , PalmieriC , et al. Doxycycline speeds up healing of chronic venous ulcers. International Wound Journal2015;12(2):179‐84. ">Serra 2015a</a>/<a href="./references#CD012841-bbs2-0017" title="SerraR , GallelliL , BuffoneG , MolinariV , StillitanoDM , PalmieriC , et al. Doxycycline speeds up healing of chronic venous ulcers. International Wound Journal2015;12(2):179‐84. ">Serra 2015b</a>). Both studies defined 'high healing' wounds as those that had a change in wound size of 1 cm²/week or greater and 'low healing' wounds as those that had a change in wound size of less than 1 cm²/week. Findings are shown on a forest plot (<a href="./references#CD012841-fig-0009" title="">Analysis 1.2</a>; <a href="#CD012841-fig-0005">Figure 5</a>). It was very uncertain whether there was a difference in protease activity between high‐ and low‐healing wounds. </p> <div class="figure" id="CD012841-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Protease activity continuous, outcome: 1.2 t‐test association of protease level and healing: high (≥ 1 cm²/week) versus low (&lt; 1 cm²/week) healing." data-id="CD012841-fig-0005" src="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/image_n/nCD012841-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Protease activity continuous, outcome: 1.2 t‐test association of protease level and healing: high (≥ 1 cm²/week) versus low (&lt; 1 cm²/week) healing. </p> </div> </div> </div> </section> <section id="CD012841-sec-0076"> <h5 class="title">Healing as continuous data</h5> <p>Three studies including 122 participants reported (or provided IPD to allow calculation of) correlation coefficients between protease levels and reduction or percentage reduction in ulcer size (i.e. healing); a positive correlation meant that as protease levels increased, the reduction in ulcer size increased (i.e. <i>more</i> healing) (<a href="./references#CD012841-bbs2-0004" title="GohelMS , WindhaberRA , TarltonJF , WhymanMR , PoskittKR . The relationship between cytokine concentrations and wound healing in chronic venous ulceration. Journal of Vascular Surgery2008;48(5):1272‐7. ">Gohel 2008</a>; <a href="./references#CD012841-bbs2-0007" title="HoffmanR , NobleJ , EagleM . The use of proteases as prognostic markers for the healing of venous leg ulcers. Journal of Wound Care1999;8(6):273‐6. ">Hoffman 1999</a>; <a href="./references#CD012841-bbs2-0010" title="McDanielJC , SzalachaL , SalesM , RoyS , ChafeeS , ParinandiN . EPA + DHA supplementation reduces PMN activation in microenvironment of chronic venous leg ulcers: a randomized, double‐blind, controlled study. Wound Repair and Regeneration2017;25(4):680‐90. ">McDaniel 2017</a>). </p> <p>Results for all studies were represented on a forest plot, even though one had no numerical data (<a href="./references#CD012841-fig-0010" title="">Analysis 1.3</a>; <a href="#CD012841-fig-0006">Figure 6</a>). <a href="./references#CD012841-bbs2-0004" title="GohelMS , WindhaberRA , TarltonJF , WhymanMR , PoskittKR . The relationship between cytokine concentrations and wound healing in chronic venous ulceration. Journal of Vascular Surgery2008;48(5):1272‐7. ">Gohel 2008</a> reported narratively that there was "no relationship" between the initial levels (of proteases) and subsequent healing at five weeks (negative, but non‐significant correlation coefficients were reported for the change in protease levels versus the change in ulcer size between zero and five weeks, but these were cross‐sectional data only and therefore ineligible). <a href="./references#CD012841-bbs2-0010" title="McDanielJC , SzalachaL , SalesM , RoyS , ChafeeS , ParinandiN . EPA + DHA supplementation reduces PMN activation in microenvironment of chronic venous leg ulcers: a randomized, double‐blind, controlled study. Wound Repair and Regeneration2017;25(4):680‐90. ">McDaniel 2017</a>, although measuring protease levels at baseline, only reported correlations between protease levels at four weeks and the percentage reduction in ulcer size between baseline and eight weeks; this study reported results for both arms of the RCT combined. <a href="./references#CD012841-bbs2-0007" title="HoffmanR , NobleJ , EagleM . The use of proteases as prognostic markers for the healing of venous leg ulcers. Journal of Wound Care1999;8(6):273‐6. ">Hoffman 1999</a> reported IPD for the seven participants included (four‐week protease levels and percentage reduction in size at 36 weeks). One of these data points appeared to be an outlier and we calculated the Pearson correlation coefficient and plotted a graph both with and without this outlier. This gave very different correlation coefficients (albeit with very wide CIs), and was thus an unstable finding; results from both calculations are shown on the forest plot. The evidence across all studies was of very low certainty showing wide CIs, high risk of bias and some inconsistency. <a href="./references#CD012841-bbs2-0004" title="GohelMS , WindhaberRA , TarltonJF , WhymanMR , PoskittKR . The relationship between cytokine concentrations and wound healing in chronic venous ulceration. Journal of Vascular Surgery2008;48(5):1272‐7. ">Gohel 2008</a> also reported pro‐MMP levels, so was likely to represent indirect evidence for protease activity and <a href="./references#CD012841-bbs2-0010" title="McDanielJC , SzalachaL , SalesM , RoyS , ChafeeS , ParinandiN . EPA + DHA supplementation reduces PMN activation in microenvironment of chronic venous leg ulcers: a randomized, double‐blind, controlled study. Wound Repair and Regeneration2017;25(4):680‐90. ">McDaniel 2017</a> had, in effect, a very short follow‐up, and combined results for different intervention arms. It was possible that there was a difference in correlation coefficients for MMP‐8 and HNE in one study (<a href="./references#CD012841-bbs2-0010" title="McDanielJC , SzalachaL , SalesM , RoyS , ChafeeS , ParinandiN . EPA + DHA supplementation reduces PMN activation in microenvironment of chronic venous leg ulcers: a randomized, double‐blind, controlled study. Wound Repair and Regeneration2017;25(4):680‐90. ">McDaniel 2017</a>), negative for MMP‐8 and no correlation for HNE, but the evidence was very uncertain. </p> <div class="figure" id="CD012841-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Protease activity continuous, outcome: 1.3 Correlation coefficients: protease levels and change in size." data-id="CD012841-fig-0006" src="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/image_n/nCD012841-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Protease activity continuous, outcome: 1.3 Correlation coefficients: protease levels and change in size. </p> </div> </div> </div> </section> </section> <section id="CD012841-sec-0077"> <h4 class="title">Associations of protease activity (dichotomous data) with healing and partial healing</h4> <p>Two studies (three cohorts) including 164 participants allowed calculation of an RR for the univariate association of elevated protease activity with healing: <a href="./references#CD012841-bbs2-0011" title="MoffattCJ , StantonJ , MurrayS , DoodyV , DavisPJ , FranksPJ . A randomised trial to compare the performance of Oxyzyme and Iodozyme with standard care in the treatment of patients with venous and mixed venous/arterial ulceration. Wound Medicine2014;6:1‐10. ">Moffatt 2014a</a>/<a href="./references#CD012841-bbs2-0012" title="MoffattCJ , StantonJ , MurrayS , DoodyV , DavisPJ , FranksPJ . A randomised trial to compare the performance of Oxyzyme and Iodozyme with standard care in the treatment of patients with venous and mixed venous/arterial ulceration. Wound Medicine2014;6:1‐10. ">Moffatt 2014b</a> reported complete healing at 12 weeks and <a href="./references#CD012841-bbs2-0002" title="CullenB , GibsonM , NisbetL . Targeted use of collagen/ORC improves clinical outcomes. Wound Repair and Regeneration2012;20(5):A93. ">Cullen 2012</a> defined healing as at least 30% reduction in area over four weeks. We did not pool the data because of the difference in healing definition, but show the results on the forest plot (<a href="./references#CD012841-fig-0011" title="">Analysis 2.1</a>; <a href="#CD012841-fig-0007">Figure 7</a>), grouped according to the interventions: <a href="./references#CD012841-bbs2-0002" title="CullenB , GibsonM , NisbetL . Targeted use of collagen/ORC improves clinical outcomes. Wound Repair and Regeneration2012;20(5):A93. ">Cullen 2012</a> gave all participants an 'established' protease modulating matrix dressing (collagen/ORC with or without silver); in the intervention arm <a href="./references#CD012841-bbs2-0011" title="MoffattCJ , StantonJ , MurrayS , DoodyV , DavisPJ , FranksPJ . A randomised trial to compare the performance of Oxyzyme and Iodozyme with standard care in the treatment of patients with venous and mixed venous/arterial ulceration. Wound Medicine2014;6:1‐10. ">Moffatt 2014a</a> participants received oxyzyme/iodozyme treatment, which was postulated to be protease modulating. In the control group of <a href="./references#CD012841-bbs2-0012" title="MoffattCJ , StantonJ , MurrayS , DoodyV , DavisPJ , FranksPJ . A randomised trial to compare the performance of Oxyzyme and Iodozyme with standard care in the treatment of patients with venous and mixed venous/arterial ulceration. Wound Medicine2014;6:1‐10. ">Moffatt 2014b</a> the treatment was not protease modulating. </p> <div class="figure" id="CD012841-fig-0007"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 7</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 2 Protease activity dichotomous, outcome: 2.1 Association of healing with elevated protease level; by protease modulating (PM) intervention." data-id="CD012841-fig-0007" src="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/image_n/nCD012841-AFig-FIG07.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 2 Protease activity dichotomous, outcome: 2.1 Association of healing with elevated protease level; by protease modulating (PM) intervention. </p> </div> </div> </div> <p>There was a <i>positive</i> association between elevated protease levels and healing in <a href="./references#CD012841-bbs2-0002" title="CullenB , GibsonM , NisbetL . Targeted use of collagen/ORC improves clinical outcomes. Wound Repair and Regeneration2012;20(5):A93. ">Cullen 2012</a> and an indication of a negative (expected) association in the usual care group of <a href="./references#CD012841-bbs2-0012" title="MoffattCJ , StantonJ , MurrayS , DoodyV , DavisPJ , FranksPJ . A randomised trial to compare the performance of Oxyzyme and Iodozyme with standard care in the treatment of patients with venous and mixed venous/arterial ulceration. Wound Medicine2014;6:1‐10. ">Moffatt 2014b</a>. Such a trend might be explained by interactions between the protease‐modulating treatment and protease levels. In non‐healing wounds with elevated protease levels, the protease‐modulating treatment may have selectively activated the healing process by removing excess protease, but in non‐healing wounds with normal protease levels, the causes of non‐healing will have been different and may not have been affected by protease‐modulating treatments. However, given the very low certainty of the evidence, there are other biases or confounding factors that may also explain any trend, including the nature and timing of action of the different proteases. </p> </section> <section id="CD012841-sec-0078"> <h4 class="title">Certainty of the evidence (GRADE)</h4> <p>All the evidence was of very low certainty: the exploratory study design meant the GRADE rating started as moderate‐certainty evidence (<a href="./appendices#CD012841-sec-0125">Appendix 4</a>), and all studies except <a href="./references#CD012841-bbs2-0013" title="MwauraB , MahendranB , HynesN , DefreitasD , AvalosG , AdegbolaT , et al. The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase‐2, tissue inhibitor of matrix metalloproteinase‐2 and PDGF‐AA on the chronicity of venous leg ulcers. European Journal of Vascular and Endovascular Surgery2006;31(3):306‐10. ">Mwaura 2006</a> were at overall high risk of bias (high risk of bias for at least two domains) and so the evidence certainty was downgraded by two more levels, taking the rating to very low certainty. There was also imprecision in the findings and some inconsistency. Furthermore, we considered it likely that in these small observational studies the possible biases and confounding factors would have a large impact on the results, so limiting their reliability even more. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD012841-sec-0079" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD012841-sec-0079"></div> <section id="CD012841-sec-0080"> <h3 class="title" id="CD012841-sec-0080">Summary of findings</h3> <p>It was uncertain whether protease activity was a prognostic factor for wound healing in people with VLUs because the certainty of the evidence was very low. Of the 21 cohorts found from extensive searching, only 13 (522 participants) had data available for analysis. Of these 13 cohorts, none reported the time‐to‐healing outcome and only two recorded the proportion of people with ulcers completely healed, with other studies recording partial healing measures (such as 1 cm²/week or greater decrease in size) or change in ulcer size. There was marked clinical and methodological heterogeneity across studies, which precluded meta‐analysis and made narrative summary difficult. This heterogeneity included differences in the definition of healing, the type of protease and its measurement, the distribution of active and bound protease species, the types of treatment and the reporting of results. No study conducted multivariable analysis or provided IPD to allow us to do so, and all the included evidence was of very low certainty. This should be interpreted as complete uncertainty of the role of protease activity in venous ulcer healing rather than evidence of no association. No reliance can be placed on the validity of the findings. </p> <p>However, this review can provide important insights for future research on the potential prognostic factors in wound healing generally and of the value of proteases for venous ulcer healing specifically. We also hope that this review presents an exemplar for future systematic reviews of biomarkers as prognostic factors in wound healing and allows reflection on the current clinical context of protease‐modulating dressing use. We enlarge on these aspects below. </p> </section> <section id="CD012841-sec-0081"> <h3 class="title" id="CD012841-sec-0081">Considerations for further prognosis research</h3> <p>The review was unable to answer the question of whether protease activity was an independent prognostic factor for the healing of VLUs. The review highlighted the heterogeneous nature of protease activity reporting, a lack of standardisation of protease measurement and a lack of standardisation of how the healing outcome was defined and measured. Proteases may have a role in defining the status of a chronic wound, but the limitations in study reporting mean that it is impossible to draw a robust conclusion about the role of proteases as biomarkers for leg ulcer healing. This remains an important question, and there is a need for well‐conducted, further research. Therefore, we propose a large prognostic factor research study that employs an appropriate study design and analytical approach, uses advanced methods for measuring protease activity, and takes account of confounding factors and treatments in its analysis. The following elements are important: study design, protease measurement and appropriate analysis. </p> <section id="CD012841-sec-0082"> <h4 class="title">Study design</h4> <p>A large prospective cohort study with adequate follow‐up times to measure complete healing as time‐to‐event is a minimum requirement for new primary prognosis studies in this field. </p> </section> <section id="CD012841-sec-0083"> <h4 class="title">Protease measurement</h4> <p>The type of proteases should be selected carefully and advanced protease activity measurement methods should be used to allow investigation of specific proteases and focus on the active form of the enzymes, rather than protease bound to other molecules or surfaces. </p> <p>The measurement of proteases has evolved over time and continues to evolve, and the studies in this review used numerous techniques ranging from radiolabelled collagen breakdown, to zymograms, ELISAs, Western blots and fluorogenic substrates. These tests have now been superseded by more advanced protein evaluations, which should be used in future research. </p> <p>It is also important to consider the type of proteases that would be measured in future research. Proteases have many different biological functions and activity of one protease does not necessarily provide a complete wound signature that relates to the wound phenotype. For example, specific MMPs such as MMP‐2 and MMP‐9 have a particular role in type IV and V collagen proteolysis, but this varies according to the study or clinical context. In addition, the different temporal and spatial location of proteases in the wound will depend on which phase of healing (coagulation, inflammation, proliferation, synthesis, remodelling) or how inflamed or infected the tissue is, hence the value of proteases as simple biomarkers may be limited. This would suggest a whole‐system approach to future research, that, as a minimum, takes into account combinations of proteases and time‐dependent effects, but preferably also considers demographics, comorbidities, wound duration, location and bioburden as possible confounding or interacting factors, which in turn could allow investigation of mechanisms of wound healing. </p> </section> <section id="CD012841-sec-0084"> <h4 class="title">Appropriate analysis</h4> <p>A future study should use multivariable analysis of survival data, with continuous factors analysed on their continuous scale, and potential non‐linear relationships also considered. The study should be sufficiently powered to take account of adjusting factors (<a href="./references#CD012841-bbs2-0185" title="KnofczynskiGT , MundfromD . Sample sizes when using multiple linear regression for prediction. Educational and Psychological Measurement2008;68(3):431‐42. ">Knofczynski 2008</a>). IPD meta‐analyses may be needed to standardise definitions and reduce heterogeneity across studies. </p> <p>Finally, there may be interactions between protease levels and protease‐modulating treatments, which distort any associations being studied. Future studies should take interactions into consideration in the analyses. </p> </section> </section> <section id="CD012841-sec-0085"> <h3 class="title" id="CD012841-sec-0085">Considerations for prognosis reviews in wound care</h3> <p>In the context of systematic reviews of biomarker prognostic factor studies in wounds, serious consideration should be given to restricting the reviews to well‐conducted studies with multivariable analyses, and identifying the ensuing evidence gaps separately. </p> </section> <section id="CD012841-sec-0086"> <h3 class="title" id="CD012841-sec-0086">Current clinical context</h3> <p>In the current clinical context, a number of protease‐modulating dressings have been marketed and are used, based on very limited research that postulates that reducing protease activity could promote healing and that timing may also be important (<a href="./references#CD012841-bbs2-0170" title="HardingK , ArmstrongDG , BarrettS , KaufmanH , Lázaro‐MartínezJL , MayerD , et al. International consensus. The role of proteases in wound diagnostics: an expert working group review. Wounds International 2011. woundchek.com/uploads/downloads/consensus_documents/Role‐of‐proteases‐in‐wound‐diagnostics‐International.pdf (accessed 31 January 2018). ">Harding 2011</a>; <a href="./references#CD012841-bbs2-0076" title="McCartySM , PercivalSL . Proteases and delayed wound healing. Advances in Wound Care2013;2(8):438‐47. ">McCarty 2013</a>). We have shown in this review that the evidence for protease biomarkers being prognostic for ulcer healing is of very low certainty. We have also shown in our PMM intervention review that it is unclear whether PMM dressings are more effective than other dressings in healing VLUs (<a href="./references#CD012841-bbs2-0242" title="WestbyMJ , NormanG , DumvilleJC , StubbsN , CullumN . Protease‐modulating matrix treatments for healing venous leg ulcers. Cochrane Database of Systematic Reviews2016, Issue 12. [DOI: 10.1002/14651858.CD011918.pub2] ">Westby 2016</a>). There is currently no study evidence on the effectiveness of a test‐and‐treat strategy, in which VLUs with elevated levels of protease are selectively treated with PMM dressings (<a href="./references#CD012841-bbs2-0205" title="NormanG , WestbyMJ , StubbsN , DumvilleJC , CullumN . A 'test and treat' strategy for elevated wound protease activity for healing in venous leg ulcers. Cochrane Database of Systematic Reviews2016, Issue 1. [DOI: 10.1002/14651858.CD011753] ">Norman 2016</a>). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD012841-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/urn:x-wiley:14651858:media:CD012841:CD012841-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/image_t/tCD012841-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD012841-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/image_n/nCD012841-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/full#CD012841-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/image_n/nCD012841-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012841-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/urn:x-wiley:14651858:media:CD012841:CD012841-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/image_t/tCD012841-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies with results. Studies without useable results do not have risk of bias assessments, and these appear blank." data-id="CD012841-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/image_n/nCD012841-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies with results. Studies without useable results do not have risk of bias assessments, and these appear blank. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/full#CD012841-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/image_n/nCD012841-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012841-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/urn:x-wiley:14651858:media:CD012841:CD012841-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/image_t/tCD012841-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study with results. Studies without useable results do not have risk of bias assessments, and these appear blank." data-id="CD012841-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/image_n/nCD012841-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study with results. Studies without useable results do not have risk of bias assessments, and these appear blank. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/full#CD012841-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/image_n/nCD012841-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012841-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/urn:x-wiley:14651858:media:CD012841:CD012841-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/image_t/tCD012841-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Protease activity continuous, outcome: 1.1 t‐test assocation of protease level and healing (dichotomous)." data-id="CD012841-fig-0004" src="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/image_n/nCD012841-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Protease activity continuous, outcome: 1.1 t‐test assocation of protease level and healing (dichotomous). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/full#CD012841-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/image_n/nCD012841-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012841-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/urn:x-wiley:14651858:media:CD012841:CD012841-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/image_t/tCD012841-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Protease activity continuous, outcome: 1.2 t‐test association of protease level and healing: high (≥ 1 cm²/week) versus low (&lt; 1 cm²/week) healing." data-id="CD012841-fig-0005" src="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/image_n/nCD012841-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Protease activity continuous, outcome: 1.2 t‐test association of protease level and healing: high (≥ 1 cm²/week) versus low (&lt; 1 cm²/week) healing. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/full#CD012841-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/image_n/nCD012841-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012841-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/urn:x-wiley:14651858:media:CD012841:CD012841-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/image_t/tCD012841-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Protease activity continuous, outcome: 1.3 Correlation coefficients: protease levels and change in size." data-id="CD012841-fig-0006" src="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/image_n/nCD012841-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Protease activity continuous, outcome: 1.3 Correlation coefficients: protease levels and change in size. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/full#CD012841-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/image_n/nCD012841-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012841-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/urn:x-wiley:14651858:media:CD012841:CD012841-AFig-FIG07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/image_t/tCD012841-AFig-FIG07.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 2 Protease activity dichotomous, outcome: 2.1 Association of healing with elevated protease level; by protease modulating (PM) intervention." data-id="CD012841-fig-0007" src="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/image_n/nCD012841-AFig-FIG07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 7</div> <div class="figure-caption"> <p>Forest plot of comparison: 2 Protease activity dichotomous, outcome: 2.1 Association of healing with elevated protease level; by protease modulating (PM) intervention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/full#CD012841-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/image_n/nCD012841-AFig-FIG07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012841-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/urn:x-wiley:14651858:media:CD012841:CD012841-AFig-FIG08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/image_t/tCD012841-AFig-FIG08.png" target="_blank"><b></b></a></p> </div><img alt="Prognostic factors for healing venous leg ulcers: participant characteristics. HR = hazard ratio; OR = odds ratio" data-id="CD012841-fig-0012" src="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/image_n/nCD012841-AFig-FIG08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 8</div> <div class="figure-caption"> <p>Prognostic factors for healing venous leg ulcers: participant characteristics. HR = hazard ratio; OR = odds ratio </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/appendices#CD012841-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/image_n/nCD012841-AFig-FIG08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012841-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/urn:x-wiley:14651858:media:CD012841:CD012841-AFig-FIG09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/image_t/tCD012841-AFig-FIG09.png" target="_blank"><b></b></a></p> </div><img alt="Prognostic factors for venous leg ulcer healing: wound characteristics 1. HR = hazard ratio; OR = odds ratio" data-id="CD012841-fig-0013" src="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/image_n/nCD012841-AFig-FIG09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 9</div> <div class="figure-caption"> <p>Prognostic factors for venous leg ulcer healing: wound characteristics 1. HR = hazard ratio; OR = odds ratio </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/appendices#CD012841-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/image_n/nCD012841-AFig-FIG09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012841-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/urn:x-wiley:14651858:media:CD012841:CD012841-AFig-FIG10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/image_t/tCD012841-AFig-FIG10.png" target="_blank"><b></b></a></p> </div><img alt="Prognostic factors for VLU healing: wound characteristics 2. HR = hazard ratio; OR = odds ratio" data-id="CD012841-fig-0014" src="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/image_n/nCD012841-AFig-FIG10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 10</div> <div class="figure-caption"> <p>Prognostic factors for VLU healing: wound characteristics 2. HR = hazard ratio; OR = odds ratio </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/appendices#CD012841-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/image_n/nCD012841-AFig-FIG10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012841-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/urn:x-wiley:14651858:media:CD012841:CD012841-AFig-FIG11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/image_t/tCD012841-AFig-FIG11.png" target="_blank"><b></b></a></p> </div><img alt="Prognostic factors for VLU healing: number of ulcers" data-id="CD012841-fig-0015" src="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/image_n/nCD012841-AFig-FIG11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 11</div> <div class="figure-caption"> <p>Prognostic factors for VLU healing: number of ulcers</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/appendices#CD012841-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/image_n/nCD012841-AFig-FIG11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012841-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/urn:x-wiley:14651858:media:CD012841:CD012841-AFig-FIG12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/image_t/tCD012841-AFig-FIG12.png" target="_blank"><b></b></a></p> </div><img alt="Prognostic factors for venous leg ulcer healing: mobility and ankle flexion. HR = hazard ratio; OR = odds ratio" data-id="CD012841-fig-0016" src="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/image_n/nCD012841-AFig-FIG12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 12</div> <div class="figure-caption"> <p>Prognostic factors for venous leg ulcer healing: mobility and ankle flexion. HR = hazard ratio; OR = odds ratio </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/appendices#CD012841-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/image_n/nCD012841-AFig-FIG12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012841-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/urn:x-wiley:14651858:media:CD012841:CD012841-AFig-FIG13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/image_t/tCD012841-AFig-FIG13.png" target="_blank"><b></b></a></p> </div><img alt="Prognostic factors for venous leg ulcer healing: bacteria and infection. HR = hazard ratio; OR = odds ratio; RR = risk ratio" data-id="CD012841-fig-0017" src="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/image_n/nCD012841-AFig-FIG13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 13</div> <div class="figure-caption"> <p>Prognostic factors for venous leg ulcer healing: bacteria and infection. HR = hazard ratio; OR = odds ratio; RR = risk ratio </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/appendices#CD012841-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/image_n/nCD012841-AFig-FIG13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012841-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/urn:x-wiley:14651858:media:CD012841:CD012841-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/image_t/tCD012841-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Protease activity continuous, Outcome 1 t‐test assocation of protease level and healing (dichotomous)." data-id="CD012841-fig-0008" src="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/image_n/nCD012841-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Protease activity continuous, Outcome 1 t‐test assocation of protease level and healing (dichotomous). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/references#CD012841-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/image_n/nCD012841-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012841-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/urn:x-wiley:14651858:media:CD012841:CD012841-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/image_t/tCD012841-CMP-001-02.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Protease activity continuous, Outcome 2 t‐test association of protease level and healing: high (≥ 1 cm²/week) vs low (&lt; 1 cm²/week) healing." data-id="CD012841-fig-0009" src="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/image_n/nCD012841-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Protease activity continuous, Outcome 2 t‐test association of protease level and healing: high (≥ 1 cm²/week) vs low (&lt; 1 cm²/week) healing. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/references#CD012841-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/image_n/nCD012841-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012841-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/urn:x-wiley:14651858:media:CD012841:CD012841-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/image_t/tCD012841-CMP-001-03.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Protease activity continuous, Outcome 3 Correlation coefficients: protease levels and change in size." data-id="CD012841-fig-0010" src="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/image_n/nCD012841-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Protease activity continuous, Outcome 3 Correlation coefficients: protease levels and change in size. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/references#CD012841-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/image_n/nCD012841-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012841-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/urn:x-wiley:14651858:media:CD012841:CD012841-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/image_t/tCD012841-CMP-002-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Protease activity dichotomous, Outcome 1 Association of healing with elevated protease level; by protease modulating (PM) intervention." data-id="CD012841-fig-0011" src="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/image_n/nCD012841-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Protease activity dichotomous, Outcome 1 Association of healing with elevated protease level; by protease modulating (PM) intervention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/references#CD012841-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/media/CDSR/CD012841/image_n/nCD012841-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="comparison" data-id="CD012841-tbl-0001"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Protease activity continuous</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 t‐test assocation of protease level and healing (dichotomous) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Completely healed vs non‐healed</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Degrading MMPs: (gelatinases/metalloelastase) healing vs non‐healing</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Reparative MMPs: (collagenases/matrilysin) healing vs non‐healing</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 t‐test association of protease level and healing: high (≥ 1 cm²/week) vs low (&lt; 1 cm²/week) healing <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 With doxycycline treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 With standard care treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Treatment not reported (other than compression)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Correlation coefficients: protease levels and change in size <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Correlation coefficient (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Change in MMP‐2 level vs reduction in ulcer size</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Correlation coefficient (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Change in MMP‐9 level vs reduction in ulcer size</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Correlation coefficient (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 MMP‐8 level at 4 weeks vs % reduction in size at 8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Correlation coefficient (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4 Elastase level at 4 weeks vs % reduction in size at 8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Correlation coefficient (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.5 Elastase at 4 weeks vs % change in size at 9 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Correlation coefficient (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Protease activity continuous</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/references#CD012841-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012841-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Protease activity dichotomous</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Association of healing with elevated protease level; by protease modulating (PM) intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Elastase &gt; 25 mU/100 μL vs ≤ 25 mU/100 μL + PM intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 MMP (unspecified) level ≥ 5 (0‐10 scale) vs &lt; 5 + possible PM intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 MMP (unspecified) level ≥ 5 (0‐10 scale) vs &lt; 5 + non‐PM intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Protease activity dichotomous</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012841.pub2/references#CD012841-tbl-0002">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD012841.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD012841-note-0003">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD012841-note-0005">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD012841-note-0002">Français</a> </li> <li class="section-language"> <a class="" href="ms#CD012841-note-0004">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="ru#CD012841-note-0001">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD012841-note-0007">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br/> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012841\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012841\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012841\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012841\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012841\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012841\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012841\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012841\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012841\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012841\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012841\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012841\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012841\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012841\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012841\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012841\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012841\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012841\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=FKeXZrqu&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012841.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012841.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD012841.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD012841.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012841.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740727233493"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012841.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740727233500"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012841.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ea707c9ef9365',t:'MTc0MDcyNzIzMy4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 